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The baculovirus Autographa californica nucleopolyhedrovirus (AcNPV) has two 
viral forms, budded virus (BV) and occlusion derived virus (ODV).  The envelopment of 
these two viral forms occurs at different locations:  BV acquires envelopes at the plasma 
membrane while ODV acquires envelopes in the nucleus.  The two viral forms carry out 
different functions in the viral life cycle.  The purpose of this study is to investigate how 
viral envelope proteins sort/traffic to the nucleus.  Of particular interest is BV/ODV E26 
(E26).  E26 is an envelope protein of both BV and ODV (Braunagel and Summers, 
1994); therefore it must traffic to the plasma membrane and the nucleus during infection.  
Thus, E26 is a bi-directional trafficking protein, which interacts with membranes in both 
locations of the cell.  As such it has been shown that there are several immunoreactive 
forms of E26 (Beniya, Braunagel, and Summers, 1998).  The da26 gene produces at 
least 2 protein products of 26 and 28 kDa with different functions respectively, which 
correlate with localization, solubility, membrane association, and temporal requirements.  
The 28 kDa form is likely a soluble protein that interacts with transcriptional activators 
and DNA in the nucleus in the early stages of infection.  A part of the 26 kDa population 
is a membrane bound form interacting with an integral membrane protein in the ER and 
likely functions as an INM sorting factor.  The 26 kDa membrane bond form is also 
found in the inner nuclear membrane, intra-nuclear microvesicles, ODV envelopes, and 
ODV in the nucleus.   
 
 






First, I would like to thank Dr. Max Summers and Dr. Sharon Braunagel for their 
support, insight, and the guidance during my Ph.D. program.  Their input has been 
invaluable and I have learned more from them than how to perform, record, and publish 
an experiment, specifically for supporting my interest in confocal microscopy.  Without 
that support I am not sure I would have ever discovered I have that particular interest.  I 
have been a member of the Summers’ lab for quite some time as an employee and finally 
as a student and have enjoyed the research, professional relationships, and friendships. 
I would like to thank the many individuals that have served on my committee for 
their time and insightful criticism including Dr. Hagan Bayley, Dr. Efthimios Skoulakis, 
Dr. Bruce Riley, Dr. Andreas Holzenburg, and Dr. Patricia Pietrantonio.   Thank you all.   
I would also like to acknowledge several members of the Summers’ lab who have 
come and gone during my time, specifically, Dr. Shawn Williamson and Susan 
Williamson, Dr. German Rosas-Acosta, Dr. Qi Ding, and Dr. Zhenping Zhong.  These 
individuals offered help, input, and sometimes just a friendly face that bolstered my 
spirits during tenuous times.  There are many other members of the lab, too numerous to 
list, whom I would like to thank for their friendship.  Thank you all. 
I would like to thank my family, both the Burks and Neely clans for their support.  I 
would like to specifically thank my parents, Roy and Karen Burks, for their support and 
love.  More specifically I would like to thank my parents for always telling me I can do 
anything and believing me when I told them I was going to do it.  I would like to thank 
my sisters, Audra, Dana, and Megan for their support.  I would like to thank my family 
for never again asking the ever present question, “Are you finished yet?”   
Finally, I would like to thank my wife, Amber, whom I met, fell in love with, and 
married during the course of my Ph.D. program.  I can say with full confidence that I 
would never have finished without her.  She gave me strength, support, hope, and love.  
She helped me celebrate my success and learn from my failure.  I am ever grateful to 
have her in my life.     




TABLE OF CONTENTS 
   Page 
ABSTRACT ..............................................................................................................       iii 
ACKNOWLEDGEMENTS .....................................................................................       iv 
TABLE OF CONTENTS .........................................................................................        v 
LIST OF TABLES ...................................................................................................     viii 
LIST OF FIGURES ..................................................................................................        x 
INTRODUCTION ....................................................................................................      1 
 1  Project Overview.......................................................................................      1 
  1.1  Baculovirus - Viral Classification .............................................  1 
  1.2  Viral Infection Cycle .................................................................  2 
  1.3  Virus Structure ..........................................................................  5 
   1.3.1  BV Envelope ..............................................................  6 
   1.3.2  ODV Envelope ...........................................................  7 
  1.4  Gene Expression and Viral DNA Replication ...........................  9 
  1.5  BV/ODV E26 ............................................................................  12 
   1.5.1  BV/ODV E26 Literature ............................................  13 
  1.5.2  The Model for BV/ODV E26......................................  17 
 2  Study Relevance and Specific Aims ........................................................  17 
 3  Structure and Function of the Nucleus .....................................................  20 
  3.1  Nuclear Envelope (NE) .............................................................  20 
   3.1.1  Outer Nuclear Membrane ...........................................  21 
   3.1.2  Nuclear Envelope Lumen ...........................................  21 
  3.1.3  Inner Nuclear Membrane ...........................................  21 
 3.2  Nuclear Pore Complex (NPC) ...................................................  25 
4  Nuclear Protein Trafficking .....................................................................  28 
 4.1  Soluble Protein Nuclear Trafficking .........................................  28 
 4.2  Membrane Protein Trafficking ..................................................  32 
 4.2.1  Membrane Associated Protein (Peripheral) Nuclear 
Trafficking ......................................................................  35 
   4.2.2  Integral Membrane Protein Nuclear Trafficking ........  39 
MATERIALS AND METHODS .............................................................................  42 
1  Cells and viruses .......................................................................................  42 
 1.1  Cloning Techniques ...................................................................  42 




   Page 
 1.2  Cloning Strategies ......................................................................  42 
 1.3  Cloning Strategies for Construction of Mutant Viruses ............  43 
  1.3.1  Strategy One:  Knockout .............................................  43 
   1.3.2  Strategy Two:  Insertion of Second Gene  
    Copy with Promoter....................................................  47 
   1.3.3  Strategy Three:  Polyhedrin (Polh) Promoter..............  62  
  1.4  Cloning Strategies for in vitro Translation and Transient  
   Expression .................................................................................  65 
 1.5  Cloning Strategies for Antibody Production..............................  71 
  1.6  Cloning Strategies for Yeast Two Hybrid Direct Cross Studies  72 
2  Recombinant Virus Production ................................................................  72 
 2.1  Previously Published Recombinant Viruses .............................  74 
3  Antibody Production .................................................................................  75 
4  Transfection/Transient Expression............................................................  76 
5  SDS-Page and Western Analysis .............................................................  77 
6  Immuno-Confocal Microscopy ................................................................  77 
7  In vitro Transcription and Translation .....................................................  79 
 7.1  Salt Extraction of in vitro Translated Proteins ...........................  80 
8  Primer Extension Analysis .......................................................................  80 
9  Triton X-114 Detergent Extractions .........................................................  81 
10  Palmitoylation .........................................................................................  82 
11  MALDI-TOF Mass Spectrometry...........................................................  83 
RESULTS .................................................................................................................  84 
1  Recombinant Virus Production.................................................................  84 
2  Multiple Forms of BV/ODV E26 .............................................................  84 
3  BV/ODV E26 Membrane Association .....................................................  93 
4  BV/ODV E26 Localization ......................................................................  105 
DISCUSSION  .........................................................................................................  114 
1  The da26 Gene Produces Multiple Protein Products during Infection ....  114 
 2  BV/ODV E26 Exists in Soluble and Peripheral Membrane Protein Forms  117 
3 BV/ODV E26 is a Soluble and Peripheral Membrane Protein of the  
 Nucleus.....................................................................................................   120 
 
SUMMARY .............................................................................................................  125 
1  The Model:  BV/ODV E26 Functions as Both a Soluble and a Membrane  
Protein during Infection .........................................................................  125 
 





REFERENCES .........................................................................................................  128 
APPENDIX  A PRELIMINARY OR INCOMPLETE DATA..................................  143 
APPENDIX  B CLONE MAPS .................................................................................  148 
VITA ........................................................................................................................  218 




LIST OF TABLES 
TABLE                           Page 
 1 Oligonucleotides used for two stage PCR deletion of the da26  
  gene and insertion of a new multiple cloning site into  
  pUC18/PSTI-G..................................................................................  45 
 2 Oligonucleotides used for PCR amplification of the  
 homologous recombination regions and multiple cloning site  
 generation for EcoRV-MCS vector ..................................................  47 
 3 Oligonucleotides used for the creation of unique multiple cloning 
 sites were inserted into pUC18 ........................................................  50 
 4 Oligonucleotides used for creation of an epitope region, which 
 were inserted into pUC-JKB extended Kpn .....................................  51 
 5 Oligonucleotides used for PCR amplification of the da26 gene  
 promoter region and insertion into pUC-JKB-Tag vector ...............  53 
 6 Oligonucleotides used in PCR amplification cloning strategies  
 for the generation of E26 domains and the insertion of those  
 domains into pUC-JKB-pE26-Tag ...................................................  56 
 7 Oligonucleotides used for insertion of MCS into pBACgus-1 vector 63 
 8 Oligonucleotides used for insertion of T7 epitope into  
 pBACgus-E26 FL (NO T7 TAG) vector ..........................................  65 
 9 Oligonucleotides used for PCR amplification of the da26 gene and 
  insertion into pGEM3z/UTR ............................................................  66 
 10 Oligonucleotides used for PCR amplification of the da26 gene and  
 insertion into pUC19 ........................................................................  67 
 11 Oligonucleotides used for PCR amplification of the da26 gene and 
 insertion into pEGFP ........................................................................  68 
 12 Oligonucleotides used for PCR amplification of the da26 gene and 
 insertion into pIE1-4 ........................................................................  69 
 13 Oligonucleotides used for insertion of a new multiple cloning site  
 into pIE1-4 .......................................................................................  70 




TABLE                           Page 
 14 Oligonucleotides used for PCR amplification of the da26 gene and 
 insertion into pMAL-CRI..................................................................  71 
 15 Oligonucleotides used for PCR verification of recombinant virus 
 production ........................................................................................  74 
 16 Oligonucleotides used for primer extension experiments for the 
  identification of the da26 gene promoters ........................................  81 
 17 Tally of the attempts at regional domain recombinant virus  
 production .........................................................................................   84 
 18 MALDI-TOF identification of amino acid fragments from an 18  
 h p.i. cell extract separated on a 15% SDS-PAGE............................  87 
 19 Protein products of the da26 gene.....................................................  114 
 20 Triton X-114 fractionation of E26 in uninfected and infected cells .  117 









LIST OF FIGURES 
FIGURE                                                                    Page 
 1  Baculovirus maturation cycle ...........................................................  3 
 2 Virion structure and components localized in budded and occlusion 
 derived virus, the two phenotypes of baculovirus.............................  6 
 3 E26 amino acid sequence .................................................................  12 
 4 E26 homologues................................................................................  16 
 5 Nuclear envelope and pore structure ................................................  20 
 6 Illustration of the nuclear envelope ..................................................  24 
 7 Model of NPC architecture ...............................................................  26 
 8 Nuclear trafficking of ICP22, ICP0, and p60....................................  29 
 9 NLS mediated nuclear trafficking via importin protein complexes..  31 
 10 Cellular trafficking of CTP:CCT ......................................................  37 
 11 Sequential cloning of the BV/ODV E26 regional domains ..............  44 
 12 pEcoRV-MCS homologous recombination vector ..........................  47 
 13 Regional domains of BV/ODV E26..................................................  49 
 14 pUC-JKB and pUC-JKB extended Kpn vector maps ......................  50 
 15 pUC-JKB-Tag (A) and pUC-JKB-Tag2 (B) vector maps ................  53 
 16 pUC-JKB-pE26-Tag vector map ......................................................  54 
 17 Regional domain cloning strategies .................................................  55 
 18 E26 regional domain #1 in the homologous recombination vector .  56 
 19 E26 regional domain #2 in the homologous recombination vector .  57 
 20 E26 regional domain #3 in the homologous recombination vector .  58 




FIGURE                                                                    Page 
 21 E26 regional domain #1-2 in the homologous recombination vector  59 
 22 E26 regional domain #2-3 in the homologous recombination vector  60 
 23 E26 regional domain FL in the homologous recombination vector .  61 
 24  Temporal Time Course Western blot ...............................................  85 
 25 Temporal Time Course Western blot II ...........................................  86 
 26 Maldi-TOF analysis of an 18 h p.i. E2 infected total cell extract .....  87 
 27 Western blot of E26 from cells transiently expressing E26 and then 
 virally infected .................................................................................  88 
 28 Western blot of total cell extracts from cells infected with polh  
 E26-T7...............................................................................................  89 
 29 Primer extension................................................................................  91 
 30 Western blot of total cell extracts comparing αE26 7554, αOrf 8,  
 and α12500 antisera .........................................................................  93 
 31 Triton X-114 extraction of infected total cell extracts ......................  94 
 32 Triton X-114 extraction of polh E26-T7 infected total cell extracts.  95 
 33 Detection of palmitoylated E26 .......................................................  97 
 34 Baculovirus E26 homologues and the conserved cysteines .............  98 
 35 Triton X-114 extraction of uninfected total cell extracts .................  99 
 36 Triton X-114 extraction of cells transiently expressing E26-T7 and 
  cells that are transiently expressing E26-T7 that have then been  
 infected .............................................................................................  101 
 37 Salt extractions of in vitro translated E26 in the presence of canine 
  pancreatic microsomal membranes .................................................  103 
 38 Salt extractions of in vitro translated E26 in the presence of  
 uninfected and infected microsomal membranes .............................  104 




FIGURE                                                                    Page 
 39 Immunoconfocal micrographs of wild type infected Sf9 cells .........  106 
 40 Immunoconfocal micrographs of uninfected cells transiently  
 expressing the da26 gene and 24 and 48 h p.i. infected Sf9 cells ....  107 
 41 PCR analysis of the recombinant virus vDa26z................................  108 
 42 Triton X-114 extractions of Sf9 cells infected with vDA26z ...........  110 
 43 Localization of E26-βgal protein by immunoconfocal analysis of  
 cells infected with vDA26z ..............................................................  110 
 44 Regional domains used in transfection/infection studies of BV/ODV 
  E26 ....................................................................................................  111 
 45 Immunoconfocal micrographs of transfected/infected Sf9 cells  
 expressing epitope tagged; n-terminal 1-148 aa, c-terminal 71-225 
  aa, or full length E26.........................................................................  112 











1. Project Overview 
The baculovirus Autographa californica Nucleopolyhedrovirus (AcNPV) has two 
viral forms, budded virus (BV) and occlusion derived virus (ODV).  The envelopment of 
these two viral forms occurs at different locations:  BV acquires envelopes at the plasma 
membrane while ODV acquires envelopes in the nucleus.  The two viral forms carry out 
different functions in the viral life cycle.  The purpose of this study is to investigate how 
viral envelope proteins sort/traffic to the nucleus, of particular interest is BV/ODV E26 
(E26).  E26 is an envelope protein of both BV and ODV (Braunagel and Summers, 
1994), therefore it must traffic to the plasma membrane and the nucleus during infection.  
Thus, E26 is a bi-directional trafficking protein, which interacts with membranes in both 
locations of the cell, as such it has been shown that there are several immunoreactive 
forms of E26 (Beniya, Braunagel, and Summers, 1998).  The goals of this study are: to 
determine which of multiple protein products the da26 gene produced during infection 
associate with membranes in the nucleus (i.e. microvesicles and ODV envelopes); to 
determine how E26 associates with membranes (specifically the ER, nuclear envelope, 
microvesicles, and ODV envelope); and to identify the molecular basis for trafficking 
the membrane associating form of E26 to membranes located in the nucleus for inclusion 
in the ODV envelope.  There are many questions the last point raises; does E26 associate 
with the ER and if so, in a co- or post-translational manner?  What are the properties of 
the membrane associated E26 and after ER association does E26 remain associated with 
membranes throughout the trafficking pathway to the ODV envelope?  
 
1.1 Baculovirus - Viral Classification 
The viral family Baculoviridae contains arthropod specific viruses capable of 
infecting over 600 host species from the orders Lepidoptera, Diptera, Hymenoptera, and  
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Decapoda.  Due to baculovirus’ specific host range they have been used for bio-control 
applications.  Improvement of the bio-control applications and development of the 
baculovirus expression system have resulted in many studies characterizing the infection 
process (Herniou et al., 2003). 
    Baculoviruses are rod shaped, double-stranded DNA, lipoprotein enveloped 
viruses with genomes ranging in size from 90 kb to 180 kb.  The Baculoviridae family is 
subdivided into two genera:  Nucleopolyhedrovirus (NPV) and Granulovirus (GV) 
(Herniou et al., 2003; van Regenmortel et al., 2000).  This subdivision is primarily based 
on the morphology of the occlusion bodies (OBs) formed around the virion during 
infection.  The genus Granulovirus produces ovoid OBs containing a single virion, 
where as Nucleopolyhedrovirus form polyhedral OBs containing many virions.  
  The research presented in this dissertation utilizes Autographa californica Nuclear 
Polyhedrosis Virus (AcNPV).  AcNPV is a member of the genus Nucleopolyhedrovirus, 
which infects over 27 species of insects (Miller, 1997).  The AcNPV virion is bacilliform 
in shape and contains 1 to 29 nucleocapsids, each containing the complete viral genome.  
Transfection of AcNPV DNA is sufficient for viral infection (Adams and McClintock, 
1991).   
 
1.2 Viral Infection Cycle 
Baculovirus infection produces two phenotypic forms of enveloped bacilliform 
virions.  ODV is the form responsible for natural ingestion in susceptible insects. It is 
enveloped in the nucleus and becomes occluded in polyhedrin, figure 1 (Miller, 1997).  
Microvesicles (intra-nuclear membranes) are hypothesized to bud from the inner nuclear 
membrane and considered precursors of the ODV envelope (Braunagel et al., 1996a; 
Braunagel et al., 1996b; Braunagel et al., 2004; Hong, Summers, and Braunagel, 1997; 
Rosas-Acosta, Braunagel, and Summers, 2001; Saksena et al., 2004).  BV is the 
hemocoelic form, which acquires its envelope by budding through the plasma membrane 
of the cell, figure 1 (Knudson and Harrap, 1976).      




Primary infection in vivo is initiated by ingesting polyhedra which contain the 
occluded virus, ODV.  The occlusion is a highly ordered crystalline matrix composed of 
the polyhedrin protein.  Under conditions of high pH (>10.5), polyhedrin protein 
interactions are disrupted to essentially dissolve the crystalline occlusion and release the 
infectious ODV to invade and infect the midgut cells, see figure 1 (Granados, 1978; 
Summers and Smith, 1975a; Summers and Smith, 1975b).  The virions may be released 
from the polyhedra with a mild alkali treatment.  Dissolution of the crystal allows for 
membrane fusion between the ODV viral envelope and the microvillar membrane of 
columnar midgut epithelium cell.  Once inside the cell, the ODV viral nucleocapsids 
traffic with the aid of microtubules to the nuclear pore and then through the nuclear pore 
into the nucleus (Charlton and Volkman, 1993; Lanier and Volkman, 1998).  The 
nucleocapsids uncoat, releasing the viral DNA to initiate replication (Harrap, 1970; 
Summers, 1969; Summers, 1971).   
 
 
A.  Primary Infection B.  Secondary Infection 
  
Figure 1.  Baculovirus maturation cycle.  Panel A represents primary infection of the insect occurring when 
the insect consumes occlusion derived virus (ODV).  ODV is encapsulated in a polyhedrin crystal that is 
dissolved in the insect gut lumen.  This allows the ODV to infect the gut epithelia cells, tracheal cells, and to 
invade the hemocoel.  Once primary infection occurs, the infected cell starts to produce budded virus (BV).  BV 
is responsible for secondary infection by receptor mediated endocytosis, panel B, which allows peripheral cells 
to be infected.  As infection progresses the nucleus enlarges and produces the virogenic stroma (VS), considered 
the site of viral DNA replication.  Later in the infection process the virus switches from production of BV to 
ODV which, once the insect is liquefied, leaves ODV for infecting a new insect. 
 
 




In infected cells the nucleus enlarges allowing for the formation of the virogenic 
stroma (VS), considered the site of viral DNA replication.  The VS is easily identified as 
an intensely DAPI stained region in the nucleus.  During the development of the 
virogenic stroma, viral nucleocapsids assemble around its periphery.  Nucleocapsids 
have two fates, early in infection they traffic to the plasma membrane for BV production 
and late they become enveloped in the nucleus for ODV production.  During the early 
trafficking of the nucleocapsid to the plasma membrane the nucleocapsids traffic from 
the periphery of the VS to and through the inner nuclear membrane (INM) into the 
perinuclear space, obtaining a temporary envelope.  These nucleocapsids then lose this 
envelope and traffic to the plasma membrane where they align anterior end-on with the 
plasma membrane (Knudson and Harrap, 1976).  The membrane aligned with the 
anterior end of the nucleocapsid is modified with glycoprotein spikes composed of the 
viral protein gp64 and termed peplomers (Adams and McClintock, 1991).  The virions 
bud through the plasma membrane forming the virus termed budded virus (BV) 
(Knudson and Harrap, 1976).   
Secondary infection of the insect is caused by the spread of BV through the 
surrounding tissues, see figure 1.  The basal lamina, a fibrous matrix of glycoprotein 
secreted by the epithelial cells, supports the midgut epithelial cells at their base.  The 
basal lamina initially limits the progeny virions from directly entering the insect 
hemocoel by acting as a physical barrier.  Virions can bypass the basal lamina by 
secondary infection of the tracheoblasts, which penetrate the basal lamina.  These 
tracheoblasts deliver virus to both the tracheal epidermal cells and the hemocoel of the 
insect (Engelhard et al., 1994; Kirkpatrick et al., 1994).  However, according to 
Krikpatrick et al., 1994 and Engelhard et al., 1994 the BV carried in the circulating 
hemolymph does not directly infect other tissues, secondary infection depends on 
passage through the tracheoblasts as they serve as portals across the basal lamina 
barriers.  However, injection of BV into the insect hemocoel results in infection of the 
insect.  BV invades other tissues through receptor-mediated endocytosis via gp64, the 
protein responsible for membrane fusion and a protein component of the BV envelope 




(Wang, Hammer, and Granados, 1997).  Once endocytosed, gp64 aids in uncoating the 
envelopes in a process that is not completely understood.  The nucleocapsids then traffic 
to the nucleus to uncoat and initiate the infection process (Granados, 1978; Hess, 
Summers, and Falcon, 1978; Summers, 1971).  Infection continues resulting in 
liquefaction of the host cadaver.  This liberates the ODV on the surface of plants to 
infect future hosts (Adams and McClintock, 1991; Miller, 1997). 
 
1.3 Virus Structure 
The nucleocapsids of BV and ODV are similar in structure and are approximately 50 
nm x 275 nm.  There are several structural proteins of the nucleocapsid for which a 
comprehensive background is beyond the scope of this dissertation; however two of 
these proteins are relevant to this research and are vp39 and FP25K.  The major protein 
of the capsid is vp39.  When FP25K is deleted the resulting mutant virus infection 
produces a phenotype of “few polyhedra,” a dramatic decrease in the number polyhedra 
produced (Beames and Summers, 1989; Braunagel and Summers, 1994; Harrison and 
Summers, 1995a; Harrison and Summers, 1995b; Miller, 1997).  Also of note, when 
FP25K is deleted ODV E66 (E66 has been shown to co-translationally insert via the 
translocon in to the ER) does not cross the nuclear envelope via the lateral channel, but 
remains in the outer nuclear membrane (Braunagel et al., 1999; Rosas-Acosta, 
Braunagel, and Summers, 2001).  E66 is the most carefully studied ODV envelope 
protein that traffics to the nuclear envelope, microvesicles, and the ODV envelope, more 
detail about this protein will follow later.  FP25K has also been reported to interact with 
E26 in yeast two hybrid experiments (Beniya, Braunagel, and Summers, 1998).          
The nucleocapsids are enveloped in a typical trilaminar envelope, composed of a 
lipid bilayer and an internal lumenal space.  Lipid and protein composition of BV and 
ODV envelopes differ markedly, however they also share several proteins.  This is due 
to the fact that ODV and BV derive envelopes from different sources, the nuclear 
envelope and plasma membrane, respectively.  This requires viral envelope proteins to 




sort and locate to the nuclear envelope, plasma membrane, or both for insertion or 
integration into BV and/or ODV envelopes.   
 
1.3.1 BV Envelope 
Viral proteins traffic to the plasma membrane via the same pathway as cellular 
proteins via vesicular trafficking, ER to golgi, golgi to the plasma membrane (Lecuit, 
2004).  The major glycoprotein of BV is gp64, which is also the envelope fusion protein 
activated by the endocytic pathway (Zhang, Han, and Blissard, 2003).  Gp64 is an early 
and late baculovirus gene allowing for expression throughout infection.  Immunologic 
and biochemical studies show gp64 accumulation in the plasma membrane in spike-like 
structures called peplomers, the sites where nucleocapsids of BV bud through the cell 
surface.  Because of this process peplomers are located only on the BV envelope surface 
at one end of the nucleocapsid, figure 2.  The gp64 protein anchors to the membrane by a 
C-terminal acylation anchor domain where palmitic acid is ester linked to the protein and 




Figure 2.  Virion structure and protein components localized in budded and occlusion derived virus, the 
two phenotypes of baculovirus.  Proteins common to both viral forms are indicated in the center of the figure 
with specific proteins to either BV or ODV noted on the left and right respectively.  ODV is also shown 
encapsulated in polyhedrin with the polyhedron envelope composed of pp34 noted.  (Adapted from Miller, 1997) 
 




There are several BV associated proteins (envelope and capsid proteins) including 
BV/ODV E26, ubiquitin, IE1, cathepsin, and actin; relevant proteins to this dissertation 
will be discussed below (Braunagel and Summers, 1994; Miller, 1997).  BV/ODV E26 
as the focus of this dissertation will be discussed in detail later.  IE1, an immediate early 
protein of the virus, is believed to be a transcriptional activator, which is capable of 
binding DNA.  Spodoptera frugiperda, Sf9, insect cells recognize the IE1 promoter 
resulting in production of IE1 protein.  Due to this fact this promoter is used commonly 
for gene expression in uninfected insect cell culture (Carson, Summers, and Guarino, 
1991; Kovacs et al., 1992).           
 
1.3.2 ODV Envelope 
Several proteins have been identified in the ODV envelope that are not relevant to 
this dissertation, a recent comprehensive summary is reported in Braunagel et al., 2003 
with an abbreviated overview presented in figure 2.  The ODV structural envelope 
proteins relevant to this dissertation include BV/ODV E26, ODV E66, and ODV E25 
(Braunagel et al., 1996a; Braunagel et al., 2003)  A brief summary follows.   
ODV E66 is produced by a late gene and is an integral membrane protein detectable 
in infected Sf 9 cell extracts from 24 to 72 h p.i. by Western blot analysis.  ODV E66 has 
an N-terminal 33-amino acid signal anchor which is not cleaved and functions to sort 
and traffic ODV E66 or reporter fusion proteins (GFP, β-galactosidase) to the intra-
nuclear microvesicles and the ODV envelope.  This 33-amino acid motif is referred to as 
an inner nuclear membrane sorting motif or INM-SM.   The INM-SM consists of a 
single hydrophobic transmembrane domain and two associated charged amino acids, 
lysines which are located 6 and 11 amino acids from the end of the transmembrane 
domain (TMD) (Braunagel et al., 2004).  This INM-SM is not cleaved and has been 
found to be sufficient to locate reporter proteins, GFP and β-galactosidase, to the viral-
induced intranuclear microvesicles and the ODV envelope (Hong, Summers, and 
Braunagel, 1997).  It is also capable of delivering fusion proteins to the inner nuclear 
membrane (INM) in the absence of infection (Braunagel et al., 2004; Hong, Summers, 




and Braunagel, 1997).  Covalent cross-linking studies performed using the sorting motif 
fused with GFP show that the lysines of the motif (+6 and +11 a.a. from the TMD) are 
proximal to BV/ODV E26 and/or FP25K in infected insect cell microsomal membranes 
(membrane fractionation technique which predominantly isolates the ER) during the 
integration and release of the INM-SM from the translocon (Braunagel et al., 2004).  
This putative interaction between E66 and E26 could create and/or stabilize a post-
translational membrane association/integration between E26 and the ER, through either a 
protein-protein interaction or by lowering the pKa of palmitoylation allowing E26 to be 
lipid anchored to the membrane. 
Initial evidence of viral INM-SM sorting has been found as early as integration at the 
translocon (Saksena et al., 2004).  Distinctive photocrosslinking patterns were observed 
with INM transmembrane sequences indicating that INM and non-INM transmembrane 
sequences occupy distinctly different sites within the insect and canine translocons, 
which in turn suggests that INM-directed transmembrane sequences are first identified 
and sorted by translocon components.  INM directed transmembrane sequences are 
proximal to both Sec61α and TRAM; either or both could be involved INM 
transmembrane sequence sorting.  INM transmembrane sequences remain proximal to 
TRAM longer than Sec61α, therefore the authors propose that TRAM is involved in the 
hand-off of INM transmembrane sequences to the next participant in the putative INM 
sorting pathway.  Viral INM-directed proteins, upon leaving the translocon, interact with 
other viral proteins that are required for sorting to the INM.  As such FP25K and 
BV/ODV E26 were identified from crosslinking with the INM-SM.  As viruses typically 
appropriate host mechanisms, the identification of viral proteins required for INM 
sorting strongly suggests the presence of similar host proteins involved in INM sorting.  
Therefore sorting to the INM for some viral and cellular integral membrane protein 
begins with protein translocation in the ER, which could be mediated by specific 
protein-protein interactions (Saksena et al., 2004).   
In the absence of FP25K, E66 does not traffic to the INM but is found to accumulate 
in the ONM and ER (Braunagel et al., 1999; Rosas-Acosta, Braunagel, and Summers, 




2001).  Braunagel et al., 2004 propose that the INM-SM sorts proteins to the inner 
nuclear membrane.  The authors hypothesize that E66 and the sorting motif fusions do 
not randomly diffuse from the endoplasmic reticulum, site of co-translational insertion, 
to the nuclear envelope and microvesicles during infection (Braunagel et al., 2004; 
Saksena et al., 2004).  For the viral integral membrane proteins their current opinion is 
that this trafficking is mediated by specific protein-protein interactions during 
integration at the translocon, the ER, the outer nuclear membrane (ONM), and the inner 
nuclear membrane (INM).  The authors suggest that E26 and/or FP25K might be directly 
or indirectly involved in facilitating the nuclear trafficking of E66 (Braunagel et al., 
2004).   
ODV E25 is another envelope protein produced by a late gene and is an integral 
membrane protein with a similar N-terminal hydrophobic transmembrane domain to 
ODV E66.  However E25 does not have the associated charged amino acids that are 
found in the E66 INM-SM.  The N-terminal signal anchor of ODV E25 is not cleaved 
and traffics ODV E25 to the microvesicles and the ODV envelope (Hong, Summers, and 
Braunagel, 1997).  E25 localization is not altered in an FP deletion virus, which makes it 
different from E66 and places relevance on the size differences of the proteins and the 
associated charged amino acids found in E66 that are not found in E25: this could 
account for different localizations of these two proteins in FP mutant virus infected cells 
(Braunagel et al., 1999; Rosas-Acosta, Braunagel, and Summers, 2001).  
 
1.4 Gene Expression and Viral DNA Replication 
Upon release of the viral DNA viral transcription is classified in four temporal 
phases, immediate early (IE), delayed early (DE), late (L), and very late.  RNA 
transcripts from the IE class of genes are detectable within the first 15 to 60 minutes 
after inoculation (Miller, 1997).  Optimal expression of delayed early and late genes 
requires early gene expression.  Transcription of the delayed early genes requires the 
presence of the immediate early genes; together the IE and DE genes represent the early 
phase of transcription.  The early phase continues until the start of viral DNA replication 




which begins about 6 to 10 hours post infection (h p.i.).  Optimal expression of late 
genes requires the expression of 18 early genes.  Late gene transcription begins 
approximately 10 h p.i. and continues until cell death with maximal late gene 
transcription occurring at approximately 24 h p.i. (Herniou et al., 2003). 
E26, the topic of this study, was classified as an early protein (Guarino and 
Summers, 1988); however the protein is an ODV envelope protein it must also be a late 
protein, as such it must also have a late gene promoter.  There is also some preliminary 
evidence from Imai et al., 2004, that suggests E26 might play a roll in viral DNA 
replication.  Because of this some preliminary experiments were performed in this 
project to clarify its expression pattern and identify its other promoters.  To clarify the 
fundamental details for E26 gene expression a short summary of baculovirus gene 
expression and viral DNA replication will follow.   
The immediate early genes are distributed throughout the circular DNA genome of 
baculoviruses and transcribed from both DNA strands by the host RNA polymerase II.  
The immediate early genes involved in viral gene transcription are ie-0, ie-1, ie-2, 
ORF121, and pe38 (Carson, Guarino, and Summers, 1988; Carson, Summers, and 
Guarino, 1991; Gong, Jin, and Guarino, 1998; Herniou et al., 2003; Kovacs et al., 1992).    
The structure of the early gene promoters resembles RNA polymerase II responsive 
cellular gene promoters.  RNA polymerase II-responsive baculovirus promoters include 
a core region surrounding the +1 RNA start site.  This core provides a basal level of 
transcriptional initiation that is activated by cis-acting elements.  These basal promoters 
can be classified as TATA-containing (TATA), initiator-containing (INR), or a 
composite containing TATA/INR promoter.  The most conserved INR motif is the 
CAGT motif, first functionally identified in the ie-1 gene, which is a typical composite 
promoter (Herniou et al., 2003).  The first CAGT in proximity to the start of the da26 
gene is located 256 nucleotides upstream of the gene in the AcNPV E2 viral genome: to 
be clarified later. 
Viral DNA replication of AcNPV in Spodoptera frugiperda (Sf 9) cells is detected by 
6 to 10 h p.i. and continues until approximately 18 h p.i., after which the rate of DNA 




replication declines.  Infection occurs when baculovirus DNA is transfected, therefore 
proteins associated with the mature virions are not essential for viral DNA replication.  
Viral DNA synthesis is dependent on IE and DE gene expression, which led to the 
discovery of a viral DNA polymerase (Mikhailov et al., 1986; Miller, Jewell, and 
Browne, 1981; Wang et al., 1983).  Recently it has been shown that the baculovirus viral 
DNA polymerase is required for viral DNA synthesis (Vanarsdall, Okano, and 
Rohrmann, 2005).   Cis- and trans-acting elements associated with DNA replication 
have been identified in baculovirus genomes, and are believed to be involved in DNA 
synthesis.  One gene of interest to this study is IE-1, which is required for viral DNA 
replication, as it is believed to be a transcriptional activator.  It is of interest as an 
interaction between E26 and IE-1 has been proposed due to experiments performed by 
Imai et al., 2004 and due to yeast two hybrid experiments performed in the Summers’ 
lab.  This will be clarified in greater detail later. 
Late genes are identified as those that are expressed after viral DNA replication.  
During the late phase, structural proteins are predominantly produced, these include 
envelope proteins of ODV, vp39 (Capsid), p6.9 (Basic core protein), and during the very 
late phase polyhedrin, and p10.  Late gene transcription begins after viral DNA 
replication and can continue throughout infection (Huh and Weaver, 1990).  A novel 
virus induced RNA polymerase is produced, which is responsible for the transition from 
early to late gene expression (Huh and Weaver, 1990).  An essential motif to late 
baculovirus gene promoters is the TAAG element.  Transcriptional mapping studies of 
several late genes have identified this TAAG motif as the initiation site (Theilmann et 
al., 1996).  E26 is an ODV envelope protein therefore it must also be a late protein; as 
such it must also have a late gene promoter.  The first TAAG element in proximity to the 
start of the da26 gene is located 783 nucleotides upstream of the gene in the AcNPV E2 








1.5 BV/ODV E26 
 
 
Figure 3.  E26 amino acid sequence.  E26 amino acid sequence with the putative domains predicted using 
computer bioinformatics’ tools and by sequence gazing, note the two putative nuclear localization signals 
(NLS), the coil-coil domain, the amphipathic helix, and the 5 cysteine amino acids.  Coil-coil domains are sites 
of protein-protein interactions.  NLS function to deliver soluble and membrane associated proteins to the 
nucleus.  Amphipathic helices and lipid anchors allow for interactions with membranes.   Cysteines amino acids 
are where lipids are covalently attached to membrane proteins.  The cysteine at amino acid 129, in yellow, has a 
great potential for lipidation due to the charged amino acids that surround it. 
 
 
The purpose of this study is to clarify factors important for E26 membrane 
association and to investigate the mechanisms of its trafficking to the ODV envelope.  
Comparisons will be made with ODV E66, in order to determine if E26 follows the same 
pathway as E66.  Examining the BV/ODV E26 (E26) primary amino acid sequence 
reveals several domains and amino acids of interest in the context of this study.  
Specifically the E26 a.a. sequence contains two putative nuclear localization signals 
(NLS), a putative amphipathic helix, a coil-coil domain, and 5 cysteine amino acids, see 
figure 3.  This search also reveals that E26 does not contain any predictable 
transmembrane sequence or signal anchor.  However, the domains identified could 
account for the nuclear localization and membrane association.  Coil-coil domains are 
common sites of protein-protein interactions, three of which have been preliminarily 
identified including IE-1, FP25K, and ODV E66.  NLSs function to deliver soluble and 
membrane associated proteins to the nucleus.  Comparing E26 to ODV E66, E66 does 
not contain any predictable NLS, as such it sorts and traffics through the membranes of 
the ER, ONM, lateral channels of the nuclear pore complex (NPC) and into the INM of 
the nucleus through the “diffusion:retention” pathway (Ellenberg et al., 1997; Smith and 




Blobel, 1993; Soullam and Worman, 1993; Soullam and Worman, 1995).   Amphipathic 
helices and lipid anchors allow interactions with membranes.  A lipid anchor, 
specifically S-acylation, covalently links a lipid inserted into the membrane bi-layer to 
cysteine amino acids, E26 contains 5 cysteine amino acids.  As mentioned earlier gp64 is 
a baculovirus protein that utilizes this type of membrane association, serving as a model 
for E26 membrane association.  The cysteine at amino acid 129, in yellow, has a great 
potential for lipidation due to the charged amino acids that surround it.  A more 
comprehensive background and examples for each of these possibilities will be 
presented in relevant sections to follow.   
 
1.5.1 BV/ODV E26 Literature 
Da26, the gene for E26, was identified by Guarino and Summers in 1988 in the PstI-
G fragment of the E2 strain of the AcNPV viral genome.  When the gene was translated 
into its amino acid sequence it predicted a highly basic 226 amino acid protein with a 
molecular weight of 25,891 Da.  Nuclease S1 mapping of da26 RNAs from infected and 
transfected cells indicated that da26 is transcribed as a delayed-early gene.  An early 
baculovirus promoter (CATTA) was identified 34 nucleotides upstream of the ATG start 
of the da26 gene (Guarino and Summers, 1988).  Guarino and Summers also found that 
late gene expression was increased 3- to 10-fold by expression of da26 and da41 by 
measuring CAT activity expressed by a late promoter in a cotransfection assays with 
IE1.  This increase in expression is not due to an increase in the steady state levels of 
mRNA, suggesting that the effect observed was post-transcriptional (Guarino and 
Summers, 1988).   
The da26 gene was found altered with insertions and deletions after several serial 
passage of the virus in cell culture, molecular characteristics that resemble those of 
transposable elements (O'Reilly et al., 1990).  Da26 transcripts were detected as early as 
1 hour post infection (h p.i.) in Trichoplusia ni cells.  This led O’Reilly et al., 1990, to 
construct a recombinant virus in which da26 was truncated after amino acid 118 by 
insertion of the lacZ gene.  They found this mutant virus to be viable in both 




Trichoplusia ni and Spodoptera frugiperdia cells with no detectable differences from 
wild type infections (O'Reilly et al., 1990).  Such a construct at this time was considered 
equivalent to a complete gene mutation or a gene knockout.  Therefore, O'Reilly et al. 
concluded that da26 was not essential for viral replication in either cell culture or in the 
insect.  In this study several of my experiments were based on O’Reilly’s data that E26 
was not essential.  As to be shown, this led to several major complications as data will be 
presented that contradicts these conclusions and explains why the O'Reilly et al. results 
were not correct.   
The nucleotide sequence of the genome region (EcoRI-A) flanking da26 is presented 
in Braunagel et al., 1992.  In Braunagel et al., (1992) the authors predicted the amino 
acid sequences for 15 putative ORFs including da26.  Amino acid homology searches 
using the da26 found a high degree of homology (20% identity and 40% similarity) to 
the outer capsid protein, VP8, of rotavirus (Braunagel et al., 1992).  Sequence similarity 
with VP8 indicated possible hemagglutination activity (Fiore, Greenberg, and Mackow, 
1991; Lizano, Lopez, and Arias, 1991) and maybe a role in host range determination 
(Zapikian and Chanock, 1990).     
Beniya et al., 1998, determined E26 to be an envelope protein of both BV and ODV.  
Thus Beniya et al., 1998, named the 26-kDa species of the protein to designate that form 
incorporated into viral progeny, incorporated into viral envelopes, and apparent 
molecular weight.  The 7554 antiserum to E26 was used in a Western blot temporal 
course analysis, which detected steady state synthesis of E26 from 4 h p.i. throughout 
infection, with maximal protein levels at 16 h p.i.  By 36 h p.i. several additional 
immunoreactive proteins were identified, which migrated at approximately 18, 26, 28, 
and 34 kDa.  Both the 26 and 18 kDa proteins were identified in Western blots of 
purified BV and ODV viral envelopes indicating they are structural envelope proteins of 
both viral forms.  By IEM E26 protein is detected in ODV envelopes at 24 and 36 h p.i.  
Also by IEM, E26 protein is detected in cytoplasmic vesicles and electron dense regions 
contained in the nucleus at 6 h p.i. (Beniya, Braunagel, and Summers, 1998).   




Immuno-precipitations (IPPs) find that E26 and FP25K are in the same precipitated 
complex of proteins from infected cell extracts and yeast two-hybrid assays find that 
they are capable of interacting.  IPPs find that E26 and cellular actin are also found in 
the same precipitated complex suggesting a possible association bewteen these two 
proteins (Beniya, Braunagel, and Summers, 1998).  The authors’ concluded, "these data 
suggest that FP25K and cellular actin may participate in the regulation, or movement 
through the cell, of baculovirus proteins and/or nucleocapsids." 
Homologues to the AcNPV E26 protein have been identified in seven of the 
sequenced baculoviruses with highly conserved homology as seen in figure 4: indentity 
and similarity are noted in the figure.  Specifically the most conserved regions of the 
E26 gene are amino acids 53 through 105 and 123 through 209, as denoted by stars 
(indentical a.a.), colons (highly conserved a.a), and periods (conserved a.a.) below the 
line up of the genes.  These regions contain the second NLS, the coil-coil domain, the 
amphipathic helix, and the 3 c-terminal cysteines.  The domains in these regions which 
are the most conserved are the character of the second NLS and the c-terminal 3 
cysteines with proximal charged or polar amino acids.  Homology to E26 with Bombyx 
mori nucleopolyhedrovirus (BmNPV), ORF8, was examined by Imai et al., 2004.  The 
authors found that orf8 was expressed as an early gene.  Immunoblot analysis failed to 
detect ORF8 protein associated with BV and/or ODV when using antisera developed 
against a bacterial expressed form of the orf8 gene (Imai et al., 2004).  This observation 
is in direct conflict with data from the Summers’ lab (Benyia et al., 1998).  Experiments 
have been performed and will be presented, which demonstrate E26 only associates with 
membranes in infected cells.  These membrane association conditions are absent in 
bacteria, thus epitopes to the membrane associated form are absent in the bacterial 
expressed protein presented as antigen to rats by the Imai group.  In Imai et al., confocal 
microscopy revealed that ORF8 protein accumulated in the nucleus with relatively 
constant levels of expression from 4 to 24 h p.i. and was found to co-localize with IE1 to 
specific nuclear foci.  The authors attempted to recreate the null mutant experiment 
presented in O'Reilly et al. with the insertion of a reporter gene.  Isolation of the null  






Figure 4.  E26 homologues.  E26 amino acid sequences from 7 different baculoviruses compared with the 
AcNPV form using DBclustal: rapid and reliable global multiple alignments of protein sequences detected by 
database searches (Thompson et al., 2000).  Stars (M) indicate identical a.a., colons (:) indicate highly conserved 
a.a., and periods (.) indicate conserved a.a.   The relevant domains of the AcNPV E26 are denoted; cysteines in 
green, NLSs in yellow, coil-coil domains in red, and the amphipathic helix in pink.  The percent identities, 
similarities, and gap are in relation to the E26 from AcNPV.  The baculovirus strains listed in the figure above 
are as follows from top to bottom:  Autographa californica NPV, Rachiplusia ou NPV, Bombyx mori NPV, 
Epiphyas postvittana NPV, Orgyia pusedotsugata NPV, Antheraea pernyi NPV, Choristoneura fumiferana 
defective NPV,  and Choristoneura fumiferana NPV. 




mutant was not possible suggesting that orf8 is essential.  Biochemical analyses 
performed indicated that ORF8 protein bound to nucleic acids suggesting a DNA 
binding activity (Imai et al., 2004).  The authors concluded that BmNPV E26 may be 
involved in viral DNA replication and/or transcription.   
 
1.5.2 The Model for BV/ODV E26 
A model for E26 that localizes to the nucleus during infection has two possibilities.  
Early during infection the protein has one role as a soluble protein and late in infection 
the role changes to that of a membrane associated protein.  That is not to say that the two 
roles are exclusive of each other, they do appear to overlap in the time course of 
infection.  Basically the da26 gene produces at least two protein products pertaining to 
the study presented in this dissertation, these two products have different functions.  The 
28 kDa form is a soluble protein that interacts with transcriptional activators and DNA in 
the nucleus during the early stages of infection (Imai et al., 2004).  Where as, a 
population of the 26 kDa form is a membrane associated form that interacts with a viral 
integral membrane protein (ODV E66) in the ER and is found in the inner nuclear 
membrane, intra-nuclear microvesicles, ODV envelopes, and ODV in the nucleus 
(Beniya, Braunagel, and Summers, 1998; Braunagel et al., 2004).  The focus of my 
research is predominately on the 26 kDa membrane associated form of E26.   
 
2. Study Relevance and Specific Aims 
E26 being an envelope protein of both BV and ODV (Braunagel and Summers, 
1994) traffics to the plasma membrane and the viral envelope in the nucleus during 
infection.  Thus, E26 is a bi-directional trafficking protein (Beniya, Braunagel, and 
Summers, 1998).  The goal of the study is to identify the molecular basis for trafficking 
E26 to membranes located in the nucleus. 
 
Specific Aims: 
1. Determine if there are multiple forms of E26 created or modified during 
infection, if so which of these forms becomes an integrated in to the ODV 
envelope. 




2. Determine if E26 associates with ER membranes, traffics to the INM via 
membrane associations, and the properties of those membrane associations in  
correlation to the E66 association and trafficking pathway.   
3. Identify regions within E26 required for the ER association and if possible  
trafficking of E26 to intra-nuclear membranes. 
4. Investigate if protein interactions play a role in the nuclear trafficking of E26.   
 
Understanding the process and mechanisms by which a virus sorts and targets protein 
to the INM can reveal insights into the molecular basis of nuclear envelopathy disease.  
Although E26 has been classified as a membrane protein, unpublished preliminary data 
suggesting it is a peripheral membrane protein will be presented in this document.  These 
studies will attempt to answer the following questions: Are there multiple forms of E26 
created or modified during infection, if so which form becomes an envelope protein of 
ODV?  How does the E26 envelope protein interact with membranes in the cell?  How 
does the virus sort this form of E26 to the ODV envelope, does it follow the pathway 
described for ODV-E66, does it aid in trafficking ODV-E66, or do the two traffic as a 
complex together?  Since E26 crosslinks in infected microsomes with E66, that form, at 
least, seems to follow some aspect of the E66 trafficking pathway.  Other questions 
could be answered, including is there a unique trafficking pathway for membrane 
associated proteins, or do they traffic as soluble or integral membrane proteins?  
Significant progress in understanding the molecular mechanisms controlling trafficking 
of a membrane associated protein can be made using E26 as a model and comparing it to 
other viral and cellular proteins including ODV E66 and LBR.  Studying these 
trafficking patterns will potentially extend our knowledge of cellular and viral controls 
of cellular membrane protein trafficking during infection, with specific comparisons of 
nuclear trafficking in infected and uninfected cells.   
For the study of pathways and mechanisms of INM proteins this research is pertinent 
and timely, as few inner nuclear membrane associated proteins have been studied, 
however this is a rapidly growing field.  Mutations or alteration of INM proteins and the 
lamins with which they interact has been found to lead to several diseases in humans and 




other organisms (Broers, Hutchison, and Ramaekers, 2004; Burke and Stewart, 2002; 
Gilchrist et al., 2004; Mounkes et al., 2003; Ostlund and Worman, 2003; Ostlund and 
Worman, 2004; Somech et al., 2005; Worman, 2005).  Diseases include cardiac and 
skeletal myopathies, partial lipodystrophy, peripheral neuropathy, and premature aging.  
These diseases are collectively known as “nuclear envelopathies” (Somech et al., 2005; 
Worman, 2005).  To date, mutations in genes encoding the nuclear envelope proteins 
emerin, MAN1, lamin A/C, and lamin B receptor (LBR) were found to cause nuclear 
envelopathies.  The diseases caused by mutations in the LMNA gene have been 
subdivided and are called “laminopathies.”   
A mutation or lack of expression of emerin in humans causes X-linked Emery-
Dreifuss muscular dystrophy.  Loss of function mutations of MAN1 result in 
osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis, an increased bone 
density disorder (Somech et al., 2005; Worman, 2005).  Two additional INM protein 
diseases are Pelger-Huet anomaly and Greenberg skeletal displasia, which are caused by 
mutations in the lamin B receptor (LBR) gene.  Pelger-Huet anomaly results in 
developmental delay, epilepsy, skeletal abnormalities and changes to both nuclear 
morphology and chromatin organization in granulocytes (Mounkes et al., 2003; Somech 
et al., 2005).     
The laminopathies account for the bulk of the diseases identified and are due to 
multiple mutations in LMNA gene (lamin A and C).  These mutations are responsible for 
at least nine different diseases which affect the skeletal and cardiac muscle.  These 
diseases are autosomal dominant Emery-Dreifuss muscular dystrophy, Limb girdle 
muscular dystrophy type 1B, dilated cardiomyopathy, Dunnigan’s familial partial 
lipodystrophy, mandibuloacral dysplasia, Hutchinson-Gilford progeria syndrome, 
atypical Werner’s syndrome, restrictive dermopathy, and Charcot-Marie-Tooth 
neuropathy type 2 B1(Broers, Hutchison, and Ramaekers, 2004; Burke et al., 2005; 
Gilchrist et al., 2004; Mounkes et al., 2003; Ostlund et al., 1999; Ostlund and Worman, 
2003; Ostlund and Worman, 2004; Somech et al., 2005; Worman, 2005). 
 




3. Structure and Function of the Nucleus* 
 
 
Figure 5.  Nuclear envelope and pore structure.  Note the central channel and lateral channel, the two 
passages through the NPC.  The nuclear pore basket is also denoted.  The nuclear envelope is composed of the 
inner and outer nuclear membrane, enclosing the nuclear lumen.  Where they meet in the lateral channel forms 
the pore membrane, a biochemically distinct membrane.  (Adapted from Blobel and Woznaik, 2000) 
 
 
Since the nuclear trafficking of E26 is the primary focus of this dissertation a short 
summary of nuclear architecture and function will follow in order to identify pathways 
and processes where E26 is likely to traffic during its sorting into the INM, intranuclear 
microvesicles, and the ODV envelope.   
 
3.1 Nuclear Envelope (NE) 
Nuclei are typically depicted as spherical in shape; however the shape of the nuclear 
envelope can diverge greatly from this model.  Grooves and invaginations have been 
found throughout the nuclear envelope of many eukaryotes (Fricker et al., 1997).  The 
envelope is made of two concentric membranes, the inner (INM) and outer nuclear 
membrane (ONM), see figure 5.  The ONM is contiguous with the endoplasmic 
reticulum (ER) (Harris, 1978).  The INM and ONM are continuous through the nuclear 
pore membrane, however they maintain distinct protein compositions (Goldberg and 
Allen, 1995; Harris, 1978).  The nuclear envelope is not just a boundary of the nucleus,  
__________________ 
*Figure 5 with adaptation reprinted with permission from “Proteomics for the pore” by 
Blobel, G. and Wozniak, R. W., 2000, Nature, 403, 835-836. © 2000 by Nature 
Publishing Group. www.nature.com.  




but also an interface between the nuclear and cytoplasmic compartments via the nuclear 
pore complex (NPC).     
 
3.1.1 Outer Nuclear Membrane 
The ONM resembles the RER as it is a contiguous membrane system sharing many 
characteristics including attached functional ribosomes (Harris, 1978).  This continuous 
membrane allows integral membrane proteins that are inserted in the ER a path through 
the ER to the ONM and into the INM via the lateral membrane channels of the NPC 
(Gant, Goldberg, and Allen, 1998).    
 
3.1.2 Nuclear Envelope Lumen 
The nuclear envelope membranes enclose an aqueous domain called the nuclear 
envelope lumen or perinuclear space.  The function of the NE lumen potentially overlaps 
with the RER lumen, but the NE lumen may have some unique functions yet to be 
identified.  The NE lumen provides an environment for the lumenal domains of integral 
membrane proteins of the ONM, INM, and pore membrane.  These integral membrane 
proteins may anchor the NPC and lamina, or, may provide a functional connection or 
communication between the lumen and the nucleus, NPC, or cytoplasm (Goldberg and 
Allen, 1995). 
         
3.1.3 Inner Nuclear Membrane* 
Baculovirus infection creates an amplified pulse of viral integral membrane proteins 
(IMP) trafficking through the continuous membranes of the ER, ONM, and INM during 
transit to the viral envelope of ODV (Braunagel et al., 2004).  Recall that the ODV 
envelope is derived of intra-nuclear membranes, microvesicles, which are precursors to 
the ODV envelopes and are hypothesized to bud from the inner nuclear membrane of  
__________________ 
*Figure 6 with adaptation reprinted with permission, from the Annual Reviews of Cell 
and Developmental Biology, Volume 21 © 2005 by Annual Reviews, 
www.annualreviews.org 
 




infected nuclei  (Braunagel et al., 1996a; Braunagel et al., 1996b; Braunagel et al., 2004; 
Hong, Summers, and Braunagel, 1997; Rosas-Acosta, Braunagel, and Summers, 2001; 
Saksena et al., 2004).  It is presumed that these viral proteins are trafficking through the 
same pathways as cellular IMPs.  An understanding of the mechanisms required to 
traffic cellular proteins to the INM should provide insights into viral protein trafficking 
to the nucleus and vice versa.   
Although the INM is connected to the ER via the NPC and the ONM, it does not 
resemble the RER or the ONM in protein composition, structure, or function.  Recent 
studies have found that some of the proteins of the INM interact with proteins of the 
ONM and connect the peripheral nucleoskeleton to the cytoskeleton.  Examples are C. 
elegans’ UNC-83 and ZYG-12, which connect to the microtubule cytoskeleton and 
centrosomes respectively.  UNC-83 and ZYG-12 interact with UNC-84 and SUN1 (or 
matefin) respectively, which are proposed to locate to the INM (Hetzer, Walther, and 
Mattaj, 2005).  These interactions and connections are responsible for nuclear 
positioning, nuclear movement, and possibly other as of yet, unidentified functions.   
The nesprin family of proteins (Syne, Myne, and NUANCE) demonstrates that NE 
proteins also fulfill a specialized roll in establishing and maintaining the three-
dimensional architecture of certain differentiated cells.  These proteins are large, integral 
proteins that are proposed to locate to the INM.  They contain many spectrin repeats, a 
C-terminal transmembrane domain, and an actin binding motif.  Some nesprins bind 
both lamin A and emerin in vitro (Apel et al., 2000; Zhang et al., 2005; Zhang et al., 
2001).   
Nuclear lamins were the first proteins identified of the INM and are a type of V 
intermediate filament proteins (Rzepecki and Fisher, 2002; Worman and Courvalin, 
2000).  Lamins have an amino-terminal head and a carboxyl-terminal tail domain 
separated by an alpha-helical rod domain, these are highly conserved domains of the 
intermediate filament protein family (Shumaker, Kuczmarski, and Goldman, 2003).  The 
lamins form the nuclear lamina on the inner surface of the INM interacting with several 
INM proteins, see figure 6.  These proteins can be divided into two classes, A-type and 




B-type, based on expression patterns, properties and localization.  A-type lamins are 
typically expressed in differentiating cells and are generally more soluble than B-type 
lamins during M-phase.  B-type lamins are expressed in almost all cells and are usually 
associated with the membrane vesicles during mitosis.  There are three types of lamins in 
vertebrates, A, B, and C.  Lamins A and C are alternative RNA splice variants of the 
LMNA gene.  Lamin B, B1 and B2, are expressed from the LMNB genes, LMNB1 and 
LMNB2 respectively (Taddei et al., 2004).  These genes produce more than ten different 
lamin proteins due to both alternative splicing and post-translational modifications in 
different types of cells (Rzepecki and Fisher, 2002).  There are two lamin genes in D. 
melanogaster; one codes for lamin Dm0, a homologue of vertebrate B-type lamins, and 
the other codes for lamin C, which is similar to vertebrate A-type lamin (Rzepecki and 
Fisher, 2002).  Most lamins are farnesylated at their carboxyl-termini, which facilitates 
their membrane association via lipid anchor.  The exception to farnesylation is vertebrate 
lamin C, which is never been detected in a  prenylated state (Gruenbaum et al., 2000; 
Worman and Courvalin, 2000).   
Otefin and Bocksbeutel are Drosophila proteins, which contain similar LEM (Lamin, 
Emerin, and Man1 like) domains (53% identical amino acids) (Wagner, Schmitt, and 
Krohne, 2004).  Otefin is one of the few INM peripheral proteins identified (Wagner, 
Schmitt, and Krohne, 2004; Worman and Courvalin, 2000).  Otefin is a 45 kDa protein 
with a large hydrophilic domain, a single C-terminal hydrophobic sequence of 17 amino 
acids, and a high content of serine and threonine (Goldberg et al., 1998).  The C-terminal 
17 amino acid hydrophobic sequence is essential for targeting otefin to the nuclear 
periphery with amino acids between 173 and 372 targeting it to the nuclear envelope, 
while amino acids between 35 and 172 stabilize the interaction with the nuclear envelope 
(Ashery-Padan et al., 1997a; Ashery-Padan et al., 1997b).   
Various integral membrane proteins of the INM are also components of the nuclear 
lamina by binding to the lamins, peripheral INM proteins, chromatin, or other structures 
of the INM, see figure 6.  The Bocksbeutel gene, CG9424, produces two isoforms via 
alternative splicing.  The α-isoform is 399 amino acids and contains a c-terminal 




transmembrane domain.  The β-isoform is 351 amino acids, which is missing the c-
terminal transmembrane domain.  When expressed in transfected cells as GFP fusions 
the β-isoform localizes to the nucleoplasm and the α-isoform is targeted to the nuclear 
envelope.  The α-isoform is the predominantly expressed in cells, larvae, and flies.  
Bocksbeutel is localized in the nuclear envelope and in the cytoplasm by indirect 
immunofluorescence using Bocksbeutel antiserum (Wagner, Schmitt, and Krohne, 
2004).   
The first integral membrane protein of the INM to be identified was lamin B receptor 
(LBR), which contains eight transmembrane domains and binds to B-type lamins  




Figure 6.  Illustration of the nuclear envelope.  INM proteins are grouped into Lamin A and B binding 
proteins with their interacting transcription and chromatin regulators noted.  Chromatin is in red, INM proteins 
orange, lamins grey.  Protein abbreviations are as follows:  barrier to autointegration factor (BAF), germ-cell 
less (GCL), Dependent protein 3-E2 transcription factor (DP3-E2F), cone-rod homeobox (CRX), Btf is a death-
promoting transcriptional repressor, Mothers against decapentaplegic homolog 1 (Smad1), Lamina-associated 
polypeptide (Lap), lamin B receptor (LBR), uncoordinated movement (UNC), SUN is a domain consisting of a 
coiled-coil region, an anti-erbB-2 IgG domain, and two hydrophobic regions contained in UNC-84, pore 
membrane protein (POM), glycoprotein 120 (gp210)(Adapted from Hetzer, Walther, and Mattaj, 2005). 




2000).  The nuclear trafficking of LBR is the model for the diffusion:retention of integral 
membrane proteins, with an inserted transmembrane domain in the ER and trafficked 
through the continuous membrane system of the ER, ONM, and INM via the lateral 
channels of the NPC.  As such it is directly comparable to ODV E66.  For information 
on other integral membrane proteins identified in the INM see the follow articles and 
reviews as the comprehensive details therein are beyond the scope of this dissertation 
(Dechat et al., 1998; Dechat, Vlcek, and Foisner, 2000; Ellenberg and Lippincott-
Schwartz, 1999; Ellenberg et al., 1997; Foisner, 2001; Gruenbaum et al., 2000; Holmer 
and Worman, 2001; Lin et al., 2000; Ostlund et al., 1999; Ostlund and Worman, 2003; 
Rolls et al., 1999; Worman, 2005; Worman and Courvalin, 2000). 
Contrasting these INM proteins is Nurim.  It is a multispanning INM protein with a 
small hydrophilic nucleoplasmic domain.  This proteins seems to exclusively reside in 
the INM, however, its function is yet to be identified (Rolls et al., 1999).  Other proteins 
are being currently identified in several of the proteomics experiments.  Two recently 
reported proteins are a 100 kDa Unc-84A like protein (C. elegans) and a 45 kDa protein 
named LUMA.  Functional analysis of these newly identified proteins has not been 
completed (Dreger et al., 2001). 
  
Nuclear Pore Complex (NPC)* 
Regulated soluble protein transport between the nucleus and cytoplasm occurs 
through the nuclear pore complex (NPC).  The nuclear pore complex is a large 
proteinaceous structure composed of roughly 40-50 distinct proteins in vertebrates 
totaling 120 MDa in mass (Suntharalingam and Wente, 2003).  The yeast NPC has been 
isolated to homogeneity, and is approximately 50 Mda in mass composed of about 30 
proteins (Rout and Aitchison, 2001; Rout et al., 2000).  The 30 proteins were identified 
and structural analysis located their positions in the yeast NPC (Allen et al., 2001;  
 
__________________ 
*Figure 7 with adaptation reprinted with permission from “Proteomics for the pore” by 
Blobel, G. and Wozniak, R. W., 2000, Nature, 403, 835-836. © 2000 by Nature 
Publishing Group. www.nature.com. 




Denning et al., 2001).   
The pore is composed of three stacked octagonally symmetric rings, with the center 
ring containing eight spoke-like structures supporting the central transporter or central 
channel, see figure 7.  The lateral channel is created by the spokes of the central ring and 
the pore membrane.  There are eight lateral channels around the central channel and each 
is ~10 nm in diameter (Hetzer, Walther, and Mattaj, 2005; Rout et al., 2003; 
Suntharalingam and Wente, 2003; Talcott and Moore, 1999).  The pore membrane is 
where the ONM and INM meet and are continuous with each other in the NPC.  This 
pore membrane is biochemically distinct from the INM or ONM (Hinshaw, Carragher, 
and Milligan, 1992).  The lumenal space of the ER and nuclear envelope meet in this 
pore membrane region.  Moving away from the NPC eight short filaments extend from 
the cytoplasmic ring and on the nuclear ring, the symmetry continues with the nuclear 
basket (Allen et al., 2001; Bayliss, Corbett, and Stewart, 2000; Blobel and Wozniak, 




Figure 7.  Model of NPC architecture.  Shown are the cytoplasmic, central, and nuclear rings.  The lumenal 
space/pore membrane connects the INM and ONM at the NPC.  Cytoplasmic and nuclear filaments are also 
depicted; the latter forms a basket structure closed by a distal ring.  (Adapted from Blobel and Woznaik, 2000) 
 
 
The component nuclear pore proteins of the NPC have been termed nucleoporins or 
nups and are present in two copies per spoke, which are located symmetrically on either 




axis of the NPC midplane (Mazzanti, Bustamante, and Oberleithner, 2001; Miller and 
Forbes, 2000; Rout et al., 2003).  Using octagonally symmetric architecture few nups 
can create the massive structure of the NPC.  There are three classes of nups from which 
the NPC is constructed.  The first class of nups contains integral membrane proteins, 
which localize to the pore membrane domain and are termed poms (Rout et al., 2003; 
Suntharalingam and Wente, 2003).  Poms anchor the NPC to the NE.  It has been 
hypothesized that poms aid in the formation of the NPC, however, little is known of their 
exact function (Rout and Aitchison, 2001).  The second class of nups is the structural 
proteins giving the NPC form and integrity.  These nups form the central and lateral 
channels, which are the passages for trafficking proteins.  The central channel allows 
proteins 50 kDa in size to freely diffuse and the lateral channel allow membrane proteins 
a passage from the ONM into the INM, see figure 7 (Pante and Kann, 2002; Talcott and 
Moore, 1999).  These nups provide the framework to support the third class of nups 
located on both sides of the NPC (Rout et al., 2003).  The third class contains the 
binding sites for the transport factors, which is a related group of proteins called the FG 
nups (Rout et al., 2003).  They have been named the FG nups because they contain 
multiple copies of a Phe-Gly motif separated by hydrophilic residues (Rout and 
Aitchison, 2001; Suntharalingam and Wente, 2003).  The FG nups account for almost 
half of the NPC mass with approximately 200 copies in each NPC (Blobel and Wozniak, 
2000; Cronshaw et al., 2002; Rout et al., 2000).  These FG nups exist on the nuclear and 
cytoplasmic filaments that extend into the nucleus and cytoplasm, repectively (Denning 
et al., 2003).  These proteins function as docking sites for importins/karyopherins, 
facilitating protein translocation into and out of the nucleus (Gant, Goldberg, and Allen, 
1998; Hinshaw, Carragher, and Milligan, 1992; Rout et al., 2000; Suntharalingam and 
Wente, 2003).  These proteins and processes are highly conserved throughout many of 
the currently studied eukaryotic organisms (Allen et al., 2001; Denning et al., 2001; 
Hetzer, Walther, and Mattaj, 2005; Rout et al., 2003).  Importin/karyopherin function 
will be discussed in detail in the protein trafficking section which follows.   
 




4. Nuclear Protein Trafficking  
Three models for nuclear protein translocation have been proposed in the literature; 
these are, “diffusion:retention” requiring an interaction with membranes (Ellenberg et 
al., 1997; Smith and Blobel, 1993; Soullam and Worman, 1993; Soullam and Worman, 
1995), free diffusion requiring proteins to be soluble (Guo and Amemiya, 2005; Talcott 
and Moore, 1999), and nuclear localization signal mediated protein-protein interaction 
transport (Kalderon et al., 1984a; Kalderon et al., 1984b; Rout et al., 2003).   
 
4.1 Soluble Protein Nuclear Trafficking 
Once translated soluble proteins traffic to the nucleus by one of two methods, free 
diffusion or NLS mediated (Rout et al., 2003; Suntharalingam and Wente, 2003; Talcott 
and Moore, 1999).  Nuclear trafficking of soluble proteins that do not interact with the 
NPC are hypothesized to translocate by free diffusion.  Free diffusion is regulated by the 
protein’s size due to the diameter of the central channel of the NPC; the approximate 
size limit for free diffusion through the nuclear pore is 40 kDa (Suntharalingam and 
Wente, 2003; Talcott and Moore, 1999).  Free diffusion is an energy independent 
process.  The protein’s molecular mass is not as important to free diffusion as the 
protein’s functional size, which can be altered by dimerization, complex formation, or 
even transient associations with other cellular factors (Talcott and Moore, 1999).  An 
example of a freely diffusing protein is the green-fluorescent protein (GFP), 
approximately 27 kDa in size.  GFP has been found to freely diffuse in both vertebrate 
cells and in baculovirus infected insect cells (Ogawa et al., 1995; Reilander, Haase, and 
Maul, 1996). 
There are many examples of soluble protein nuclear trafficking, for example there 
are several herpes simplex virus-1 (HSV-1) soluble regulatory proteins.  One is ICP0, 
which localizes to small dense nuclear structures called promelocytic leukemia proteins 
(PML) just before the onset of DNA synthesis with ICP22 and p60 (Bruni et al., 1999; 
Jahedi et al., 1999).  ICP0 is a promiscuous transactivator, which freely diffuses into the 
nucleus.  The protein requires a zinc ring finger and an N-terminal 180aa domain for this 




diffusion to occur.  After the onset of viral DNA replication ICP0 is translocated into the 
cytoplasm where it interacts with elongation factor EF-1δ and is phosphorylated, see 




Figure 8.  Nuclear trafficking of ICP22, ICP0 and p60.  ICP0, a promiscuous transactivator, localizes to 
nuclear dense bodies termed promelocytic leukemia proteins (PML).  Nuclear localization of ICP0 occurs by 
free diffusion; however it requires the zinc ring finger and N-terminal 180aa domains.  ICP0 co-localizes with 
p60 and ICP22 at these PML early in HSV-1 infection.  ICP 22 localizes to the nucleus via its’ two NLS, after 
the onset of viral DNA replication it re-localizes to replicative complexes where it is required for late gene 
expression.  ICP0 is translocated into the cytoplasm, where phosphorylation occurs and it interacts with 
elongation factor EF-1δ.  The translocation of ICP0 and ICP22 results in the nuclear dispersal of p60 a 
relatively new protein of unknown function, hypothesized to localize to the nucleus via it putative NLS (Bruni 
et al., 1999; Jahedi et al., 1999).  A cartoon schematic of the proteins, with the relevant domains denoted, is 
below the trafficking cartoon (Adapted from Bruni et al., 1999; Jahedi et al., 1999). 
 
 
Several soluble proteins traffic through the NPC by a regulated transport, which 
requires a specific interaction with the NPC or an intermediate carrier.  Proteins utilizing 
a receptor/carrier for nuclear trafficking contain a targeting signal and are typically too 
large to freely diffuse through the pore, greater than 40 kDa in size.  This targeting 
signal allows for an interaction between the receptor/carrier, which then interacts 
directly with the components of the NPC.  Targeting signals directing proteins to the 
nucleus are referred to as nuclear-localization signals (NLSs).  In the absence of the 




receptor/carrier, these nucleoproteins have no affinity for the NPC (Hetzer, Walther, and 
Mattaj, 2005; Rout et al., 2003).   
The most common NLS is the KRKK amino acid sequence and variations there of, 
which are found in many nucleoproteins (Kalderon et al., 1984a; Kalderon et al., 1984b).  
Example of a soluble protein with a KRKK signal sequence is SV-40 Large T antigen 
(Kalderon et al., 1984a).  Two HSV-1 soluble proteins, ICP22 and p60, localize to the 
nucleus via NLS transport, see figure 8.  ICP 22 localizes to the nucleus via its’ two 
NLS, after the onset of viral DNA replication ICP22 localizes to replicative complexes 
where it is required for late gene expression.  The translocation of ICP0 and ICP22 
results in the nuclear dispersal of p60 a relatively new protein of unknown function, 
hypothesized to localize to the nucleus via it putative NLS (Bruni et al., 1999; Jahedi et 
al., 1999).   
The receptor/carrier function is performed by the protein super-family of 
karyopherins/importins (Gorlich and Kutay, 1999; Mosammaparast and Pemberton, 
2004; Pemberton and Paschal, 2005; Riddick and Macara, 2005; Talcott and Moore, 
1999).  These receptor/carrier proteins will be discussed and for uniformity of language, 
the importin nomenclature will be used.  These various nomenclatures exist because of 
coincidental discovery by multiple laboratories (Wente, 2000).  NLS mediated import 
requires energy, physiological temperatures, a NLS, and soluble transport machinery 
(Gorlich and Kutay, 1999; Mosammaparast and Pemberton, 2004; Pemberton and 
Paschal, 2005; Riddick and Macara, 2005).  There are three steps in NLS mediated 
nuclear import: (1) docking at the NPC, (2) translocation, and (3) nuclear deposition of 
the cargo, see figure 9 (Kaffman and O'Shea, 1999; Pemberton and Paschal, 2005; Rout 
et al., 2003). 
Docking at the NPC begins as the cargo protein containing the NLS interacts with 
the importin proteins.  This importin protein belongs to the importin-β family of 
proteins, which is characterized by a RanGTP binding domain at the N-terminus.  
Interactions with importin-β is in some cases direct, in others mediated by the NLS 
generated protein-protein interaction with importin-α (Gorlich and Kutay, 1999; 




Kaffman and O'Shea, 1999; Pemberton and Paschal, 2005; Quimby and Corbett, 2001; 
Rout et al., 2003).  The importin-cargo complex then docks with the cytoplasmic fibers, 
which are composed of FG nups.  Translocation through the pore traverses a 200-300 Å 
distance delivering the cargo to the nucleus.  Although this process is least understood 
two hypotheses have been suggested:  (1) the importin-cargo complex could be 
translocated by “hopping” between the FG nups or (2) movement through the pore 
occurs by random non-directed diffusion with an irreversible point committing the 
complex to nuclear diffusion (Bayliss, Corbett, and Stewart, 2000; Gorlich and Kutay, 
1999; Kaffman and O'Shea, 1999; Pemberton and Paschal, 2005; Rout et al., 2003).  
Once the importin-cargo complex has reached the nucleus, the cargo is deposited by 
being displaced from the importin by Ran.  Ran in its GTP-bound form, which is found 
inside the nucleus, binds with more affinity to the importin releasing the cargo.  The 




Figure 9.  NLS mediated nuclear trafficking via importin protein complexes.  Importin α interacts with the 
cargo protein via the NLS binding sites denoted in the cartoon schematic of the protein.  Once importin α 
interacts with the cargo protein the new complex can interact with importin β via importin α beta binding site 
(IBB).  Importin b is then responsible for interacting with the nups of the NPC.  Once through the NPC, the 
importin cargo complex is disrupted, depositing the cargo in the nucleus, by the higher binding affinity of ran-
GTP for the importins.  The importin ran-GTP complex is recycled into the cytoplasm where the ran is 
hydrolyzed freeing the importins for the next round of import (adapted and simplified from Kaffman and 
O'Shea 1999; Rout and Aitchison 2001; Rout et al. 2003; Pemberton and Paschal, 2005).  




and the importin is released (Gorlich and Kutay, 1999; Kaffman and O'Shea, 1999; 
Pemberton and Paschal, 2005; Rout et al., 2003).    
 
4.2 Membrane Protein Trafficking 
Membrane proteins either bind to one leaflet or completely span a lipid bilayer while 
maintaining contact with the surrounding aqueous medium on one or both sides of the 
membrane and the lumen.  There are two types of membrane proteins; integral 
membrane and membrane associated.  Integral membrane proteins typically span the 
membrane with a transmembrane segment or a lipid anchor (von Heijne, 1996).  
Membrane associated proteins, also known as peripheral membrane proteins, typically 
bind to one side, one leaflet, of the membrane or associate by noncovalent interaction 
with other membrane proteins.  Membrane associated proteins interact with a membrane 
either directly or indirectly.  A direct interaction with the membrane is mediated by an 
amphiphilic α-helices and/or a lipid anchor, and an indirect interaction occurs via a 
protein-protein interaction (Kaffman and O'Shea, 1999; von Heijne, 1996).  
Membrane proteins integrate in the membrane in either a co- or post-translational 
manner at the translocons in the ER.  The co-translational integration is where the 
membrane protein is being translated by the ribosome at the same time that the protein is 
being integrated at the translocon.  Because of this membrane proteins are not typically 
translated on cytosolic free ribosomes, but instead at ER bound ribosomes.  Post-
translational insertion occurs after the protein is completely translated, typically from 
cytosolic free ribosomes.   
Co-translational insertion occurs as the ribosome bound nascent chain is targeted to 
the translocation site, termed the translocon, in the ER membrane by binding the signal 
recognition particle (SRP) (Clemons et al., 2004; Johnson and van Waes, 1999; 
Rapoport et al., 2004).  The SRP then targets its membrane receptor in a GTP-dependent 
manner (Johnson and van Waes, 1999; Keenan et al., 2001; Wilkinson, Regnacq, and 
Stirling, 1997).  Co-translational insertion can occur in a SRP independent manner, 
however, this is a rare event (Kalies and Hartmann, 1998).   




There are two different models for the construction of the translocon and 
translocation of the nascent protein based primarily on two different laboratories work, 
the Johnson lab and the Rapoport lab.  The eukaryote translocon is composed of 
minimum of four proteins as it can be successfully reconstituted by these four proteins; 
Sec61α, Sec61β, and Sec61γ (known as heterotrimeric Sec61), and TRAM 
(translocation-associated membrane protein) (Johnson and van Waes, 1999).   The 
Johnson lab proposes that the ER lumen side of the translocon is sealed prior to binding 
by the protein BiP (Johnson and van Waes, 1999).  However, the Rapoport lab proposes 
that the Sec61 complex forms an hourglass pore shape; as such the pore residues fit like 
a gasket around the translocating polypeptides, hindering ions and other small molecules 
from passing.  Rapoport’s group propose that it is this action and not BiP that seals the 
translocons pore (Clemons et al., 2004; Rapoport et al., 2004).   
The resulting complex of RNC (ribosome-nascent chain) with the SRP binds to the 
translocon to begin integration (Johnson, 2005).  Once the nascent chain is about 70 
amino acids in length the Johnson proposes that BiP is released from the lumen side of 
the translocon exposing the nascent chain to the ER lumen (Johnson, 2005).  When the 
transmembrane (TM) sequence of the protein is being synthesized by the ribosome the 
translocon is open to the ER lumen but sealed to the cytosol by the bound ribosome.  
Once the TM sequence is synthesized the lumenal end of the pore is either directly or 
indirectly resealed by BiP.  After a few more residues are added to the nascent chain the 
ribosome seal is broken to allow the cytoplasmic domain of the protein to enter the 
cytosol.  When the synthesis of the protein is complete the TM sequence of the protein 
leaves the BiP sealed translocon as in traffics through the ER with termini in the cytosol 
and lumen of the ER (Johnson, 2003; Johnson, 2005; Johnson and van Waes, 1999). 
However, the Rapoport proposes based on a 3D crystal structure of a non-integrating 
translocon without an attached ribosome that the translocon takes on a clam shell shape 
and as the signal sequence is translated it intercalates between two of the transmembrane 
domains of the Sec61 complex, thus opening the clam shelf.  This destabilizes the 
interactions of the plug helix that keeps it in the center of the Sec61 complex and creates 




the open pore.  The front of the clam shell provides a lateral gate for the hydrophobic 
transmembrane domains to exit into the lipid phase, which would occur sequentially as 
they are synthesized (Clemons et al., 2004; Rapoport et al., 2004).      
Regardless of the models recent crosslinking studies from the Summers and 
Johnson’s labs suggest that membrane protein sorting to the INM for some viral and 
cellular proteins is an active process involving specific non-nuclear proteins (Saksena et 
al., 2004).  These studies found that the first transmembrane sequence of integral 
membrane proteins directed to the INM, photocrosslinked to TRAM, where as non-INM 
directed integral membrane proteins did not.  Because few transmembrane sequences of 
non-INM directed membrane proteins photocrosslink to TRAM, the authors concluded 
that the INM-directed transmembrane sequences occupy different sites within the 
translocon from the non-INM directed transmembrane sequences (Saksena et al., 2004).  
Therefore protein sorting to the INM begins with protein translocation in the ER, a 
process mediated by protein-protein interactions, which has been shown in McCormick 
et al., 2003. 
Post-translational insertion occurs after protein synthesis is complete.  Proteins using 
this mode have a less hydrophobic signal sequence and may therefore escape interacting 
with SRP during synthesis.  Little is known of the membrane targeting mechanism of 
post-translational translocation, but a mechanism has been determined in S. cerevisiae.  
In yeast many of the proteins that function in co-translational translocation have been 
identified as components of post-translational translocation.  In post-translational 
translocation, the channel partners are another membrane protein complex (Sec62/63 
complex) and BiP, a member of the HSP 70 family of ATPases.  These proteins form a 
tetramer which binds with Sec61 to form a seven-component Sec complex (Johnson, 
2005; Kalies and Hartmann, 1998; Osborne, Rapoport, and van den Berg, 2005; 
Rapoport et al., 2004; Wilkinson, Regnacq, and Stirling, 1997). 
The hypothesized mechanism for post-translational translocation is a ratchet method.  
Basically, a polypeptide in the translocon can slide either direction, but binding to BiP 
inside the ER lumen prevents back movement into the cytosol, resulting in translocation.  




There are five stages to this mechanism.  First, before translocation the polypeptide loses 
all bound cytosolic chaperones, allowing it to move into the translocon.  Second, the 
polypeptide is targeted to the translocon, for translocation.  Third, BiP binds to the 
polypeptide as it enters the lumen.  As additional portions of the polypeptide enter the 
lumen, additional BiP molecules bind to it, inhibiting back movement, ratcheting the 
polypeptide further into the translocon.  Fourth, Brownian motion moves the polypeptide 
forward.  And finally fifth, BiP is released upon exchange of ADP for ATP (Johnson, 
2005; Kalies and Hartmann, 1998; Osborne, Rapoport, and van den Berg, 2005; 
Rapoport et al., 2004; Wilkinson, Regnacq, and Stirling, 1997). 
 
4.2.1 Membrane Associated Protein (Peripheral) Nuclear Trafficking 
Membrane associated proteins most often interact in a post-translational manner with 
the ER or other membrane systems.  This is achieved by several mechanisms including 
protein-protein interactions, amphipathic helices, and lipid anchors, all of which are 
possible membrane interactions of E26 as it contains no predictable transmembrane 
domain.  There are several examples in the literature where protein-protein interactions 
account for a membrane interaction and/or localization, including Young Arrest (YA), 
otefin, and the HSV protein UL31 (Goldberg et al., 1998; Liang and Baines, 2005; Liang 
et al., 2004; Mani et al., 2003; Reynolds et al., 2001).  These examples will be discussed.   
An amphipathic helix is a structural motif, which has been found in many classes of 
globular and lipid-associating proteins.  The key feature of an amphipathic helix is the 
presence of two clearly defined faces of the helix, one hydrophobic which interacts with 
the acyl chains of the phospholipids and the other hydrophilic which is oriented towards 
the aqueous phase (Rosseneu et al., 1992).  Having this arrangement allows amphipathic 
helical protein to insert in the out leaflet of a lipid bi-layer.  The amphipathic helix-loop-
helix (HLH) motif has been identified in some developmental regulators and in genes 
coding for eukaryotic DNA-binding proteins, while not directly relevant to membrane 
proteins this might apply to the soluble form of E26.  This motif enables proteins to 




dimerize, and a basic region near this motif to specifically contact DNA (Phoenix et al., 
2002; Rosseneu et al., 1992).   
There are many types of lipid modifications that anchor proteins to a membrane 
system, most are beyond the scope of this dissertation as they do not appear to apply to 
the E26 membrane interaction, however palmitoylation will be discussed as E26 
contains 5 cysteine amino acids which are possible site of palmitoylation.  Protein 
palmitoylation is the addition of fatty acids to a protein through an N-amide or a 
thioester bond.  A thioester bond is also known as S-acylation which is unique in that it 
is the only reversible lipid modification (Linder and Deschenes, 2003).  This lipid 
covalent linking to cysteine amino acids anchors proteins to the membrane as the lipid is 
inserted into the bi-layer of the membrane system.  Palmitoylation is thought to occur by 
a palmitoytranferase (PAT) or acyltransferase in an enzymatic reaction, however there is 
some contradictory evidence as spontaneous palmitoylation can occur in the presence of 
palmitoyl-CoA (Dietrich and Ungermann, 2004).  Palmitoylation can occur anywhere in 
the cell, but predominantly occurs in the ER.  Recently three proteins have been 
identified that are believed to be PATs.  There is no consensus sequence for 
palmitoylation; however the common features of most palmitoylated proteins are a 
membrane targeting sequence near the target cysteines that consist of positive charges, 
adjacent lipid anchors, or transmembrane domains.  Cysteines with proximal polar or 
charged side chains can increase the potential to form a thiolate by as much as six orders 
of magnitude by decreasing the pKa of the target cysteine (Mossner, Iwai, and 
Glockshuber, 2000).  The cysteine located at amino acid 129 in E26 is flanked by 
charged amino acids, figure 4.  Protein-protein interactions have also been theorized to 
influence protein stability, which would increase accessibility of the sulphydryl group or 
change the local pKa of the target cysteine increasing the chances of palmitoylation 
(Bhattacharyya and Wedegaertner, 2000; Dietrich and Ungermann, 2004).  E26 has 
several putative protein interactions including ODV E66, FP25K, IE-1, and actin 
(Beniya, Braunagel, and Summers, 1998; Braunagel et al., 2004; Imai et al., 2004).  The 
interaction with E66 could initiate or promote E26’s membrane association.  




Palmitoylation has also been shown to redirect proteins in the cell.  When these proteins 
become palmitoylated they are redirected from their primary location in the cell to a 
secondary location.  In the case of the 37 kDa phospholipid scramblase 1 protein, 
palmitoylation has been shown to redirect scramblase 1 from the nucleus to the plasma 
membrane.  Scramblase 1 is directed to the nucleus via a non-classical NLS, which 
interacts with importin-α (Ben-Efraim et al., 2004; Chen et al., 2005).  
Trafficking of membrane associated proteins occurs by the same mechanisms of 
soluble and integral membrane protein trafficking, free diffusion, NLS mediated, or 
“diffusion:retention” (For a full explanation of the “diffusion:retention” model please 
see section 4.2.2).  The membrane associated proteins most often interact with the 
membrane after trafficking to their final locations.  Examples of a membrane associated 
proteins with a functional KRKK NLS sequences are the cytidine 5’-




Figure 10.  Cellular trafficking of CTP:CCT.  CTP:CCT catalyzes the formation of cytidine 5’-diphosphate 
choline (CDP choline), which is the head-group donor in the synthesis of phospatidylcholine.  CTP:CCT 
localizes to the nucleus via an N-terminal NLS and alternates between a soluble inactive form and a membrane 
bound active form.  Binding of the membrane domain activates CTP:CCT by relieving an inhibitory constraint 
in the catalytic domain.  The membrane binding domain of CTP:CCT responds to changes in the physical 
properties of phosphatidylcholine deficient membranes.  CTP:CCT binds to the outer leaflet of the ER and 
INM via an amphipathic helix found in domain M of the cartoon schematic of the protein domains.  Domain P 
is a phosphorylation site (Adapted from Cornell and Northwood, 2000; DeLong et al., 2000; Xie et al., 2004; 
Bogan et al., 2005). 




and Young Arrest (YA) protein (Cornell and Northwood, 2000; Dechat et al., 1998; 
Donnelly and Elliott, 2001; Goldberg et al., 1998; Worman and Courvalin, 2000).   
CTP:CCT is a 367 amino acid protein, which exhibits amphitropism, proteins whose 
activities are regulated between an inactive soluble form and an active membrane-lipid-
bound form, see figure 10.  Binding of the membrane domain activates CTP:CCT by 
relieving an inhibitory constraint in the catalytic domain.  The membrane binding 
domain of CTP:CCT responds to changes in the physical properties of 
phosphatidylcholine deficient membranes.  CTP:CCT is soluble, yet becomes membrane 
bound in the cytoplasm and nucleus (DeLong, Qin, and Cui, 2000).  The interaction with 
membranes occurs by an amphipathic helix, allowing the protein to associate with the 
outer leaflet of the INM.  When in the membrane bound state, CTP:CCT catalyzes the 
formation of cytidine 5’-diphosphate choline (CDP choline), which is the head-group 
donor in the synthesis of phospatidylcholine (Bogan et al., 2005; Cornell and 
Northwood, 2000; Xie et al., 2004). 
The nuclear lamins traffic to the nucleus using a NLS and once there bind to proteins 
of the INM (Broers et al., 1999; Gruenbaum et al., 2000).  This interaction with the INM 
occurs because the lamins are prenylated, specifically farnesylated, at their C-terminus 
once in the nucleus, lipid anchoring them to the inner nuclear membrane (Hofemeister, 
Weber, and Stick, 2000).  The exception is lamin C, which is never prenylated (Worman 
and Courvalin, 2000). 
Otefin and Young’s Arrest (YA), Drosophilia proteins, are two other proteins of the 
INM.  These proteins like the others traffic to the nucleus via a NLS.  YA is a 696 amino 
acid hydrophilic protein that lacks any decernable transmembrane domain or known 
membrane-targeting motif similar in this aspect to E26, however once in the nucleus it 
interacts with chromatin and laminas of cleavage-stage embryos in a cell cycle 
dependent manner (Liu and Wolfner, 1998; Lopez and Wolfner, 1997; Mani et al., 
2003).   Otefin is a 45 kDa protein that contains a large hydrophilic domain and a single 
C-terminal 17 amino acid hydrophobic domain.  The C-terminal hydrophobic sequence 
is essential for targeting otefin to the nuclear periphery, however amino acids between 




173 and 372 are required for efficient targeting of otefin to the nuclear envelope.  Amino 
acids between 35 and 172 are required for further stabilization of the otefin-nuclear 
envelope interaction (Ashery-Padan et al., 1997a; Ashery-Padan et al., 1997b; Goldberg 
et al., 1998; Liu and Wolfner, 1998; Lopez and Wolfner, 1997; Padan et al., 1990).     
Two viral proteins of HSV-1, UL34 and UL31, traffic together to the INM.  UL34 is a 
30 kDa integral membrane protein with a 22 amino acid transmembrane domain.  This 
protein localizes to the nucleus where it is required for envelopment of nucleocapsids at 
the nuclear membrane (Yamauchi et al., 2001).  UL34 is believed to traffic to the nucleus 
via lateral diffusion.  UL34 also acts to traffic UL31, a 32 kDa protein, to the nuclear 
envelope.  UL34 it interacts with the UL31 in the cytoplasm  after it is inserted into the 
ER and then the complex of UL34 and UL31 traffic to the nucleus (Reynolds et al., 
2001).  Thus UL31 traffics to the nuclear envelope via a protein-protein interaction as 
demonstrated by the absence of UL34, where UL31 is more susceptible to proteaosome 
degradation and no longer localizes to the nuclear rim, but accumulates in the 
nucleoplasm (Liang and Baines, 2005; Liang et al., 2004; Reynolds et al., 2001; Ye et 
al., 2000).  Transiently expressed UL34, which is membrane associated, is sufficient to 
target UL31 to the nuclear rim in uninfected cells (Reynolds et al., 2001; Yamauchi et 
al., 2001).  UL31 has also been suggested to have roles in both viral DNA synthesis and 
DNA cleavage and packaging (Liang and Baines, 2005).  UL34 and UL31 trafficking 
could be similar in mechanism to ODV E66 and E26 as the putative interaction between 
the E66 and E26 could direct the membrane association targeting this form of E26 to 
ODV envelopes located in the nucleus.   
 
4.2.2 Integral Membrane Protein Nuclear Trafficking 
The prevailing hypothesis states that “diffusion:selective retention” occurs as IMPs 
interact with the endoplasmic reticulum (ER) and traffic to the inner nuclear membrane 
via lateral diffusion (Smith and Blobel, 1993; Soullam and Worman, 1995).  IMPs 
transmembrane segments are inserted into the membrane in either a co- or post-
translational event.  Once inserted in the ER, the protein traffics by laterally diffusing 




through the contiguous membrane of the ER and the ONM.  Nuclear trafficking 
progresses as the integral membrane protein in the ONM traffics through the 10 nm 
lateral channels of the NPC and into the INM.  Trafficking through the lateral channel is 
limited by the size of the cytosolic portion of the protein; however, larger proteins can 
traffic through these channels depending on the orientation of the trafficking protein in 
the membrane (Talcott and Moore, 1999).  Thus proteins with cytosolic domains larger 
that 45-70 kDa should be excluded from the INM as they should not pass through the 
size restrictive lateral channel.  Coincidentally, most of the INM proteins studied have 
cytosolic domains smaller that this limitation supporting the model (Ellenberg et al., 
1997; Lin et al., 2000; Ostlund et al., 1999).  However, one group of INM proteins, the 
Nesprins, recently identified contains cytosolic domains up to 1 mDa in size.  Note, that 
studies on this family of proteins is rapidly progressing, which suggests that there are 
several different isoforms and the INM isoform is yet to be identified (Apel et al., 2000; 
Mislow et al., 2002a; Mislow et al., 2002b; Zhang et al., 2005; Zhang et al., 2001).  
Once the integral membrane protein reaches the INM it is retained via immobilization 
through binding with immobilized nuclear components and/or other resident INM 
proteins.  Proteins lacking affinity for nuclear components should continue to diffuse by 
this model not effectively concentrating to detectible levels. A considerable amount of 
data supports that binding nuclear components is required for accumulation in the INM, 
recently there has been a few papers that suggest that binding is not required and that 
sorting of these proteins to the INM can begin in the translocon (Braunagel et al., 2004; 
Hofemeister and O'Hare, 2005; Ohba et al., 2004; Rolls et al., 1999; Saksena et al., 
2004; Smith and Blobel, 1993). 
Lamin B receptor (LBR) and ODV E66 are model proteins in our studies for integral 
membrane protein localization to the inner nuclear membrane via lateral diffusion 
(Braunagel et al., 1999; Braunagel et al., 2004; Ellenberg and Lippincott-Schwartz, 
1999; Ellenberg et al., 1997; Rosas-Acosta, Braunagel, and Summers, 2001; Saksena et 
al., 2004).  ODV E66 has previously been discussed in the baculovirus section, 1.3.2 
ODV Envelope, of this document.  LBR has also been studied in HSV-1 infected cells, 




where it traffics normally to the INM (Scott and O'Hare, 2001).  Many other integral 
membrane proteins are speculated to traffic by lateral diffusion including nurim, emerin, 
MAN1, UNC-84 and LAPs (Gruenbaum et al., 2000; Rolls et al., 1999; Tews, 1999; 
Worman and Courvalin, 2000).   
 
 




MATERIALS AND METHODS 
 
1 Cells and viruses 
 Sf9 cells, cloned from Spodoptera frugiperda IPLB-Sf21-Ae cells, were infected with 
wild type AcNPV (E2 strain) and various constructed mutant viruses.  Infections were 
performed at various multiplicities of infection (moi) from 0.5-20 as described by 
Summers and Smith, 1987.  Inoculation of the cells with the virus is defined as time 
zero.  Viral inocula were removed after 1 hour of absorption.  
 
1.1 Cloning Techniques  
 During the following cloning experiments many basic cloning protocols were 
performed.  For brevity, a summary of those basic techniques will follow, for complete 
details protocols were followed from Ausubel et al., 1992.  Complete clone maps are 
presented in Appendix B for all cloning strategies and clones.  DNAs used in these 
experiments were restriction enzyme digested with Promega and New England Biolabs 
(NEB) restriction endonucleases.  DNA fragment isolation was performed using 0.5–
2.0% agarose gels via electrophoresis.  Isolated DNAs used in the following cloning 
strategies were purified from the agarose using BioRad’s Gene Clean or Qiagen’s 
QiaQuick gel purification kits.  Once the DNAs were gel purified, the fragments were 
ligated together using Promega T4 DNA ligase overnight at 16 0C.  One microliter of the 
ligation mix was then electrotransformed in to 50 µl of electro-competent E.coli DH5α 
cells using a BioRad Gene Pulser II electrophorator set at 25 µF, 200 Ohms, 1.8kV, with 
a 1 mm gap cuvette.  The transformed mixture was then plated for isolation on LM 
plates containing ampicillin (50 µg/ml) as a selection agent.  Individual colonies were 
grown in liquid medium, from which the amplified resulting vector construct was 
isolated, and sequence confirmed utilizing the Gene Technology Laboratory (GTL, 
Texas A&M University, College Station, TX) service facility. 
 
1.2 Cloning Strategies  
The goals of the cloning strategies are to identify the regions of E26 that are 




responsible for directing E26 to intranuclear microvesicles, identify regions of E26 that 
interact with nuclear membranes, identify possible protein interactions that might assist 
E26 in its nuclear trafficking, and to get a better understanding of the membrane 
associated protein that the da26 gene produces during infection.  A genetic approach was 
employed deleting regions of the da26 gene for investigations using in vitro translations, 
transient expression in uninfected and infected cells, and recombinant virus production.  
These experiments where then used to identify characteristics of the E26 protein relevant 
to the goals stated above.    
 
1.3 Cloning Strategies for Construction of Mutant Viruses 
Three strategies were employed sequentially for the development of regional domain 
deletions of the da26 gene.   
The first strategy (1.3.1 – Knockout) was based on the conclusions of O’Reilly et al., 
1990 and was an attempt to remove the da26 gene and insert the β-glucuronidase gene 
into the da26 locus as a color selector for the identification of the recombinant virus.  
Then truncations of the da26 gene were to be inserted in to the da26 locus to determine 
what function each of the different regions of the gene had on trafficking the protein to 
the nucleus.  This strategy failed as the da26 gene was found to be essential.  The clones 
for this strategy are described in appendix B14-17.   
The second strategy (1.3.2 – Insertion) employed a special recombination vector, 
constructed for this purpose that allowed two of the da26 promoters to be shifted to a 
non-coding region of the virus genome with the full or truncated da26 gene, termed 
regional domains, and appropriate epitope tags.  The epitope tags were required to 
differentiate the products from the second copy of the da26 gene from the native copy.  
This strategy also failed; it was concluded that a trans-acting factor must be missing for 
transcription to occur.  The clones for this strategy are described in appendix B18-50.   
The third strategy (1.3.3 – Polh Promoter) employed the commercially available 
pBAC-gus vector and the intermediate constructs built in the previous strategy, resulting 




in placing the da26 gene and truncations under the polyhedrin promoter.  The clones for 
this strategy are described in appendix B51-58. 
The evolution of the cloning strategies for this project used many of the preceding 
clones in the subsequent strategies.  As such for the ease of the reader the global 
sequential strategy is listed in figure 11, below.  The individual details of each strategy 





 Figure 11.  Sequential cloning of the BV/ODV E26 regional domains.  The da26 gene was truncated to 
produce several regional domains that were used in many different attempts to study E26 localization and 
membrane association.  This is the global strategy of the evolution of the subsequent constructs.  
 
 
1.3.1 Strategy One: Knockout 
In order to knock out or remove the da26 gene from the viral genome the PstI-G 
fragment of the genome was utilized, which had been previously placed into a pUC18 
vector.  As this construct will allow for homologous recombination in the E26 native 
locus, it was altered to remove the bulk of the da26 gene.  The whole gene was not 
removed as the c-terminal region contains the promoter for da16.  The knockout was 
produced by a two step PCR method where the upstream and downstream regions of the 
da26 gene were PCR amplified with a homologous region on the c-terminus or n-
terminus respectively.  The PCR reaction utilized four oligonucleotides:  forward, E26-
S1 and reverse, E26-CS1, and also forward, E26-CS2, and reverse E26-S2, see table 1.  




These oligonucleotides will insert a small MCS in the E26 locus containing 3 restriction 
sites, including SacI, SmaI, and HindIII.  The DNA was amplified using an initial 
denaturation step for 2.5 min at 95 0C followed by 30 cycles of 20 sec at 95 0C, 1 min 30 
sec at 68 0C, 45 sec at 72 0C, and after the thirty cycles for full extension a 7 min period 
at 72 0C.  The PCR products were electrophorated onto a 1.5% agarose gel, from which 
they were cut and gel purified with the Gene Clean III Kit as used in the second stage 
PCR. The second stage PCR used an initial denaturation step for 4 min at 95 0C followed 
by 10 cycles of 20 sec at 95 0C, 1 min 30 sec at 68 0C, 1 min 15 sec at 72 0C.  The E26-
S1 and E26 S2 oligos were then added and the PCR continued with 25 cycles of 20 sec 
at 950C, 1 min 30 sec at 680C, 1 min 15 sec at 720C, and after the thirty cycles for full 
extension a 7 min period at 72 0C.  The resulting PCR product had the da26 gene 
removed from the ATG start to the da16 promoter, the 417th nucleotide of the da26 
gene. The PCR product and the pUC18/PSTI-G vector were digested with NcoI and 
BglII.  The PCR product was ligated into the digested vector and then electrophorated 
into DH5α cells from which the amplified DNA was isolated.  The clone named 




Oligonucleotides used for two stage PCR deletion of the da26 gene and insertion of a new multiple cloning site 
into pUC18/PSTI-G. 
 




E26 S2 CTGACATTTAAACAGATCTCAGTATC 
E26 CS1 GAGCTCTCCCGGGTAAGCTTTTCGATGTTTCGCCTTTGAACGTC 
E26 CS2 AAGCTTACCCGGGAGAGCTCGTAAGGAGACGTTTGGCCGAGC 
 
 
In order to use the SmaI site inserted into the new MCS the SmaI site contained in 
pUC18 had to be removed.  As such the pUC18 vector was digested with EcoRI and 
SmaI.  The digestion mix was phenol:chloroform extracted and the DNA was isolated by 
ethanol washes.  The EcoRI site was then blunted by the exonuclease activity of Mung 




Bean Nuclease (Promega) for 30 minutes at 30 0C.  A second phenol:chloroform 
extraction was performed with an associated ethanol wash.  The resulting blunt ended 
DNA was ligated together overnight to create ∆pUC18 (EcoI-SmaI), described in 
appendix B15. 
The pUC18/∆E26 KO and ∆pUC18 (EcoI-SmaI) were then used to create ∆pUC18 
(EcoI-SmaI)/∆E26 KO, thus making the SmaI site found in the MCS da26 gene locus 
unique.  This was done by digesting both clones with PstI.  PstI restriction sites flank 
both ends of the PSTI-G (∆E26 KO) genome library fragment, which is contained in the 
pUC18/∆E26 KO vector, thus digestion with PstI liberates the altered PSTI-G (∆E26 
KO) insert.  The ∆pUC18 (EcoI-SmaI) contains one copy of the PstI site, which is 
located in its MCS.  The altered PSTI-G (∆E26 KO) library fragment was ligated into 
the digested ∆pUC18 (EcoI-SmaI) vector and then electrophorated into DH5α cells from 
which the amplified DNA was isolated.  The clone named ∆pUC18 (EcoI-SmaI)/∆E26 
KO is described in appendix B16. 
In order to detect the recombinant virus the β-Gus gene was inserted into the E26 
native locus for a color selector during the plaque purification stages of the virus 
production.  The resulting virus is similar to the one constructed in O’Reilly et al., 1990.  
The β-Gus gene was digested from pUC18-β-Gus (commercially available) with SmaI 
and SacI and agarose gel purified using the Gene Clean III kit.  The ∆pUC18 (EcoI-
SmaI)/∆E26 KO vector was also digested with SmaI and SacI and agarose gel purified 
using the Gene Clean III kit.  The β-Gus gene was ligated into the vector and then 
electrophorated into DH5α cells from which the amplified DNA was isolated.  The clone 
named ∆pUC18 (EcoI-SmaI)/∆E26 KO/β-Gus is described in appendix B17. 
Ultimately this strategy failed because purification of the recombinant virus from the 
recombination vector was not possible due to the fact that the da26 gene was found to be 
essential.   
 
 




1.3.2 Strategy Two:  Insertion of second gene copy with promoters 
A homologous recombination vector was constructed to aid in the production of 
recombinant viruses; this vector allows a second epitope tagged copy of BV/ODV E26 
gene with mutations and native promoters (-38 and -262) to be place into the viral 
genome.  The construction of a recombination vector, pEcoRV-MCS, would allow for 




Oligonucleotides used for PCR amplification of the homologous recombination regions and multiple cloning 
site generation for EcoRV-MCS vector. 
 
Name 5’ ----Sequence---- 3’ 
EcoRV MCS 1 GCGTTGACTCGCTGCACCTCGAGCAGTTCG 
EcoRV MCS 2 TCTAGAGCTCCAGATCTGCAGCGGCCGCCCGGGGAATTCCAGTAAG
TTAGGTATTTATTTGCAACTATATATG ATAGACATTTTCC 
EcoRV MCS 3 CCCGGGCGGCCGCTGCAGATCTGGAGCTCTAGATGCCATGGATATC
ACTAGTGGAGATAATTAAAATGATAAATCTCGC 




Figure 12.  pEcoRV-MCS homologous recombination vector.  Note the unique multiple cloning sites with 
the homologous recombination regions up- and downstream.  Note the shifted Orf6 promoters. 




stream the polyhedrin gene.  Construction of this vector occurred in stages.  The first 
stage was to generate the upstream region by PCR for insertion into pUC 18.  The 
upstream region was PCR amplified using two oligonucleotides: forward, EcoRV MCS 
1 and reverse, EcoRV MCS 2, table 2.  The DNA was amplified using an initial 
denaturation step for 2 min 30 sec at 95 0C followed by 30 cycles of 2 min 30 sec at 95 
0C, 1 min 30 sec at 57 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 
10 min period at 72 0C.  The PCR product was digested with XhoI and PstI and the 
pUC18 vector was digested with SfoI and PstI.  The PCR product was ligated into the 
digested vector and then electrophorated into DH5α cells from which the amplified 
DNA was isolated.  Once sequence confirmed, the second stage of the construct was 
initiated, as the downstream region was PCR amplified using two oligonucleotides:  
forward, EcoRV MCS 3 and reverse, EcoRV MCS 4, see table 2.  The DNA was 
amplified using an initial denaturation step for 2 min 30 sec at 95 0C followed by 30 
cycles of 2 min 30 sec at 95 0C, 1 min at 55 0C, 3 min at 72 0C, and after the thirty cycles 
for full extension a 10 min period at 72 0C.  The downstream PCR product and the 
upstream/pUC18 vector were digested with PstI and SnaBI and then ligated into the 
digested vector.  This mixture was then electrophorated into DH5α cells from which the 
amplified DNA was isolated and sequence confirmed, see figure 12.  The clone named 
pEcoRV-MCS is described in appendix B37. 
A series of truncations in the da26 gene were constructed and termed regional 
domains, figure 13.  These truncations were produced in an attempt to identify the 
regions responsible for the membrane association and nuclear localization of E26.  This 
required the truncations to be epitope tagged to allow for the differentiation of the E26 
regional domain from the E26 produced by the infection.  This utilized the T7 epitope 
and antisera to this epitope, which was placed on the c-terminus of the resulting proteins.  
Construction of the regional domains (truncations/mutations) in the second copy of 
the da26 gene required many intermediate constructs to achieve the final clones.  First, a 
modified pUC 19, pUC-JKB, was made with a new multiple cloning sites.  Second, 
epitope tag sequences were added to the pUC-JKB construct for delineation of native  





Figure 13.  Regional domains of BV/ODV E26.  The da26 gene was truncated to produce these regional 
domains.  For comparison the full length gene with the putative domains have been included above.  The 
domains include cysteine amino acids (C) possible palmitoylation sites, nuclear localization signal (NLS), coil-
coil domains regions of protein-protein interactions, and amphipathic helix possible membrane association 
domains.   
 
 
E26 from the additional recombinant copy (Jarvik and Telmer, 1998).  Third, the da26 
promoters, -38 and -262, were cloned into this vector, pUC-JKB-Tag.  Fourth, the E26 
regional domains were cloned into the pUC-JKB-pE26-Tag vector.  Lastly, the 
completed promoter-E26 regional domain-Tag gene was removed and cloned into the 
homologous recombination vector, pEcoRV-MCS for recombinant virus production. 
 The modification of pUC19 was produced through the addition of annealed 
oligonucleotides.  The pUC 19 vector was digested with EcoRI and HindIII allowing the 
ligation of the new multiple cloning site (MCS) between these digested sites using two 
oligonucleotides:  forward, JKB-For and reverse, JKB-Rev, see table 3.  The new MCS 
was required for the addition of enough unique restriction enzyme sites for future clone 
constructs.  The two oligonucleotides were added together in equal molar ratios and  





Oligonucleotides used for creation of unique multiple cloning sites were inserted into pUC19. 
 














Figure 14.  pUC-JKB (A) and pUC-JKB Extended Kpn (B) vector maps.  These two vectors allow for 
intermediate cloning to be achieved before the end result is cloned into the EcoRV-MCS homologous 
recombination vector.  Note the similar MCS to the EcoRV-MCS vector.  There is no red/white selection with 
this pUC based vector as the new MCS inserted a stop codon.   




heated to 95 0C and cooled 0.1 0C per sec until the solution reached 4 0C.  These 
annealed oligonucleotides were added to a known amount of digested and gel purified 
pUC18 DNA and ligated together using T4 DNA ligase from Promega overnight at 16 
0C.  The ligated DNA was then electro-transformed and plated for isolation on LM-Amp 
plates.  Individual colonies were grown in liquid medium, from which the amplified 
resulting vector was isolated, and sequence confirmed, see figure 14A.  The clone was 
named pUC18/19-JKB, and is described in appendix B18. 
During the cloning process it was determined the addition of a KpnI site was needed.  
This site was added by the use of two oligonucleotides: forward, Kpn-For, and reverse, 
Kpn-Rev, see table 3.  The two oligonucleotides were added together in equal molar 
ratios and heated to 95 0C and cooled 0.1 0C per sec until the solution reached 4 0C.  
These annealed oligonucleotides were added to a known amount of digested and gel 
purified pUC18 DNA and ligated together using T4 DNA ligase overnight at 16 0C.  The 
ligated DNA was then electro-transformed and plated for isolation on LM-Amp plates.   
Individual colonies were grown in liquid medium, from which the amplified resulting 
vector was isolated, and sequence confirmed, see figure 14B.  The clone named 




Oligonucleotides used for creation of an epitope region, which were inserted into pUC-JKB extended Kpn. 
 













T7 For TAACATGG CCAGCATGACTGGC GGTCAGCAAATGGGCGCATG 
T7 Rev CGCCCATTTGCTGACCGCCAGTCAT GCTGGCCATGTTAAT 




 Once the pUC18/19-JKB-Ext KpnI was made, the in-frame fusion epitope tag 
sequence was then added.  As it could not be predicted which type of epitope tag would 
perform best under all types of experimental conditions in virally infected cells, three 
different epitope tags were used; T7, Flag, and His (Jarvik and Telmer, 1998).  Two tags 
were placed in each construction, either T7-Flag or T7-His, to give the greatest 
flexibility to all future experiments.  These constructions were produced through the 
addition of annealed oligonucleotides.  pUC-JKB extended was digested with NheI and 
NcoI allowing ligation of the epitope tag between these digested sites using two 
oligonucleotides:  forward, Flag-For for Flag, or His-For for His; reverse, Flag-Rev for 
Flag, or His-Rev for His, see table 4.  The two oligonucleotides were added together in 
equal molar ratios and heated to 95 0C and cooled 0.1 0C per sec until the solution 
reached 4 0C.  These annealed oligonucleotides were added to a known amount of 
digested and gel purified pUC18 DNA and ligated together using T4 DNA ligase 
overnight at 16 0C.  The ligated DNA was electrotransformed and plated for isolation on 
LM-Amp plates.  Individual colonies were grown in liquid medium, from which the 
amplified resulting vector was isolated, and sequence confirmed, see figure 15A. The 
clones named pUC18/19 FLAG Tag and pUC18/19 HIS Tag are described in appendix 
B20 and 21, respectively.   
The T7 epitope tags were then added to each of these clones, pUC-JKB-His and 
pUC-JKB-Flag, with annealed oligonucleotides.  The vector-tag constructs were 
digested with PacI and SphI allowing ligation of the T7 Tag using two oligonucleotides:  
forward, T7-For; reverse, T7-Rev, see table 4.  The two T7 oligonucleotides were added 
together in equal molar ratios and heated to 95 0C and cooled 0.1 0C per sec until the 
solution reached 4 0C.  These annealed oligonucleotides were added to a known amount 
of digested and gel purified pUC-JKB-HIS and pUC-JKB-FLAG DNA and ligated 
together using T4 DNA ligase overnight at 16 0C.  The ligated DNA was 
electrotransformed and plated for isolation on LM-Amp plates.  Individual colonies were 
grown in liquid medium, from which the amplified resulting vector was isolated, and 




sequence confirmed, see figure 15B.  The clones named pUC18/19 FLAG-T7 Tag and 








Figure 15:  pUC-JKB-Tag (A) and pUC-JKB-Tag2 (B) vector maps.  These two intermediate clones were 
constructed allowing for the attachment of an epitope tag sequence.  Figure 15A has either the FLAG or HIS 
epitope tags inserted with a linker arm spacing them from the insertion area of the gene of interest.  This vector 
also has a genenase cleavage sequence to remove the epitope tag.  Figure 15B in the same construct shown in 
Fig 15A with the addition of a second epitope tag, a T7 tag.   
   
 
Table 5 
Oligonucleotides used for PCR amplification of the da26 gene promoter region and insertion into pUC-JKB-
Tag vector. 
 
Name 5’ ----Sequence---- 3’ 










Figure 16.  pUC-JKB-pE26-Tag vector map.  This is an intermediate clone with the addition of the da26 
promoters.  These promoters will allow for similar levels of expression of the recombinant regional domains to 
those of native E26.   
 
 
 With the epitope tags in place the da26 promoters, -38 (CATTA) and -262 
(GACATC), were then added to the vector to allow for native expression of the E26 
regional domains in the mutant viruses.  This was achieved with a PCR strategy allowing 
amplification of the promoters from the viral genome using two oligonucleotides: 
forward, pE26-For; reverse, pE26-Rev, see table 5.  The DNA was amplified using an 
initial denaturation step for 2 min 30 sec at 95 0C followed by 30 cycles of 2 min 30 sec 
at 95 0C, 1 min 30 sec at 57 0C, 1 min at 72 0C, and after the thirty cycles for full 
extension a 10 min period at 72 0C.  The PCR product and the pUC-JKB-Tag vector 
were digested with PstI and NheI to allow for ligation of the promoters into the vector 
and generation of the new MCS to be used for insertion of da26 gene regional domains 
in frame with the epitope tag sequences.  The PCR product was ligated into the digested 
vector and electrophorated into DH5α cells from which the amplified DNA was isolated 
and sequence confirmed, figure 16.   The clones named pUC18/19/pE26/FLAG-T7 Tag 
and pUC18/19/pE26/HIS-T7 Tag are described in appendix B24 and 25, respectively.   
Regional domain constructs were generated by PCR.  For this strategy, the da26 gene 
was divided into 3 relatively equal portions, figure 17.  The oligonucleotides in table 6 
were used in the generation of the regional domains. 
 





Figure 17.  Regional domain cloning strategies.  Regional domain cloning strategies are displayed in this 
figure.  All regional domains of E26 were PCRed from the viral genome using the primers denoted above; the 
sequence of these primers is described in table 8.  Note the E26 protein has been split into almost equal thirds 
for the use in the trafficking studies to follow.  





Oligonucleotides used in PCR amplification cloning strategies for the generation of E26 domains and the 
insertion of those domains into pUC-JKB-pE26-Tag. 
 









E26 Domain #1 
 The E26 regional domain #1 clones, figure 17, were generated with F1 and R1 
oligonucleotides shown in table 6.  The DNA was amplified using an initial denaturation 
step for 2 min 30 sec at 95 0C followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 
58 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 10 min period at 72 
0C.  The PCR product and the pUC-JKB-pE26-Tag vector were digested with KpnI and 
NheI to allow for ligation of the regional domain into the vectors.  The PCR products 
were ligated into the digested vectors and electrophorated into DH5α cells from which 
the amplified DNA was isolated and sequence confirmed.  The clones were named 
pUC18/19/pE26/E26 1/FLAG-T7 Tag and pUC18/19/pE26/E26 1/HIS-T7 Tag, and are 




Figure 18.  E26 regional domain #1 in the homologous recombination vector.  Regional domain 1 will 
examine the role of the C-terminal region in trafficking of the E26 protein.  Note the epitope tags that will be 
used to differentiate the recombinant from the native. 




The regional domain constructs were then digested with PstI and EcoRV to isolate 
the newly constructed E26 regional domains with promoters and epitope tag sequences, 
see figure 17.  These new regional domains were then ligated, using the same restriction 
sites, into the EcoRV-MCS recombinant virus constructs for virus production.  These 
new constructs amplified and sequence confirmed as before, see figure 18.  The clones 
named pEcoRV-MCS/E26 1/FLAG-T7 Tag and pEcoRV-MCS/E26 1/HIS-T7 Tag are 
described in appendix B39 and 40, respectively. 
 
E26 Domain #2 
 The E26 regional domain #2 clones, figure 17, were generated with F2 and R2 
oligonucleotides shown in table 6.  The DNA was amplified using an initial denaturation 
step for 2 min 30 sec at 95 0C followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 
58 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 10 min period at 72 
0C.  The PCR product and the pUC-JKB-pE26-Tag vectors were digested with ApaI and 
SacI to allow for ligation of the regional domain into the vectors.  The PCR product was 
ligated into the digested vectors and electrophorated into DH5α cells from which the 
amplified DNA was isolated and sequence confirmed.  The clones named 
pUC18/19/pE26/E26 2/FLAG-T7 Tag and pUC18/19/pE26/E26 2/HIS-T7 Tag are 




Figure 19.  E26 regional domain #2 in the homologous recombination vector.  Regional domain 2 will 
examine the role of the central region in trafficking of the E26 protein.  Note the epitope tags that will be used 
to differentiate the recombinant from the native. 
 




The regional domain constructs were digested with PstI and EcoRV to isolate the 
newly constructed E26 regional domain with promoters and epitope tag sequences, see 
figure 17.  These new regional domains were then ligated, using the same restriction 
sites, into the EcoRV-MCS recombinant virus constructs for virus production.  These 
new constructs were amplified and sequence confirmed as before, see figure 19.  The 
clones named pEcoRV-MCS/E26 2/FLAG-T7 Tag and pEcoRV-MCS/E26 2/HIS-T7 
Tag are described in appendix B41 and 42, respectively. 
 
E26 Domain #3 
 The E26 regional domain #3 clones, figure 17, were generated with F3 and R3 
oligonucleotides shown in table 6.  The DNA was amplified using an initial denaturation 
step for 2 min 30 sec at 95 0C followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 
58 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 10 min period at 72 
0C.  The PCR product and the pUC-JKB-pE26-Tag vectors were digested with ApaI and 
SacI to allow for ligation of the regional domain into the vectors.  The PCR product was 
ligated into the digested vector and electrophorated into DH5α cells from which the 
amplified DNA was isolated and sequence confirmed.  The clones named 
pUC18/19/pE26/E26 3/FLAG-T7 Tag and pUC18/19/pE26/E26 3/HIS-T7 Tag are 




Figure 20.  E26 regional domain #3 in the homologous recombination vector.  Regional domain 3 will 
examine the role of the N-terminal region in trafficking of the E26 protein.  Note the epitope tags that will be 
used to differentiate the recombinant from the native. 
 




The regional domain constructs were digested with PstI and EcoRV to isolate the 
newly constructed E26 regional domain with promoters and epitope tag sequences, see 
figure 17.  These new regional domains were then ligated, using the same restriction 
sites, into the EcoRV-MCS recombinant virus constructs for virus production.  These 
new constructs were amplified and sequence confirmed as before, see figure 20.  The 
clones named pEcoRV-MCS/E26 3/FLAG-T7 Tag and pEcoRV-MCS/E26 3/HIS-T7 
Tag are described in appendix B43 and 44, respectively. 
 
E26 Domain #1-2 
 The E26 regional domain #1-2 clones, figure 17, were generated with F1 and R2 
oligonucleotides shown in table 6.  The DNA was amplified using an initial denaturation 
step for 2 min 30 sec at 95 0C followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 
58 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 10 min period at 72 
0C.  The PCR product and the pUC-JKB-pE26-Tag vectors were digested with KpnI and 
SacI to allow for ligation of the regional domain into the vectors.  The PCR product was 
ligated into the digested vectors and electrophorated into DH5α cells from which the 
amplified DNA was isolated and sequence confirmed.  The clones named 
pUC18/19/pE26/E26 1-2/FLAG-T7 Tag and pUC18/19/pE26/E26 1-2/HIS-T7 Tag are 




Figure 21.  E26 regional domain #1-2 in the homologous recombination vector.  Regional domain 1-2 will 
examine the role of the C-terminal and central regions in trafficking of the E26 protein.  Note the epitope tags 
that will be used to differentiate the recombinant from the native. 




The regional domain constructs were digested with PstI and EcoRV to isolate the 
newly constructed E26 regional domain with promoters and epitope tag sequences, see 
figure 17.  These new regional domains were then ligated, using the same restriction 
sites, into the EcoRV-MCS recombinant virus constructs for virus production.  These 
new constructs were amplified and sequence confirmed as before, see figure 21.  The 
clones named pEcoRV-MCS/E26 1-2/FLAG-T7 Tag and pEcoRV-MCS/E26 1-2/HIS-
T7 Tag are described in appendix B45 and 46, respectively. 
 
E26 Domain #2-3 
 The E26 regional domain #2-3 clones, figure 17, were generated with F2 and R3 
oligonucleotides shown in table 6.  The DNA was amplified using an initial denaturation 
step for 2 min 30 sec at 95 0C followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 
58 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 10 min period at 72 
0C.  The PCR product and the pUC-JKB-pE26-Tag vectors were digested with ApaI and 
SacI to allow for ligation of the regional domain into the vectors.  The PCR product was 
ligated into the digested vectors and electrophorated into DH5α cells from which the 
amplified DNA was isolated and sequence confirmed.  The clones named 
pUC18/19/pE26/E26 2-3/FLAG-T7 Tag and pUC18/19/pE26/E26 2-3/HIS-T7 Tag are 




Figure 22.  E26 regional domain #2-3 in the homologous recombination vector.  Regional domain 2-3 will 
examine the role of the central and N-terminal regions in trafficking of the E26 protein.  Note the epitope tags 
that will be used to differentiate the recombinant from the native. 




The regional domain constructs were digested with PstI and EcoRV to isolate the 
newly constructed E26 regional domain with promoters and epitope tag sequences, see 
figure 17.  This new regional domain was then ligated, using the same restriction sites, 
into the EcoRV-MCS recombinant virus constructs for virus production.  These new 
constructs were amplified and sequence confirmed as before, see figure 22.  The clones 
named pEcoRV-MCS/E26 2-3/FLAG-T7 Tag and pEcoRV-MCS/E26 2-3/HIS-T7 Tag 
are described in appendix B47 and 48, respectively. 
 
E26 Domain FL 
 The complete da26 gene, figure 17, was PCR generated with the F1 and R3 
oligonucleotides, shown in Table 6.  The DNA was amplified using an initial 
denaturation step for 2 min 30 sec at 95 0C followed by 30 cycles of 30 sec at 95 0C, 1 
min 30 sec at 58 0C, 1 min at 72 0C, and after the thirty cycles for full extension a 10 min 
period at 72 0C.  The PCR product and the pUC-JKB-pE26-Tag vectors were digested 
with KpnI and SacI to allow for ligation of the regional domain into the vectors.  The 
PCR product was ligated into the digested vectors and electrophorated into DH5α cells 
from which the amplified DNA was isolated and sequence confirmed.  The clones 
named pUC18/19/pE26/E26 FL/FLAG-T7 Tag and pUC18/19/pE26/E26 FL/HIS-T7 




Figure 23.  E26 regional domain FL in the homologous recombination vector.  The full length protein will 
examine the trafficking of the protein in the presence of the epitope tags to confirm it traffics normally.  Note 
the epitope tags that will be used to differentiate the recombinant from the native. 




The regional domain constructs were then digested with PstI and EcoRV to isolate 
the newly constructed E26 regional domain with promoters and epitope tag sequences, 
see figure 17.  This new regional domain was then ligated, using the same restriction 
sites, into the EcoRV-MCS recombinant virus constructs for virus production.  These 
new constructs were amplified and sequence confirmed as before, see figure 23.  The 
clones named pEcoRV-MCS/E26 FL/FLAG-T7 Tag and pEcoRV-MCS/E26 FL/HIS-T7 
Tag are described in appendix B49 and 50, respectively. 
 Recombinant genes for the construction of mutant viruses were constructed in a 
homologous recombination vector called pEcoRV-MCS, described above (figure 12, 
page 45, appendix B38).  This vector contains a 2.1 kb upstream and a 0.9 kb 
downstream homologous recombination region for the AcNPV genome.  These 
recombination regions are separated by a multiple cloning site, which has been placed in 
a non-coding region of the viral genome near the polyhedrin gene.  Upon transfection of 
pEcoRV-MCS DNA with Bac-Pak 6 DNA, homologous recombination of the vector 
with BacPak 6 occurs resulting in production of a polyhedra positive recombinant virus 
(Summers and Smith, 1987).   
Recombination occurred and viable mutant viruses were isolated.  These viruses 
however either did not transcribe or translate the recombinant epitope tagged genes.  It 
was concluded from preliminary investigations that trans-acting factors were missing 
that were required by the two da26 promoters, which were used.      
 
1.3.3 Strategy Three: Polyhedrin (Polh) Promoter 
The third strategy employed the commercially available pBAC-gus vector and the 
pIE1-E26 regional domain constructs built in the in vitro translation and transient 
expression strategy (1.4, page 63), resulting in placing the da26 gene and truncations 
under the polyhedrin promoter.  This required an alteration to the pBAC-gus vector to 
allow for cut and paste insertion of the constructs listed in the previous section and 
addition of a single T7 epitope on the c-terminus of the protein.  The pBACgus-1 vector 
was digested with BamHI and SphI to allow for insertion of a new MCS, which was 




generated by annealed oligonucleotides, see table 7.  The two MCS oligonucleotides 
were added together in equal molar ratios and heated to 95 0C and cooled 0.1 0C per sec 
until the solution reached 4 0C.  These annealed oligonucleotides were added to a known 
amount of digested and gel purified pBACgus-1 DNA and ligated together using T4 
DNA ligase overnight at 16 0C.  The ligated DNA was electrotransformed and plated for 
isolation on LM-Amp plates.  Individual colonies were grown in liquid medium, from 
which the amplified resulting vector was isolated, and sequence confirmed.  The clone 




Oligonucleotides used for insertion of MCS into pBACgus-1 vector. 
 











To generate pBACgus-E26#1, the pIE1-E26#1 clone (appendix B8) was used as an 
intermediate and was digested with NcoI and XhoI.  The new vector pBACgus-MCS was 
also digested with NcoI and XhoI and ligated to the insert.  The ligation product was then 
electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  A small sequence was removed from a non-essential region of the 
MCS of the final construct; this should not affect the function of the clone, for details see 
the clone named pBACgus-E26#1 in appendix B52.     
To generate pBACgus-E26#2, the pIE1-E26#2 clone (appendix B9) was used as an 
intermediate and was digested with NcoI and XhoI.  The new vector pBACgus-MCS was 
also digested with NcoI and XhoI and ligated to the insert.  The ligation product was then 
electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pBACgus-E26#2 is described in appendix B53. 




To generate pBACgus-E26#3, the pIE1-E26#3 clone (appendix B10) was used as an 
intermediate and was digested with NcoI and XhoI.  The new vector pBACgus-MCS was 
also digested with NcoI and XhoI and ligated to the insert.  The ligation product was then 
electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  A small sequence was removed from a non-essential region of the 
MCS of the final construct; this should not affect the function of the clone, for details see 
the clone named pBACgus-E26#3 in appendix B54.     
To generate pBACgus-E26#1-2, the pIE1-E26#1-2 clone (appendix B11) was used 
as an intermediate and was digested with NcoI and XhoI.  The new vector pBACgus-
MCS was also digested with NcoI and XhoI and ligated to the insert.  The ligation 
product was then electrophorated into DH5α cells from which the amplified DNA was 
isolated and sequence confirmed.  A small sequence was removed from a non-essential 
region of the MCS of the final construct; this should not affect the function of the clone, 
for details see the clone named pBACgus-E26#1-2 in appendix B55.     
To generate pBACgus-E26#2-3, the pIE1-E26#2-3 clone (appendix B12) was used 
as an intermediate and was digested with NcoI and XhoI.  The new vector pBACgus-
MCS was also digested with NcoI and XhoI and ligated to the insert.  The ligation 
product was then electrophorated into DH5α cells from which the amplified DNA was 
isolated and sequence confirmed.  A small sequence was removed from a non-essential 
region of the MCS of the final construct; this should not affect the function of the clone, 
for details see the clone named pBACgus-E26#2-3 in appendix B57.         
To generate pBACgus-E26 FL, the pIE1-E26#FL clone (appendix B13) was used as 
an intermediate and was digested with NcoI and XhoI.  The new vector pBACgus-MCS 
was also digested with NcoI and XhoI and ligated to the insert.  The ligation product was 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  Two small sequences were removed from a non-essential region of 
the MCS and the T7 epitope sequence of the final construct; this required additional 
cloning to generate the necessary construct, for details see the clone named pBACgus-
E26#FL (NO T7 TAG) in appendix B57.     




To generate pBACgus-E26 FL-T7, the pBACgus-E26 FL (NO T7 TAG) clone 
(appendix B57) was used as an intermediate and was digested with XhoI and BamHI for 
oligonucleotide insertion of the need T7 epitope sequence, table 8.  The two T7 
oligonucleotides were added together in equal molar ratios and heated to 95 0C and 
cooled 0.1 0C per sec until the solution reached 4 0C.  These annealed oligonucleotides 
were added to a known amount of digested and gel purified pBACgus-1 DNA and 
ligated together using T4 DNA ligase overnight at 16 0C.  The ligated DNA was 
electrotransformed and plated for isolation on LM-Amp plates.  Individual colonies were 
grown in liquid medium, from which the amplified resulting vector was isolated, and 





Oligonucleotides used for insertion of T7 epitope into pBACgus-E26 FL (NO T7 TAG) vector. 
 
Name 5’ ----Sequence---- 3’ 
T7 For TCGAGATGGCCAGCATGACTGGCGGTCAGCAAATGGGCG 
T7 Rev CTACCGGTCGTACTGACCGCCAGTCGTTTACCCGCCTAG 
 
 
1.4 Cloning Strategies for in vitro Translation and Transient Expression 
In vitro translation clones were developed to determine how the da26 gene is 
transcribed and translated in infected and uninfected in vitro environments.  In vitro 
translation strategies were employed in an attempt to understand if newly produced E26 
can interact with either dog or insect microsomal membranes.  These experiments went 
further to determine how the newly produced E26 protein interacts with infected and 
uninfected Sf9 microsomal membranes.  The goals of these experiments were designed 
to answer the following questions.  Can E26 interact with a membrane in the absence of 
infection?  Does the E26 membrane interaction require other viral or soluble cellular 
factors?  Is the timing of infection relevant to the E26 membrane interaction?  If an 
interaction between E26 and the microsomes is possible other experiments could be 




performed to determine which amino acids of E26 are responsible for the interaction.  
Two cloning constructs were generated for use in in vitro translation experiments; da26 
was placed under the control of the Sp 6 and T7 promoters in the pGEM vector system 
(Promega P2151 and P2161).  For a detailed cloning map of these constructs reference 
appendix, B1 and B2.   
The da26 gene was PCR generated and placed in the pGEM3z/UTR vector using the 
XbaI and HindIII restriction sites.  The PCR reaction utilized two oligonucleotides:  
forward, E26-N-term-XbaI and reverse, E26-N-HIS-R, see table 9.  The DNA was 
amplified using an initial denaturation step for 2 min 30 sec at 95 0C followed by 30 
cycles of 30 sec at 95 0C, 1 min 30 sec at 52 0C, 45 sec at 72 0C, and after the thirty 
cycles for full extension a 7 min at 72 0C.  The pGEM3z/UTR was digested with XbaI 
and HindIII.  The PCR product was ligated into the digested vector and then 
electrophorated into DH5α cells from which the amplified DNA was isolated and 




Oligonucleotides used for PCR amplification of the da26 gene and insertion into pGEM3z/UTR. 
 







The da26 gene and the UTR region were digested with EcoRI and HindIII from 
pGEM3Z/UTR/E26 and isolated from an agarose gel using the Gene Clean III kit.  This 
insert was then ligated into pGEM4z, which was digested with EcoRI and HindIII.  The 
ligated product was then electrophorated into DH5α cells from which the amplified 
DNA was isolated and sequence confirmed.  The clone named pGEM4z/UTR/E26 is 
described in appendix B2.   
Several clones were generated for use in the transient expression studies.  These 
experiments were performed to determine how the da26 gene is expressed in the absence 




of infection.  Can the E26 protein interact with membranes and are multiple forms of the 
protein produced in the absence of infection?  To extend these studies a T7 epitope tag 
was added to the c-terminus of the da26 gene so that the transfected cells could be 
infected.  The addition of the T7 tag would allow for the differentiation of the transiently 
expressed form from the form or forms expressed by the viral infection.  These 
experiments took the approach of recovery of function or interacting partners as E26 is 
not expressed in the absence of infection as it is a viral protein.  These studies were 
furthered through the use of confocal microscope to determine where E26 locates in an 
uninfected cell.   
The da26 promoters, -38 a.a. (CATTA) and -262 (GACATC), were initially utilized 
in the pUC19/pE26-E26 and pEGFP/pE26-E26 constructs as it was believed that the 
uninfected cell would recognize the da26 promoters and function like the IE-1 promoter 
which is capable of producing transcripts, which results in protein production in an 
uninfected cell.  The da26 promoters were not so capable.  For information about the 
da26 promoters, reference figure 28, page 85.  For a detailed cloning map of these 




Oligonucleotides used for PCR amplification of the da26 gene and insertion into pUC19. 
 





 The da26 gene and promoters (-38 and -262) were PCR generated and placed in the 
pUC19 vector using the HindIII restriction site.  The PCR reaction utilized two 
oligonucleotides:  forward, E26-GFP-F and reverse, E26-N-HIS-R, see table 10.  The 
DNA was amplified using an initial denaturation step of 2 min 30 sec at 95 0C followed 
by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 52 0C, 45 sec at 72 0C, and after the 
thirty cycles for full extension a 7 min period at 72 0C.  The PCR product and pUC19 




were digested with HindIII.  The PCR product was ligated into the digested vector and 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pUC19/E26 (no stop codon) is described in 
appendix B4.    
 The da26 gene and promoters (-38 and -262) were PCR generated and placed in the 
pEGFP vector (Clonetech 6077-1) using the HindIII and BamHI restriction sites.  This 
was done to achieve an auto-fluorescent E26 fusion protein of a size exceeding the free 
diffusion limit of the NPC to confirm regulated nuclear trafficking.  The PCR reaction 
utilized two oligonucleotides:  forward, E26-GFP-F and reverse, E26-GFP-R, see table 
11.  The DNA was amplified using an initial denaturation step for 2 min 30 sec at 95 0C 
followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 54 0C, 45 sec at 72 0C, and 
after the thirty cycles for full extension a 7 min period at 72 0C.  The PCR product was 
digested with HindIII and BamHI and the pEGFP vector was digested similarly.  The 
PCR product was ligated into the digested vector and then electrophorated into DH5α 
cells from which the amplified DNA was isolated. The clone named pEGFP/E26 is 




Oligonucleotides used for PCR amplification of the da26 gene and insertion into pEGFP. 
 





It was found that the -38 and -262 da26 promoters did not produce and transcripts 
and thus no protein in uninfected cells.  As these constructs did not produce protein the 
pIE1-4/E26 construct was produced for a series of transfection experiments to determine 
the how E26 is produced in an uninfected cell for comparison with E26 produced during 
infection, appendix B6.   




Since the above constructs apparently were not transcribed or translated the da26 
gene was PCR generated and placed in the pIE1-4 vector (Novagen 69091-3) using the 
BamHI and BglII restriction sites.  The PCR reaction utilized two oligonucleotides:  
forward, E26-N-HIS-F and reverse, E26-BglII, see table 12.  The DNA was amplified 
using an initial denaturation step for 4 min at 95 0C followed by 30 cycles of 30 sec at 95 
0C, 1 min 30 sec at 58 0C, 45 sec at 72 0C, and after the thirty cycles for full extension a 
10 min period at 72 0C.  The PCR product and pIE1-4 were digested with BamHI and 
BglII.  The PCR product was ligated into the digested vector and then electrophorated 
into DH5α cells from which the amplified DNA was isolated.  The clone named pIE1-




Oligonucleotides used for PCR amplification of the da26 gene and insertion into pIE1-4. 
 





To further the transfection studies and to allow the cells transiently expressing the 
da26 gene to be infected, a series of truncations in the da26 gene were constructed and 
termed regional domains, figure 13.  These truncations were produced in an attempt to 
examine the membrane association and nuclear localization of E26.  This required the 
truncations to be epitope tagged to allow for the differentiation of the transiently 
expressed E26 or truncation there of from the E26 produced by the infection, appendix 
B7-13.  This utilized the T7 epitope and antisera to this epitope, which was placed on the 
c-terminus of the protein.   
These regional domains, figure 13, have been previously produced for a recombinant 
virus production (PCR generation details in the previous section); as such they were cut 
and ligated into a modified pIE1 vector with an altered multiple cloning site (MCS).  
The pIE1-MCS clone was developed by inserting a new MCS using complementary 




oligonucleotides, see table 13.  The pIE1-4 vector was digested with SacII and BglII and 
the annealed oligos were ligated into it overnight.  The oligos were annealed by placing 
equal molar oligonucleotides were placed in a PCR machine heating to 95 0C and slowly 
cooling to room temperature at 0.1 0C per second.  These annealed oligos were then 
added in an approximately 3 molar excess to the vector for overnight ligation.  The 
ligated product was then electrophorated into DH5α cells from which the amplified 
DNA was isolated and sequence confirmed.  The clone named pIE1-MCS is described in 




Oligonucleotides used for insertion of a new multiple cloning site into pIE1-4. 
 







 In order to generate pIE1-E26#1 domain the intermediate recombinant virus clone 
pUC18/pE26/E261/FLAG-T7 (appendix B26) was digested with KpnI and NheI.  The 
new vector pIE1-MCS was digested with KpnI and AvrII, as NheI and AvrII will ligate 
together.  The ligated product was then electrophorated into DH5α cells from which the 
amplified DNA was isolated and sequence confirmed.  The clone named pIE1-E26#1 is 
described in appendix B8.     
In order to generate pIE1-E26#2 domain the intermediate recombinant virus clone 
pUC18/pE26/E262/FLAG-T7 (appendix B28) and the new vector pIE1-MCS were 
digested with ApaI and SacI and ligated together overnight.  The ligated product was 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pIE1-E26#2 is described in appendix B9.     
In order to generate pIE1-E26#3 domain the intermediate recombinant virus clone 
pUC18/pE26/E263/FLAG-T7 (appendix B30) and the new vector pIE1-MCS were 




digested with ApaI and SacI and ligated together overnight.  The ligated product was 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pIE1-E26#3 is described in appendix B10.     
In order to generate pIE1-E26#1-2 domain the intermediate recombinant virus clone 
pUC18/pE26/E261-2/FLAG-T7 (appendix B32) and the new vector pIE1-MCS were 
digested with KpnI and SacI and ligated together overnight.  The ligated product was 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pIE1-E26#1-2 is described in appendix B11.     
In order to generate pIE1-E26#2-3 domain the intermediate recombinant virus clone 
pUC18/pE26/E262-3/FLAG-T7 (appendix B34) and the new vector pIE1-MCS were 
digested with ApaI and SacI and ligated together overnight.  The ligated product was 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pIE1-E26#2-3 is described in appendix B12.     
In order to generate pIE1-E26 FL domain the intermediate recombinant virus clone 
pUC18/pE26/E26 FL/FLAG-T7 (appendix B36) and the new vector pIE1-MCS were 
digested with ApaI and SacI and ligated together overnight.  The ligated product was 
then electrophorated into DH5α cells from which the amplified DNA was isolated and 
sequence confirmed.  The clone named pIE1-E26 FL is described in appendix B13.     
 
1.5 Cloning Strategies for Antibody Production 
 
Table 14 
Oligonucleotides used for PCR amplification of the da26 gene and insertion into pMAL-CRI. 
 





The da26 gene was placed in a pMal vector for the expression and purification of the 
gene in bacteria for the purpose of producing antisera to the gene’s protein product.  The 
pMal-CRI vector was digested with BamHI and HindIII for insertion of the da26 gene, 




which was PCR generated with BamHI and HindIII restriction sites.  The PCR reaction 
utilized two oligonucleotides:  forward, E26-N-HIS-F and reverse, E26-N-HIS-R, see 
table 14.  The DNA was amplified using an initial denaturation step for 4 min at 95 0C 
followed by 30 cycles of 30 sec at 95 0C, 1 min 30 sec at 58 0C, 45 sec at 72 0C, and 
after the thirty cycles for full extension a 10 min period at 72 0C.  The PCR product was 
digested with BamHI and HindIII.  The PCR product was ligated into the digested vector 
and then electrophorated into DH5α cells from which the amplified DNA was isolated.  
The clone named pMAL-cRI/E26 is described in appendix B3.  
 
1.6 Cloning Strategies for Yeast Two Hybrid Direct Cross Studies 
A series of constructs were developed for yeast two hybrid direct cross studies, using 
the pIE1-E26 regional domain clones as intermediate constructs.  These yeast two hybrid 
clones were developed to investigate the E26 – FP25K interaction previously detected in 
the yeast system.  Each of the regional domains found in pIE1-MCS (appendix B8-13) 
were digested with NcoI and SalI to isolate the regional domain insert.  These isolated 
DNAs were gel purified using Qiagen’s QiaQuick kit and ligated into both pACT2 and 
pAS2-1 (Clonetech Matchmaker System).  The pACT2 activation domain vector was 
digested with NcoI and XhoI as SalI will ligate to XhoI.  The pAS2-1 binding domain 
vector was digested with NcoI and SalI.  Twelve constructs were made and sequence 
confirmed and is described in appendix B 59-70.  Unfortunately these yeast two hybrid 
experiments were never performed as other experiments took the project in a different 
direction.  Specifically these constructs were made to identify the regional domain of 
E26 that is interacting with FP25k, this interaction or lack there of as found from the use 
of FP25K deletion virus did not alter the ability of E26 to locate to intranuclear 
microvesicles or interact with membranes.  While the interaction with FP25k is 
intriguing it is outside the primary focus of the project. 
 
2 Recombinant Virus Production 
Recombinant virus production followed protocols outlined in Summers and Smith, 




1987.  In brief, 2 µg of recombinant DNA was co-transfected with 1 µg of Bac Pac 6 
DNA into 2.5x105 Sf9 cells by a calcium phosphate precipitation technique.  The 
recombinant and viral DNA mixture was added to 750 µl of Grace’s medium and 750 µl 
of transfection buffer (25mM HEPES, pH 7.1, 140 mM NaCl, 125 mM CaCl2).  Cells 
were then incubated in the presence of the DNA/transfection mixture for 4 hours.  After 
4 hours the DNA/transfection mixture was removed, the transfected cells were rinsed 
with and grown in fresh TNM-FH + 10% FBS + antibiotics.  The transfected cells were 
incubated 5-7 days at 27 0C and frequently examined for the appearance of infection, 
specifically the production of polyhedra.  The media containing the newly generated BV 
was collected and centrifuged to remove any cell debris.   
The newly generated BV was purified from the background Bac Pac 6 virus by the 
plaque assay technique.  Sf9 cells were seeded into a 60 x 15 mm culture plate at a 
density of 2.0 x 106 cells per plate and allowed to attach.  Ten-fold dilutions were 
prepared from the transfection media containing the newly produced BV or isolated BV 
collected from a previous plaque assay.  Transfection mixes were diluted from 10-3 
through 10-5 and viruses picked from a plaque were diluted from 10-1 through 10-2.  The 
1ml of diluted virus inoculums were added to each plate and allowed to infect for 1 hour.  
After an hour the virus inoculum was removed and the virally infected cells were 
overlaid with 4 mls of 1.5% low melting point (SeaPlaque) agarose made with TMN-FH 
+ FBS.  The LMP agarose was allowed to solidify and the plates were incubated in a 
humidified incubator for 4-7 days at 27 0C.  Plaques were identified in the agarose and 
cored.  The cored plaques were placed in 1 ml of TMN-FH + 10% FBS and the virus 
was allowed to diffuse into the media.  Further plaque assays were performed to further 
purify the virus, if necessary, or the virus was scaled by passage through Sf9 cells.   
To confirm the recombinant virus was made correctly viral DNA was isolated and 
tested for the correct gene insertion with PCR (Invitrogen, 2000).  An aliquot, 750 µl, of 
the first passage of the recombinant virus was microfuged at 5000 rpm for 3 min at room 
temperature.  The viral supernatant was removed and placed in a new microfuge tube 
where 750 µl of 20% polyethylene glycol (PEG) in 1 M NaCl was added.  The mixture 




was inverted several times to mix.  The solution was then microfuged at max speed for 
10 min at room temperature, after which the supernatant was discarded and the pellet 
was resuspended in 100 µl of disruption buffer (10 mM Tris pH 7.6, 1 mM EDTA, and 
0.25% SDS).  In order to degrade the viral proteins and expose the viral DNA for PCR, 
10 µl of Proteinase K (20mg/ml) was added and the mixture was incubated overnight at 
37 0C.  The mixture was then extracted twice with an equal volume of phenol-
chloroform (1:1).  The upper aqueous phase was precipitated with the addition of 1/10 
the total volume of 3 M sodium acetate and 2 volumes of 100% ice cold ethanol.  The 
precipitation was centrifuged at max speed for a minimum of 30 min at 4 0C.  The 
ethanol was removed and the DNA pellet was resuspended in 10 µl of sterile water. 
Once the viral DNA was isolated, the PCR reaction could occur as normal, using 5 µl 
of the DNA.  The two oligonucleotides used in this reaction are critical to correctly test 
for a properly made recombinant virus, see table 15.  The forward oligonucleotide was 
made to a region upstream from where the recombinant gene was inserted.  The reverse 
oligonucleotide was made to the T7 epitope.  Thus, a PCR product of predicted size 
should occur if the gene was properly inserted into the correct region of the viral 




Oligonucleotides used for PCR verification of recombinant virus production. 
 
Name 5’ ----Sequence---- 3’  
EcoRV-For CCATTGTAATGAGACGCAC 
T7 PCR-Rev CCATTTGCTGACCGCCAG 
 
 
2.1 Previously Published Recombinant Viruses 
 Two recombinant viruses, pVLDa26 and vDa26z, produced previously by others 
were used in these studies.  pVLDa26 is an over-expression of the E26 protein by 
placing a second copy of the gene under the polyhedrin promoter.  This virus is reported 
by Benyia et al, 1998.  vDa26z has an in frame insertion of the lacZ gene in the da26 




gene following amino acid #118.  This virus was a gift from Lois Miller and is reported 
by O’Reilly et al, 1990.    
 
3 Antibody Production 
The E26 antiserum 7554 was published in Benyia et al., 1998.  Briefly, the da26 
gene was placed under the polyhedrin promoter and a recombinant virus for the 
abundant expression of E26 was produced.  Polyhedrin-expressed 26 kDa protein was 
cut from SDS-PAGE gels, eluted, and used as antigen for preparation of antibody.  
Rabbits were injected every 28 days, for a total of four injections with antigen (RIBI; 
Hamilton, MA).  To generate high affinity antisera, the second and third injections 
contained approximately one-half the amount of the first injection, and the final injection 
contained approximately one-fourth the initial amount of antigen.  Ten days after the last 
injection, sera were collected and titer was evaluated.   
This serum was found to have a weak affinity for ODV-E25.  To remove this cross-
reactivity the E25 gene was cloned into pGEX for expression in bacteria.  The bacterial 
expressed E25 was collected and bound to a GST beads and exposed to the E26 serum to 
bind the epitopes which cross-react.  This slurry was then tap spun to pellet the beads in 
order to remove the 7554 serum.  The serum was removed and cross reactivity with E25 
was no longer detected by Western blot analysis at 1:500 (appendix A6).  This pre-
absorbed 7554 serum was used in all cases where 7554 was used in this study at a 
dilution of 1:20,000 in Western blot analysis. 
Bacterial expressed E26 was used to produce antiserum in this study by using the 
pMAL-cRI/E26 construct (appendix B3).  E26 was expressed in bacteria according to 
the pMAL-cRI vector system (New England Biolabs).  The E26 protein (26 kDa) was 
then purified using maltose resin or was cut from SDS-PAGE gels, eluted, and used as 
antigen for preparation of antibody.  Rabbits were injected every 28 days, for a total of 
four injections with antigen (RIBI; Hamilton, MA).  The initial injection consisted of 
approximately 200 µg of protein plus adjuvant.  To generate high affinity antisera, the 
second and third injections contained approximately one-half the amount of the first 




injection, and the final injection contained approximately one-fourth the initial amount 
of antigen.  Ten days after the last injection, sera were collected and titer was evaluated.  
Two serums (12499 and 12500) were found to have affinity to E26 as well as a cellular 
protein of approximately the same size.  To remove the cross-reactivity for the cellular 
protein, Sf9 cells were fixed and permeablized for 10 minutes in each of the following 
solutions with three 5 minute washes of 1x PBS pH 7.2 between each solution: 3.7 % 
paraformaldehyde, methanol, and 0.5% Triton X-100 in 1x PBS pH 7.2 in a T-25 flask.  
The 12499 and 12500 antisera were diluted to 1:500 in blocking solution (1x PBS pH 
7.2, 3% BSA, 1% Normal Serum typically chicken, filter sterilize) and exposed to the 
fixed cells for 1 hour.  The supernatant was removed and microfuged for 10 minutes at 4 
0C to remove any cell debris and frozen.  Cross reactivity with the unknown cellular 
protein was no longer detected by Western blot analysis at 1:500 (appendix A7).  Note 
this pre-absorbed serum was used in all cases where either 12499 or 12500 were used in 
this study at a dilution of 1:1,000 in Western blot analysis. 
 
4 Transfection/Transient Expression 
Transfections for transient expression of foreign genes in Sf9 cells were performed 
following protocols outlined in Summers and Smith, 1987.  In brief, 1-10 µg (typically 
2.5 µg) of DNA was transfected into 1.0x106 Sf9 cells by a calcium phosphate 
precipitation technique.  The DNA was added to 750 µl of Grace’s medium and 750 µl 
of transfection buffer (25mM HEPES, pH 7.1, 140 mM NaCl, 125 mM CaCl2).  Cells 
were then incubated in the presence of the DNA/transfection mixture for 4 hours.  After 
4 hours the DNA/transfection mixture was removed, the transfected cells were rinsed 
with and grown in fresh TNM-FH + 10% FBS + antibiotics for the desired time post 
transfection, typically 48 to 72 hours. 
For transfection experiments followed by infection the above protocol was followed 
allowing the cells to recuperate for 48 hours post transfection before infecting them with 
E2 wild type virus at an MOI of 20.  Infections were allowed to progress for 72 to 96 
hours, when the cells were isolated for subsequent experiments.     




5 SDS-Page and Western Analysis 
SDS-PAGE by Laemmli (1970) was performed using vertical slab gels; a 3% 
stacking gel was used above a 15% separating gel.  Samples were denatured in 4x SDS-
PAGE sample buffer for 15 min at 65 0C.  After electrophoresis, SDS-PAGE gels were 
either Coomassie blue stained, dried and exposed to film, or transferred to PVDF 
membrane (Immobilon P) using the wet transfer method (Sambrook et al. 1989).  
Western blot analysis exposed the membrane to 3% Blotto-TTBS (3% nonfat dry milk, 
50 mM Tris-HCl, 150 mM NaCl, and 0.05% Tween-20, pH 7.4) for 1 hour.  The 
membrane was then exposed to primary antibody for 2 hr to overnight.  Following 
exposure to the primary Ab, the membrane was washed 3 times for 5 minutes in TTBS 
(50 mM Tris-HCl, 150 mM NaCl, and 0.05% Tween-20, pH 7.4).  The membrane was 
then exposed to a secondary Ab, appropriate to the primary Ab, which has been 
conjugated to either horseradish peroxidase (ABR) or alkaline phosphatase (Sigma) for 1 
hr.  The membrane was washed 3 times as before and exposed to either 
chemilumenscent reagents or color development.  In the case of chemilumenscent 
reagents the membrane was exposed to x-ray film and the film was developed (Ausubel 
et al., 1992; Harlow and Lane, 1999; Sambrook, Fritsch, and Maniatis, 1989).   
 
6 Immuno-Confocal Microscopy 
Sf9 cells were seeded into a 6 well tissue culture plate at a density of 1x106 cells per 
well and infected with the appropriate virus at varying MOI (typically MOI 20).  After 1 
h p.i. the virus containing media was removed and replaced with fresh TMN-FH + 10% 
FBS + antibiotics.  At the desired time post infection, the infected cells were washed 
from the 6-well plate and collected into a microfuge tube.  The cells were microfuged at 
2000 rpm for 5 min at 4 0C, for collection, the supernatant was removed and replaced 
with Grace’s media, and the cell pellet was gently resuspended.  The cells were pelleted 
again, resuspended as before in Grace’s media, and then counted.  An aliquot of Grace’s 
media containing 2.1x105 cells was transferred to a Cytofuge concentrator and allowed 
to sit undisturbed for 5 min for cell attachment.  The media was aspirated from the 




concentrator and replaced with approximately 300 µl of 3.7% paraformaldehyde in 1x 
PBS pH 7.2, for 10 min for fixation.  The cells were washed 3 times in 1x PBS pH 7.2 
with 3-5 min incubations for each wash.  The final wash was removed and the cells were 
permeablized in room temperature methanol for 10 min.  Further permeablization was 
performed as the methanol was removed and replaced with 0.5% Triton X-100 in 1x 
PBS pH 7.2 for 10 min.  The cells were wash twice as before in 1x PBS (Ausubel et al., 
1992; Harlow and Lane, 1999).   
Once the cells were fixed and permeablized, they were then exposed to the blocking 
solution (1x PBS pH 7.2, 3% BSA, 1% Normal Serum typically chicken, filter sterilize) 
for 1 hr at room temperature with gentle shaking.  The blocking solution was removed 
and replaced with the primary antibody diluted in blocking solution, incubating the cells 
in primary Ab overnight at 4 0C.  The cells were wash in 1x PBS as stated in the 
previous paragraph.  After the final wash, the cells were exposed to the secondary Ab for 
30 min to 1 hr with gentle shaking in the dark at room temperature.  Typically, the 
secondary Ab used in these experiments consists of the Alexa conjugated secondary Ab 
from Molecular Probes.  These antisera were pre-absorbed to fixed and permeablized Sf9 
cells and frozen at a dilution of 1:1000.  The Alexa secondary antibodies were used in 
these experiments at a final dilution of 1:2000 with blocking solution.  The cells were 
again washed 3 times in 1x PBS as previously described and exposed to diluted DAPI 
(1:10,000 in 1x PBS pH 7.2) for 5 sec.  DAPI is a fluorescent dye that labels DNA.  
After exposure to DAPI the cells were again washed 3 times in 1X PBS.  The Cytofuge 
concentrator was removed from the slide and the cells were exposed to 15 µl of anti-fade 
from Dako (Cat S3023).  The cells had a number 1.5 cover slip placed over the cells and 
sealed with nail hardener to prevent desiccation(Ausubel et al., 1992; Harlow and Lane, 
1999).   
Samples were viewed for up to 1 month from preparation date on a Zeiss Axiovert 
135 microscope with a CARV nip-cow spinning disk confocal attachment.  Data 
collection was performed using a Hamamatsu Orca or Orca ER cameras with either 




Atto’s CARVer or Zeiss’ Axiovision software.  Deconvolution software, Zeiss KS-400, 
was utilized on some specific images.    
 
7 In vitro Transcription and Translation 
In vitro transcription was performed using Ambion mMessage mMachine high yield 
capped RNA transcription kit (Cat # 1344).  This kit uses RNA polymerase in 
conjunction with the T7 promoter for RNA production.  The protocol accompanying the 
Ambion kit was followed for the generation of all RNA used for in vitro translation 
experiments.  In brief, the gene of interest was place into a vector containing the T7 
promoter.  This construct was linearized to increase RNA yield.  The transcription 
reaction was assembled from the following component; 10 µl of NTP/CAP, 2 µl of 10x 
reaction buffer, 1 µg of linear DNA, and 2 µl of enzyme.  The reaction was brought to 
20 µl with nuclease-free water.  The transcription reaction was incubated for 2 hr at 37 
0C to allow for transcription.  After 2 hr the template DNA was removed from the 
mixture with the addition of DNAse 1, which was incubate for 15 min at 37 0C.  The 
RNA was precipitated by LiCl method and quantified on an RNA TBE denaturing 
agarose gel.  The RNA was stored in nuclease free water and stored at -80 0C. 
In vitro translation was performed as per Promega’s Rabbit Reticulocyte Lysate 
System instructions.  The Promega’s Canine Pancreatic Microsomal Membranes were 
also used in conjunction with the Rabbit Reticulocyte Lysate System in certain 
experiments.  In brief, the RNA was titrated into the Rabbit Reticulocyte Lysate (RRL) 
system in 25 µl reaction volume.  In addition to the RNA and the RRL, an amino acid 
mixture minus cysteine, 35S Cysteine, and RNAsin were all added to the reaction.  These 
additions add the amino acids required for protein production, a radiolabeled amino acid 
for identification of the translated protein, and inhibitors of RNases that might degrade 
the input RNA.  Once the optimal quantity of RNA was found for any reaction, future 
experiments were conducted with that quantity.  To determine translation in the presence 
of membranes, Canine Pancreatic Microsomal Membranes (CPMM) was also added to 




the translation mixture.  These experiments were Triton-X114 extracted to determine if 
the translated protein fractionates with the membrane or aqueous fractions.   
 
7.1 Salt Extraction of in vitro Translated Proteins 
Salt extraction of in vitro translate proteins followed protocols outlined in Borel and 
Simon, 1996 with modification from Mothes et al., 1997.  In brief a 25 µl in vitro 
translation reactions translated in the presence of microsomal membranes were overlaid 
onto a 100 µl sucrose pads (0.5 M sucrose, 120 mM potassium acetate, 3 mM 
magnesium acetate) and centrifuged at 100,000 RPMs in a Beckman TL-100 
ultracentrifuge using a TLA-100 rotor for 5 min at 4 oC.  This was done to remove the 
soluble proteins and anything not associated with the microsomal membranes.  The 
supernatant generated by this centrifugation was labeled the sucrose supernatant.  The 
sucrose pellet fraction containing the microsomal membranes and associated proteins 
was resuspended in 25 µl of a low salt/sucrose buffer (250 mM sucrose, 100 mM 
potassium acetate, 5 mM magnesium acetate, 50 mM HEPES-KOH pH 7.9).  This 
mixture was overlaid on to a 100 µl of a high salt/sucrose pad (250 mM sucrose, 500 
mM potassium acetate, 5 mM magnesium acetate, 50 mM HEPES-KOH pH7.9) and 
centrifuged at 130,000 x g for 10 min at 4 oC in a TLA 100 rotor.  The salt supernatant 
was collected, which contains membrane associated proteins.  The salt pellet fraction 
was also collected, which contains integral membrane proteins.  All volumes were 
normalized with the low salt/sucrose buffer and an equal volume of 4X SDS-PAGE 
buffer was added prior to loading on an SDS-PAGE gel.   
 
8 Primer Extension Analysis 
Primer extension techniques were used to map transcription initiation (Sambrook et 
al. 1989).  The three oligonucleotide probes shown in the table 16 were 5’ end 
radiolabeled with T4 polynucleotide kinase (Promega).  Cellular mRNA, 3-5 µg, was 
probed against these radiolabeled oligonucleotides and allowed to hybridize.  The 
oligonucleotides were extended with MMLV reverse transcriptase (SuperScript II) in the 




presence of RNAsin (40U, Promega) and Actinomycin D (1.5µg, Promega).  The 
extension products were analyzed by denaturing gel electrophoresis (Gel Conditions).  
The primer extension oligonucleotides were used in sequencing reactions following the 




Oligonucleotides used for primer extension experiments for the identification of the da26 gene promoters. 
 
Name 5’ ----Sequence---- 3’  
E26 Ext #1 GTCAAACTGTTCACAGAACCGACCGG 
E26 Ext #2 CCCCTCTCAAAAAAACCAGGTAAATAATGG 
E26 Ext #3 GTAGGCGCGTTAAACAACACGTCG 
 
 
9 Triton X-114 Detergent Extractions 
Phase separation of membrane proteins by Triton X-114 was performed as per 
Bordier, 1981 and modified by Rosenberg 1996.  In brief, the Triton X-114 was prepared 
by adding 2 ml of Triton X-114 to 100 ml of cold TBS in a graduated cylinder.  The 
detergent-TBS solution was thoroughly mixed and allowed to stand overnight at 37 0C.  
The lower layer of approximately 10-20 ml is enriched in detergent.  The upper 
detergent depleted liquid was aspirated away and discarded.  The lower layer was 
adjusted to 100 ml with cold TBS and thoroughly mixed.  As before, the detergent-TBS 
mixture was allowed to stand overnight at 37 0C.  Again, the upper detergent depleted 
liquid was removed leaving a stock solution of Triton X-114 at 11.4%, which will be 
used in the experiments that follow (Bordier, 1981; Rosenberg, 1996). 
A cell lysate from 5x106 cells was prepared by adding 1 ml of the 11.4% Triton X-
114 stock prepared above.  The mixture was incubated with mild agitation for 1 hr at 4 
0C.  Cell debris was removed from the mixture by centrifugation at max speed for 10 
min at 4 0C.  The supernatant was removed and loaded directly onto 100 µl of sucrose 
cushion buffer (6% Sucrose, 0.6% Triton X-114 in TBS).  The microfuged tube was 
placed in a heat block, allowing for the formation of the two phases, detergent and 
aqueous for 3 min at 37 0C.  The tube was then centrifuged for approximately 5 min for 




further separation of the two layers at 400 x g at 37 0C.  The upper aqueous layer was 
transferred to a new microfuge tube and incubated on ice.  The detergent layer was 
resuspended in 500 µl of cold TBS and incubated on ice.  The detergent fraction was 
then taken through the incubation and centrifugation again at 37 0C.  The new aqueous 
layer was added to the previous aqueous layer and incubated on ice.  The detergent 
fraction containing the membrane proteins was resuspended in 2 ml of cold TBS and 
incubated on ice.  The combined aqueous fractions were re-extracted by adding 50 µl of 
11.4% Triton X-114 stock solution, which was mixed and incubated for 3 min at 37 0C.  
After the incubation, the aqueous layers were centrifuged as before.  The aqueous phase, 
containing water-soluble proteins, was carefully removed from the detergent layer and 
incubated on ice.  The detergent and aqueous fractions were run on an SDS-Page gel that 
was transferred to a PVDF for Western blot analysis, allowing for localization of the 
protein of interest in the two fractions (Bordier, 1981; Rosenberg, 1996).  
 
10 Palmitoylation 
Virally infected cells were metabolically labeled with [3H] palmitate and immuno-
precipitated with the E26 antisera 7554 to determine if the E26 protein incorporates the 
radiolabel and is thus lipid anchored to the membrane.  Protocols were followed from 
Zhang et al., 2003.  In brief, 2x106 Sf9 cells were infected at an MOI of 20 allowing the 
infection to progress to 34 h p.i.  At 34 h p.i. the infected cells were metabolically 
starved by incubating in Grace’s media minus FBS for 1.5 hours.  Then 800 µl of 
Grace’s media plus 0.5% FBS and 500 mCi of [3H] palmitate was added to the infected-
starved cells for 8 hours.  These cells were then collected for immunoprecipitation.   
The radiolabeled cells were lysed by exposing them to 700 µl of RIPA buffer (150 
mM NaCl, 1% NP40, 0.5% Deoxycholic Acid, 0.1% SDS, 50 mM Tris pH8, 10 µg/ml 
leupeptin) and agitating for one hour on a rotation spindle.  The lysed cells were then 
centrifuged at 16,000 x g for 10 minutes to remove the insoluble material.  Antisera were 
then added (25 µl); GP64 (pos control), pre-immune (neg control), and E26 7554 and the 
mixture was incubated for 1 hour at 4 0C.  Next, 50 µl of Immuno Pure Plus (G) 




immobilized protein G beads were added and the mixture was again incubated for 1 hour 
at 4 0C.  The bound protein was then pelleted for collection by centrifugation at 16,000 x 
g for 10 min.  The pelleted beads were washed twice with RIPA buffer with the beads 
being resuspended in 40 µl of 1x disruption buffer (125 µM Tris-HCL, 1% SDS, 2.5% 
mercaptoethanol, 10% glycerol, 0.2% bromophenol blue).  Proteins liberated from the 
beads were separated through a 15% SDS-PAGE gel, which was fixed in 25% 
isopropanol – 10% acetic acid solution for 10 min.  An Enhancer solution was added to 
help with the detection of the tritium label for 30 min according to the manufactures 
instructions.  The film was then dried and exposed to x-ray film.   
 
11 MALDI-TOF Mass Spectrometry 
The proteins from a total cell extract of 18 h p.i. Sf9 cells were separated on a 15% 
SDS-PAGE.  The separated proteins were stained with Coomassie blue, subjected to in-
gel trypsin digestion and then analyzed using matrix assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) MS (Mortz et al., 1994).  The 28 and 26 kDa regions of 
the gel were excised from the gel and further cut into 8 pieces, 3 pieces in the 28 kDa 
region and 5 pieces in the 26 kDa region.  The separated proteins in these gel fragments 
were subjected to in-gel trypsin digestion and analyzed by using a matrix assisted laser 
desorption/ionization time of flight MSMALDI-TOF was performed on an Applied 
Biosystems Voyager-DE STR MALDI-TOF mass spectrometer. The databases were 
searched using the Profound (http://prowl.rockefeller.edu/cgi-bin/ProFound) or Mascot 










1 Recombinant Virus Production 
Through the course of this dissertation a major effort was placed on making 
recombinant viruses containing truncations/mutations in the da26 gene, table 17.  Three 
different recombinant strategies were attempted with only limited success.  The first 
recombinant strategy was based on the conclusions of O’Reilly et al., 1990.  The 
conclusions in O’Reilly et al., 1990 were found to be incorrect in the process of this 
study.  They reported that the da26 gene was not essential, however in their studies they 
were working with a virus with either an incomplete recombination event or 
contaminated with a wild type helper virus that was beyond the detectable limits at the 
time the paper was published.  The second recombinant virus strategy used these 
truncation/mutation regional domains in a non-coding region of the viral genome with 2 
of the 4 da26 promoters.  However, an incomplete understanding of the da26 promoters 
yielded 12 viruses that do not express recombinant protein.  The third recombinant virus 
strategy did yield a virus used in these studies, however several of the regional domain 
viruses still failed to express recombinant protein.  This resulted in the construction of 6 




Tally of the attempts at regional domain recombinant virus production.  Several attempts were made to 
construct recombinant viruses containing truncations/mutations “regional domains” in the da26 gene.  These 
attempts yielded few productive results. 
 
Recombinant Virus Strategy Failed Viruses Functional Viruses 
Strategy 1: Knockout 1 0 
Strategy 2: Insertion 12 0 
Strategy 3: Polh Promoter 5 1 
 
 
2 Multiple Forms of BV/ODV E26 
 
Benyia et al., 1998 reported during viral infection that the da26 gene produces 
multiple forms of the protein of 34, 28, 26, and 18 kDa sizes as detected by antisera to  






Figure 24.  Temporal Time Course Western blot.  Western blot of E26 from cell extracts of wild type 
infected cell extracts (5µg/lane) using pAb E26 7554 (1:20,000).  This technique detects as many as four 
immuno-reactive bands to the E26 antisera at 34 (top arrow), 28 (red arrows), 26 (middle three arrows), and 18 
(bottom arrow) kDa.  The Western blot was optimized to detect the 28 and 26 kDa forms of E26.  The 28 and 
26 kDa forms were presented in Benyia et al. 1998 as the 26 kDa broad diffuse banding pattern resulting from 
multiple protein species.  LRU = Low range unstained marker, PP = Precision prestained marker, E2 = AcNPV 
E2 strain infected Sf9 cells, hpi = hours post infection.  Protein sizes were originally determined by unstained 
standards, most experiments in this dissertation utilize prestained standards, and as such molecular weights 
were established and kept for consistency, see appendix A1 for a more detailed explanation.   
 
 
E26 (7554): they identified 3 forms of E26 migrating at or near 26 kDa.  Figure 24 is a 
similar Western blot to the one presented in Benyia et al., 1998 to confirm these results.  
Each of these 26 kDa forms was immuno-selected and Benyia found that each immuno-
selected sera cross-reacted with each of the other protein forms, thus it was concluded 
they were the same protein.  Through the course of this project an alternative denaturant, 
DTT, was  tested and was found to more fully denature the 3 band smear at 26 kDa into 
two bands, supporting Benyia et al., 1998 (appendix figures A2 and A3). 
To compare the effects of infection and possibly the effects other viral proteins on 
the production and localization of the different forms of E26, the da26 gene was placed 
into the pIE1-4 vector for transient expression of E26 in uninfected cells to analyze the 
immunoreactivity of the different E26 protein products (pIE1-4/E26, appendix B6).  A 
Western blot analysis of the cells transiently expressing the da26 gene detects a single 
28 kDa band, figure 25 lane Tr Sf9.  A 28 kDa form of the protein is detectable during  
 





Figure 25.  Temporal Time Course Western blot II.  Western blot of E26 from cell extracts transiently 
expressing E26 (20µg/lane) compared to a temporal time course wild type infected cell extracts (5µg/lane) 
using pAb E26 7554 (1:20,000).  This technique detects as many as four immuno-reactive bands to the E26 
antisera at 34 (top arrow), 28 (red arrows), 26 (middle two arrows), and 18 (bottom arrow) kDa.  The Western 
blot was optimized to detect the 28 and 26 kDa forms of E26.  The 28 and 26 kDa forms were presented in 
Benyia et al. 1998 as the 26 kDa broad diffuse banding pattern resulting from multiple protein species.  
Identification of the transient form as a single 28 kDa species has not been previously identified (red arrow).  Tr 
Sf9 = Transfected Sf9 cells, E2 = AcNPV E2 strain infected Sf9 cells, hpi = hours post infection.  Protein sizes 
were originally determined by unstained standards, most experiments in this dissertation utilize prestained 
standards, and as such molecular weights were established and kept for consistence, see appendix A1 for a 
more detailed explanation.   
 
 
viral infection as early as 18 h p.i., right hand red arrow.  The Western blot presented in 
figure 25 was optimized to detect the 28 and 26 kDa forms of E26.   
To confirm that the da26 gene produces at least two of the multiple forms detected 
by the 7554 antiserum MALDI-TOF mass spectrometry analysis was performed on an 
18 h p.i. E2 infected total cell extract.  This analysis was performed by Dr. Bill Russell 
in the TAMU/Laboratory for Biological Mass Spectrometry (LBMS) under the direction 
of Dr. Dave Russell.  The proteins in this extract were separated on a 15% SDS-PAGE 
gel allowing two regions to be cut from the gel corresponding to 28 and 26 kDa.  These 
regions were then trypsin digested for analysis by mass spectrometry.  Amino acid  





MALDI-TOF identification of amino acid fragments from an 18 h p.i. cell extract separated on a 15% SDS-
PAGE.  Two amino acid fragments corresponding to computer predicted trypsin digested fragments of E26 
were identified in each of the corresponding molecular weight regions of the SDS-PAGE gel.  Total sequence 
coverage of E26 from these fragments for each individual region was 7%. 
 
Da26 Product Position Amino Acid 
Sequence 
28 kDa 66-73 NTHLNFNK 





26 kDa 66-73 NTHLNFNK 







Figure 26.  Maldi-TOF analysis of an 18 h p.i. E2 infected total cell extract.  Mass spectrometry was 
performed on an 18 h p.i. E2 infected total cell extract separated on a 15% SDS-PAGE gel (25µg/lane).  The 
double arrow region was excised for the 28 kDa form and the area between the single black arrows was excised 
and cut into 5 pieces according to the Coomassie labeling.  Masses corresponding to E26 amino acid fragments 
were found in both the 28 and 26 kDa regions of the gel.  In the 26 kDa region in the middle band, band 3 as 
denoted by the red arrow.   
 
 
fragments were identified with molecular weights corresponding to computer predicted, 
trypsin digested, E26 amino acid fragments.  Two of these E26 amino acid fragments 
were identified in each the 28 and 26 kDa regions of the SDS-PAGE gel denoted by the 
double headed arrow and the red arrow, figure 26 and table 18.  
 




       
Figure 27.  Western blot of E26 from cells transiently expressing E26 and then virally infected.  A c-
terminal T7 epitope sequence was added to the e26 gene which was then place under the pIE-1 promoter.  This 
construct was then transiently expressed in uninfected cells producing a single protein of approximately 28 kDa 
(red arrow) as detected in the total cell extract (10µg/lane).  When these cells transiently expressing E26-T7 
were then infected and examined by Western blot analysis two protein products were detected by the T7 
antiserum at approximately 28 (red arrow) and 26 kDa (black arrow) as detected from total cell extract 
collected (25µg/lane). T = Transfected Sf9 cell extracts, T/I = Cells transiently expressing E26 that were then 
wild type infected 
 
 
To reaffirm the existence of the 28 and 26 kDa species during infection a transient 
expression followed by infection experiment was performed using pIE1-E26 FL-T7 
(pIE1-E26 FL, appendix B13).  The T7 epitope with restriction sites used in its addition 
adds 23 amino acids to the c-terminus of the E26 protein.  As seen in figures 25 and 26, 
the da26 gene when transiently expressed produces a 28 kDa protein in uninfected cells.  
The E26-T7 fusion construct when transiently expressed in uninfected Sf9 cells also 
produces a single protein product of approximately 28 kDa, see figure 27 lane T.  To 
confirm the effects of infection on the expression of the da26 gene, cells transiently 
expressing the E26-T7 fusion were infected with wild type virus.  These cells were 
transfected with E26-T7, allowed to recover for 48 h post transfection, and then infected 
with E2 virus.  Transfected-infected cells were then collected at 72 h p.i. and prepared 
for Western blot analysis using the T7 antiserum to detect the fusion proteins produced 




by the transient expression/infection process.  Notice after infection a protein 
approximately 2 kDa smaller than the higher molecular weight protein is produced, 
figure 27.  Therefore, viral infection alters the protein produced by the da26 gene, 
resulting in the production of 28 and 26 kDa forms.  Recall that the two proteins 
produced are larger than the 28 and 26 kDa forms of native E26 due to the addition of 





Figure 28.  Western blot of total cell extracts from cells infected with polh E26-T7.  Western blot 
comparing the different protein detected by the E26 7554 and T7 antisera.  The 7554 antiserum detects the 
native E26 as well as some slightly higher molecular weight bands corresponding to the detection by the T7 
antiserum.  The recombinant protein E26-T7 expressed by the polyhedra promoter produces multiple molecular 
weight proteins as detected by the T7 antiserum.  The ~28 kDa molecular weight transiently expressed protein 
is not detected as strongly by the E26 7554 antiserum as by the T7 antiserum; note the double ended red arrow 
depicting this band.  The double headed arrow depicts the 28 kDa form produced by the native gene and the 
single headed red arrow depicts the ~28 kDa form produced by the E26-T7 gene placed under the polyhedron 
promoter.  The native gene produces the 34 (top left black arrow), 28 (double headed red arrow), 26 (middle 
left black arrow), and 18 (lower left black arrow) kDa.  The E26-T7 gene produces the ~34 (top right black 
arrow), ~28 (right red arrow), and ~26 (middle right black arrow) kDa.  The 18 kDa form equivalent is not 
detected.  The reason the bands are referred to as approximately X kDa is due to the size increase created by the 
addition of the T7 epitope. 
 
 
To further investigate the roll infection plays on the expression of the E26 protein the 
recombinant virus, polh E26-T7, was created and used to infect Sf9 cells for time course 
analysis by Western blot using T7 antiserum, figure 28.  In this virus the T7 epitope adds 




15 amino acids to the c-terminus of the E26 protein (pBACgus-E26 FL-T7, B58).  
Detection of multiple E26-T7 protein products was possible late in infection.  Recall that 
the polh promoter is a late promoter of baculovirus with protein expression beginning at 
approximately 18 h p.i.  The recombinant protein is detected as early as 18 h p.i. and by 
48 h p.i. multiple E26-T7 protein forms are detected by the T7 antiserum.  When 
compared to the proteins expressed by da26 as detected by the E26 7554 antiserum, 
weak detection of the recombinant E26-T7 protein is noted (large head red arrow, lane 
48 and 72 h p.i.), which could be indicate less binding efficiency of the 7554 to the 
recombinant protein as equal protein amounts were loaded in each lane of the SDS-
PAGE gel.  Even when the recombinant E26-T7 protein is transiently expressed in 
uninfected cells only weak detection of the fusion is noted by the 7554 antiserum; 
however the T7 antiserum strongly detects the recombinant protein as noted when the 
two Tr Ex lanes are compared.  The weak detection of the 28 versus 26 kDa forms is 
probably due to lower binding efficiencies of the serum; indicate few shared epitope in 
the polyclonal antisera; or a possible masking of epitopes by altering the protein folding 
due to the addition of the T7 epitope.   
As the da26 gene produces multiple forms of related proteins during infection and 
these forms appear to be expressed at later time points of infection; investigation into the 
promoters used to transcribe the da26 gene was performed.  Due to the fact that the 
multiple forms of related proteins are detected late in infection the identity of the late 
promoter responsible for production of the late forms of E26 is critical, as the previously 
identified da26 promoter CATTA, 38 nucleotides upstream of the protein’s ATG start, 
was classified as an early promoter.  Also this information was needed for production of 
recombinant viruses developed in an attempt to study the regional domains of E26. 
Primer extension was used to precisely locate the 5’ end of the transcripts containing 
the da26 gene.  This analysis used three different reverse strand oligonucleotides to 
identify promoters at various lengths from the initiation site of the da26 gene.  Four 
promoters producing transcripts containing the da26 gene were identified at various 
lengths from the initiation site including two that are over 780 nucleotides from the da26  






Figure 29.  Primer extension.  Three different reverse strand oligonucleotides were used to identify the 5’ 
ends of transcripts containing the e26 gene.  Four promoters producing transcripts containing the e26 gene were 
identified at various lengths from the initiation site including two that are over 780 nucleotides from the e26 
methionine initiation.  These are the CATTA promoter, 38 nucleotides upstream of the initiation site; the 
GACATC promoter, 262 nucleotides upstream; the TAAG promoter, 783 nucleotides upstream; and the TAAG 
promoter, 838 nucleotides upstream.  The e26 gene is transcribed by the CATTA promoter as early as 2 h p.i. 
and is maximally produced between 6-12 h p.i.  The other three promoters’ produces transcripts at much lower 
level predominately at later times during infection starting at 12 h pi and continuing throughout the 72 h pi time 
point of this experiment.   
 
 
methionine initiation, see figure 29.  The CATTA promoter, 38 nucleotides upstream of 
the initiation site, was previously identified by Guarino and Summers, 1988.  Three 
additional promoters were identified for the da26 gene including GACATC, 262 
nucleotides upstream; TAAG, 783 nucleotides upstream; and TAAG, 838 nucleotides 
upstream.  The da26 gene is transcribed by the CATTA promoter as early as 2 h p.i. and 
is maximally produced between 6-12 h p.i.  The other three promoters’ produces 
transcripts at much lower levels, predominately at later times during infection starting at 
12 h pi and continuing throughout the 72 h pi time point of this experiment.  Other 
promoter factors such as cis or trans-acting elements may yet be identified as in an 
unrelated experiment when the first two promoters (-38 and -262) of the da26 gene were 




shifted to a non-coding region of the viral genome with the da26 gene, no recombinant 
protein was produced from a viable infection.   
The data presented above addresses the conclusions of Imai et al., 2004 which states 
that the protein identified as BV/ODV E26 is not encoded by da26, but is encoded by 
another gene.  The authors found that the E26 antisera 7554 was unable to detect or 
weakly detected ORF8, but exhibited a strong cross reactivity with another slightly 
smaller protein.  Recall that orf8 is a homolog of the AcNPV da26 gene from BmNPV, 
which has a 97% identity and a 98% similarity to the AcNPV da26 gene.  The 
transfection/infection and polhE26-T7 infection studies, figure 27 and 28, using the T7 
epitope demonstrate that the da26 gene does indeed produce at least the 28 and 26 kDa 
forms of E26 and the mass spectrometry data, figure 26, confirms this finding.  To 
further examine this issue a Western blot analysis was performed to compare the antisera 
used to detect the ORF8 protein with the E26 antiserum 7554.  An antiserum derived 
from bacterial expressed da26, 12500, was also used in this analysis to help explain the 
Imai et al., 2004 results.  The membrane associations of these two forms will be 
addressed shortly as this point was also questioned in the Imai et al., 2004, publication.     
Antibodies produced to protein expressed by the da26 gene in bacterial cells (αOrf8 
and α12500) detect a single protein on a Western blot at approximately 28 kDa (right 
red arrow figure 30).  However, antibodies produced to protein expressed by the da26 
gene in AcNPV infected insect cells (7554) detect the multiple protein forms of da26 on 
a Western blot.  These multiple forms include 34, 28, 26, and 18 kDa forms (left arrows: 
black, red, black, black, respectively figure 30).  The forms are detected late in infection 
as opposed to the single 28 kDa form which is detected as early as 6 h p.i. in the Western 
blot in figure 30.  The data presented in figures 27 and 28 demonstrate that viral 
infection alters the protein expressed by the da26 gene, therefore protein expressed in 
the absence of infection does not produce the 26 kDa form, figures 25-28, and sera 
derived from protein expressed in the absence of infection is unlikely to detect the 26 
kDa form.  Also of interest the sera derived from bacterially expressed protein are used 
in a Western blot at a dilution of 1:1000, with sporadic results given at this dilution by  






Figure 30.  Western blot of total cell extracts comparing αE26 7554, αOrf8, and α12500 antisera.  
Western blots comparing the different protein detected by antisera produced against virally and bacterially 
expressed E26.  AcNPV E2 produced E26 was used to generate αE26 7554 (1:20,000) in rabbits.  Bacterially 
expressed BmNPV Orf 8 (E26 homology) was used to generate αOrf8 (1:1000) by Imai et al. 2004 in rats and 
bacterially expressed AcNPV E26 was used to generate α12500 (1:2000) in rabbits.  The protein produced in 
bacteria that were used for antibody production detect a 28 kDa protein (red arrow), however the virally 
produced protein used for antibody production detects multiple forms at 34 (top black arrow), 28 (red arrow), 
26 (middle black arrow), and 18 (lower black arrow) kDa.  The green arrow denotes cross reactivity of αOrf8 
with some cellular protein as it appears in the uninfected mock lane. 
 
 
the Orf8 serum.  The antiserum produced to protein expressed during infection detects 
both the 28 and 26 kDa forms and is used at a 1:20,000 dilution.  If the sera derived from 
protein expressed in bacterial has fewer epitopes to the shared domains of the 28 and 26 
kDa forms they would be less immuno-reactive to the 26 kDa form than the serum 
derived from protein collected from infected cells.  However, the inverse would not be 
true as the serum derived from protein collected from infected cells expresses both forms 
of the protein and is more immuno-reactive as it must be extensively diluted for use. 
 
 
3 BV/ODV E26 Membrane Association 
Previous studies have been conflicting, indicating that E26 is a membrane protein 
and/or a soluble protein.  Imai et al., 2004, state that they were unable to detect ORF8, 




an E26 homolog, as an envelope protein of either BV or ODV in BmNPV.  In order to 
address this issue and determine the ability of E26 to associate with membranes several 
studies were performed, which indicate that the 28 kDa form of E26 is soluble and that 
the 26 kDa form can be membrane associated.  These results are consistent with the Imai 
et al., 2004 data when you consider that they were unable to detect the 26 kDa form and 





Figure 31.  Triton X-114 extraction of infected total cell extracts.  E2 infected cells were extracted with 
triton x-114 detergent to fractionate the proteins into three fractions, insoluble (INS), detergent (DT), and 
aqueous (AQ).  These fractions were then used in a Western blot to determine how E26 fractionates under these 
conditions.  Samples were optimized to view the 28 and 26 kDa proteins detected by the E26 7554 antiserum 
(1:20,000), however only the 26 kDa form (black arrow).  The total cell extracts (TCE) were also placed on 
these Western blots for a positive control (5µg/lane).  E26 fractionates into the detergent fraction of the wild 
type infected cells and 24 and 48 h p.i.  
 
 
Wild type infected cells were extracted with triton X-114 detergent to fractionate the 
cellular proteins into three fractions; insoluble, detergent, and aqueous.  This protocol 
determines if a protein is considered to be a membrane or soluble protein.  These 
fractions were then examined in a Western blot to determine where E26 fractionates with 
these extraction conditions (figure 31).  Samples volumes were loaded on the SDS-
PAGE gels to optimize the detection of the 28 and 26 kDa proteins with the E26 7554 




antiserum.  The total cell extracts (TCE) were used as positive controls.  E26 was not 
detected using these conditions at 6 h p.i. as denoted in the first four lanes of the Western 
blot shown in figure 31.  At 24 and 48 h p.i., the 26 kDa form was detected in the TCE 
lanes as well as the detergent fraction lanes (DT) but was not detected in the insoluble 
(INS) or aqueous (AQ) fraction lanes (figure 31).  Therefore, the 26 kDa form is 





Figure 32.  Triton X-114 extraction of polh E26-T7 infected total cell extracts.  polh E26-T7 infected cells 
were extracted with triton x-114 detergent to fractionate the proteins into three fractions, insoluble (INS), 
detergent (DT), and aqueous (AQ).  These fractions were then used in a Western blot to determine how E26 
fractionates under these conditions using T7 antiserum.  The total cell extracts (TCE) were also placed on these 
Western blots for a positive control (5µg/lane).  The ~28 kDa form of E26 fractionates (left red arrow) 
predominantly into the insoluble fraction early, 18 h p.i.  However, with the progression of infection, 24 h p.i. 
and beyond, E26 fractionates, into the insoluble, detergent, and aqueous fractions.  Specifically the ~28 kDa 
form (right red arrow) fractionates into the insoluble, detergent, and aqueous fractions.  The other forms, ~34 
and ~26 are detected at low levels in the insoluble fraction at 24 hpi as denoted by the black arrows. 
 
 
To further study the membrane association of E26, the recombinant virus polh E26-
T7 was constructed placing a second copy of the da26 gene containing a c-terminal T7 
epitope tag under the polh promoter.  The T7 epitope adds 15 amino acids to the c-




terminus of the protein (pBACgus-E26 FL-T7, B58).  Cells were infected with polh E26-
T7, harvested at the corresponding time post infection and extracted with triton X-114 
detergent to fractionate the proteins into three fractions; insoluble, detergent, and 
aqueous.  Western blot was then used to determine where E26-T7 fractionates, figure 32.  
The total cell extracts were used as a positive control.  The bulk of E26 fractionates into 
the insoluble fraction initially after the recombinant protein is expressed at 18 h p.i. with 
some protein detected in the aqueous fraction.  At 24 h p.i. and later, E26 fractionates 
between the insoluble, detergent, and aqueous fractions.  This indicates that the 
membrane association of the 26 kDa form is a temporal phenomenon and that the 
membrane association occurs independently from the size differences exhibited by other 
forms of the protein.  
To determine how E26 is interacting with membranes in the absence of a predictable 
transmembrane segment, several protein modifications known to result in membrane 
association were examined: these included protein-protein interactions, amphipathic 
helices, and lipid anchors.  Recall that by cross-linking using a BS3 (a lysine-lysine cross 
linker) E26 is in close proximity to the INM-SM of E66 in the microsome, E26 contains 
putative amphipathic helices, and cysteines, which are potential sites for the thioester 
bonds in palmitoylation.  Due to the nature of triton X-114 extractions, only proteins 
tightly associated with the membrane, integral or lipid anchored, will typically 
fractionate into the detergent fraction (Bordier, 1981).   
Because E26 is tightly associated with the membranes in the triton X-114 
extractions, palmitoylation studies were performed to determine if it is lipid anchored to 
the membrane, figure 33.  Cells were infected with wild type virus.  At 34 h p.i. the cells 
were starved and palmitic acid labeled with 3H added.  The cells were then collected and 
protein immunoprecipitated using the 7554 E26 antiserum.  As reported the baculovirus 
protein gp64 is palmitoylated and therefore was used as a positive control in these 
experiments, figure 33A (Zhang, Han, and Blissard, 2003).  The immunoprecipitation 
using the E26 antiserum isolated one labeled protein migrating between the 20 and 25 
kDa markers, see figure 33B.  This band corresponds to the major 26 kDa detected in the  






Figure 33.  Detection of palmitoylated E26.  Cells were infected with wild type virus.  At 34 h p.i. the cells 
were starved and then fed palmitic acid labeled with 3H.  The cells were then collected and lysed for use in an 
immunoprecipitation using the 7554 E26 antiserum.  Antibodies to gp64 were used as a positive control, see 
part A (black arrow denote gp64).  The immunoprecipitation using the E26 antiserum isolated one labeled 
protein migrating between the 20 and 25 kDa markers, see part B, black arrow denote E26 26 kDa form (recall 
relative mobility difference between prestained and unstained standards).  This band corresponds to the major 
26 kDa band of E26 detected in the Western blot in part C.  Top right black arrow denotes 34 kDa form, red 
arrow denotes 28 kDa form, middle black arrow denotes 26 kDa form, and the lower black arrow denotes the 
18 kDa form.   
 
 
Western blot in figure 33C.  The nature of this type of experiment does not allow for the 
Western blot to be performed on the same gel as the immunoprecipitation (IPP).  This is 
due to the IPP being labeled with radioactive 3H, which requires extended exposure time 
(typically greater than 6 months) to identify the radioactive incorporation in to the 
protein of interest.  As palmitoylation of a protein occurs at cysteine amino acids, thus 
anchoring the protein to the membrane via a lipid anchor, the 5 cysteine amino acids of 
E26 are suspect, with specific interest focused on the cysteine at amino acid 129.  This 
cysteine is of particular interest as it is surrounded by charges which increase the 
likelihood that it is palmitoylated.  However, any of the cysteines could be palmitoylated 
during infection.  These cysteine amino acids, specifically the three located in the C-
terminal region are conserved in the E26 homologues found in other baculoviruses, see 
figure 34.  






Figure 34.  Baculovirus E26 homologues and the conserved cysteines.  The cysteine amino acids are 
possible sites for palmitoylation of the E26 protein.  Note the high conservation of the cysteines located in the 
C-terminal portion of the protein.   
 






Figure 35.  Triton X-114 extraction of uninfected total cell extracts.  Uninfected transiently expressing E26 
cells were extracted with triton x-114 detergent to fractionate the proteins into three fractions, insoluble (INS), 
detergent (DT), and aqueous (AQ).  In uninfected cells when E26 is transiently expressed it fractionates into the 
insoluble and aqueous fractions and only produces a 28 kDa protein product (red arrow).  
 
 
As the membrane association of the 26 kDa form has been found to be palmitoylated 
during infection, studies to characterize the 28 kDa form were performed to address the 
issues of membrane association stated in the Imai et al., 2004 paper.  Recall that their 
antiserum derived from bacterially expressed protein only detected the 28 kDa form.  
I’ve shown that the 28 kDa form is the only form detected in cells transiently expressing 
the da26 gene, figures 25-27, therefore these cells were extracted with triton X-114 
detergent to fractionate the proteins into three fractions; insoluble, detergent, and 
aqueous.  These fractions were tested by Western blot to determine the distribution of 
E26 in these fractions, figure 35.  The 28 kDa form was detected in the insoluble and 
aqueous fractions instead of the detergent fraction as found for the 26 kDa form during 
infection, figure 35 lanes INS and AQ.  Therefore the 28 kDa is a soluble protein in 
uninfected cells, which is consistent with the results in Imai et al., 2004 as this is the 
only form they were detecting. 
To further understand this, cells were transfected with the da26-T7 gene and then 
infected to determine the effects of infection on the membrane association of the 28 kDa 




form.  The da26 gene was placed in frame with a T7 epitope tag at the c-terminus of the 
gene and the fusion was placed under the pIE1 promoter in the vector pIE1-4 (pIE1-E26 
FL, B13).  The addition of the c-terminal T7 epitope adds 23 amino acids to the E26 
protein.  This was done to allow for expression of an epitope tagged form of E26 in 
order to discriminate it from the other forms of E26 produced during infection from the 
native gene locus.  One set of Sf 9 cells was transfected with the da26-T7 gene (pIE1-
E26 FL, B13) and tested by Western analysis using antisera to the T7 epitope as a 
positive control, figure 36 Transient Expression lanes.  Another set of cells was 
transfected with da26-T7, allowed to recover for 48 h post transfection, and then infected 
with E2 virus.  Transfected-infected cells were then collected at 72 h p.i. and prepared 
for Western blot analysis using the T7 antiserum to detect the fusion proteins produced 
by the transient expression/infection process, figure 36 Transient Expression/Infection 
lanes.  As shown in figure 36 the da26-T7 gene produces one protein product migrating 
at approximately 28 kDa and this form fractionates into the insoluble and aqueous 
fractions consistent with the data in figure 35.  However, when da26-T7 transfected cells 
were infected with E2 virus 48 h after the cells were transfected and analyzed by 
Western blot analysis, five protein products were detected in the AQ lane by the T7 
antisera including 2 predominant bands at approximately 28 and 26 kDa and as many as 
3 minor bands, see figure 36.  The 3 minor bands are visible on the original Western blot 
film and depending on the printing of this reproduction are only slightly visible.  The 28 
kDa and 26 kDa forms were detectable in the insoluble lane.  Therefore the 28 kDa form 
expressed from da26 is a soluble protein in infected and uninfected cells and the 
alteration or expression of the 26 kDa form during infection is independent of its 
membrane association.  This is consistent with a possible post-translational modification 
of the protein, specifically with palmitoylation which is a reversible post-translational 
lipid anchor.  This observation is consistent with the observations of Imai et al., 2004 in 
that they were only detecting the 28 kDa soluble form of E26/ORF8 which is why they 
were unable to identify it as a BmNPV ODV or BV envelope protein. 
 






Figure 36.  Triton X-114 extraction of cells transiently expressing E26-T7 and cells that are transiently 
expressing E26-T7 that have then been infected.  E26-T7 fractionates as E26 did in the previous figure, 35, 
in uninfected cells (Red arrow on left).  However when the cells that are transiently expressing E26-T7 are 
infected with wild type virus and then fractionated with triton X-114 multiple forms are detected.   Multiple 
forms of E26 are detected in the aqueous lane indicating that the E26-T7 protein is altered during infection, 
arrows on right.  Red arrow on right denotes 28 kDa, top black arrow is slightly larger than 28 kDa, the lower 
three black arrows on the right could represent the 26 kDa equivalents.   Note the vertical black arrow in the 
insoluble lane pointing to the 26 kDa equivalent in that lane. 
 
 
Previous crosslinking studies identified E26 in close proximity to the in vitro 
translated INM-SM of E66 in wild type infected insect microsomal membranes and in 
vitro from infected enriched nuclei membranes (Braunagel et al., 2004).  Microsomal 
membranes are prepared from cell extracts and are made predominantly of endoplasmic 
reticulum.  The enriched nuclei factions contain intact nuclei with attached ER and are in 
vitro translation competent.  The INM-SM of E66 contains a transmembrane segment 
that has been demonstrated to insert into these microsomes in a co-translational 
translocation fashion (Saksena et al., 2004).  The crosslink of the INM-SM and E26 was 
initially identified by mass spectrometry from in vitro translations performed using the 
enriched nuclei preparation.  This was confirmed by in vitro translating the INM-SM in 
infected Sf9 microsomal membranes, crosslinking (amine-amine), and extracting 
proteins in close proximity by IPP using sera to the epitope tagged INM-SM.  E26 was 




identified in these IPP by Western blot analysis using the 7554 E26 antiserum.  Because 
E26 was found to associate with membranes during infection and found in these 
microsomes a series of in vitro translations were performed to determine if newly 
produced E26 could associate with microsomal membranes in vitro.   
First, E26 RNA was translated in vitro with canine pancreatic microsomal 
membranes (CPMM) to determine if the protein will associate with the membranes in 
the absence of the other insect and viral proteins as it is the standard membrane system 
used in these types of studies.  In vitro translations with infected and uninfected Sf9 cell 
microsomal membranes will be presented shortly.  The CPMMs were collected from in 
vitro translated E26 reactions by pelleting them through a sucrose cushion.  This allowed 
the proteins associated with the CPMMs to be salt extracted to determine if in vitro 
translated E26 associates with the canine membranes.  In vitro translations (totals) were 
placed on the Western blot as a positive control for the in vitro translation of E26 
protein.  The protein detected in the sucrose supernatant is the soluble form, which is not 
incorporated into the membranes, note that a single ~28 kDa form of E26 is detected; 
this could correlate to the same 28 kDa soluble form found in infected and uninfected 
cells.  The sucrose pellet contains the CPMMs and any protein associated with these 
membranes.  Very little E26 is detected in the sucrose pellet fraction.  When the CPMMs 
are exposed to a high salt cushion and centrifuged the integral membrane proteins 
fractionate with the CPMMs into the salt pellet fraction and the membrane associated 
protein fractionate into the salt supernatant fraction.   The small portion of E26 found to 
fractionate with the CPMMs after the initial sucrose pellet, which removed the soluble 
protein, is fractionated into the salt supernatant at barely detectable levels, figure 37.  
Therefore the ~28 kDa form, produced by in vitro translation of da26 in the presence of 
CPMMs is predominantly a soluble protein. 
To further the above experiments and determine the effects of cellular and viral 
integral membrane proteins on the membrane association of E26, in vitro translation 
studies were performed with uninfected and infected Sf9 microsomal membranes 
(UIMM and IIMM respectively).  The da26 RNA was in vitro translated in the presence  






Figure 37.  Salt extractions of in vitro translated E26 in the presence of canine pancreatic microsomal 
membranes.  E26 RNA was in vitro translated in the presence of canine pancreatic microsomal membranes 
and then salt extracted to determine if the newly produced E26 is incorporated into the membranes.  The 
sucrose supernatant is the E26 not incorporated into the membranes (black arrow).  The sucrose pellet contains 
the membrane associated form of E26.  When salt is applied the E26 associating with the membranes 
fractionates into the supernatant fraction, however this is a minimum of the total E26 produced.   
 
 
of these Sf9 microsomal membranes and then salt extracted to determine if the in vitro 
translated E26 is incorporated into insect membranes in the absence of the soluble 
cellular and viral components.  In vitro translations (totals) were placed on the Western 
blot as a positive control for the in vitro translation of E26 protein, figure 38 Total.  The 
E26 detected in the sucrose supernatant is the soluble form of the protein, which is not 
incorporated into the membranes; note that a single ~28 kDa form is detected in the 
sucrose supernatant of the uninfected microsomal membranes, which could correlate to 
the same 28 kDa soluble form found in infected and uninfected cells.  The sucrose 
supernatant of the infected microsomal membranes contains 5 other protein bands, 2 of 
larger molecular weight and 3 of smaller molecular weight.  This could indicate that the 
modification of E26 into its multiple forms is capable of occurring in the presence of 
infected microsomal membranes and the proteins that associate with them or this could  






Figure 38.  Salt extractions of in vitro translated E26 in the presence of uninfected and infected 
microsomal membranes.  E26 RNA was in vitro translated in the presence of uninfected and infected 
microsomal membranes and then salt extracted to determine if the in vitro translated E26 is incorporated into 
the membranes.  Salt extraction protocols were followed from Borel and Simon, 1996 with modifications from 
Mothes et al., 1997.  The protein contained in the sucrose supernatant is soluble protein, therefore not 
incorporated into the membranes and thus removed before salt extracting the remainder.  The sucrose pellet 
contains the forms interacting with membranes.  When salt is cushion is applied and centrifuged the membrane 
associated forms fractionate into the salt supernatant and the integral membrane proteins fractionate into the salt 
pellet.  The E26 associating with the infected microsomal membranes fractionates into the supernatant fraction 
in the broad band detected above.  Slightly more E26 associates with the infected microsomes over the 
uninfected; however this is a very small portion of the total.  Note the appearance of additional forms of E26 in 
the infected microsomes that are not visible in the uninfected microsomes.  Top arrow on right is 34 kDa, red 
arrow on right is 28 kDa, lower three arrows correspond to the 26 kDa smear.       
 
 
be partial degradation and random incorporation of the radioactive label that identifies 
these proteins.  The sucrose pellet contains the UIMM and IIMMs in the respective 
experiments and any protein associated with these membranes.  Very little or no E26 is 
detected in the sucrose pellet fraction of the UIMMs; however a small amount of E26 is 
detected in the sucrose pellet fraction of the IIMMs.  When the UIMM and IIMMs are 
exposed to a high salt cushion and centrifuged the integral membrane proteins 
fractionate with the membrane in the salt pellet fraction and the membrane associated 
protein fractionate into the salt supernatant fraction.   As very little or no E26 was 
detected in the UIMM sucrose pellet, no E26 protein should be identified in either the 




salt pellet or the salt supernatant, which is the case and indicates that E26 when in vitro 
translated in the presence of UIMMs is a soluble protein of ~28 kDa.  The small portion 
of E26 found to fractionate with the IIMMs after the initial sucrose pellet, which 
removed the soluble protein, is fractionated into the salt supernatant at low levels in the 
broad band shown in the corresponding lane of figure 38.  Therefore ~28 kDa form, 
expressed by in vitro translation in the presence of UIMMs is a soluble protein.  The E26 
expressed by in vitro translations in the presence of IIMMs is predominantly soluble 
with low levels detected peripherally associating with the infected microsomal 
membranes.  The E26 lipid anchor previously identified would not be accountable for 
this membrane association as it would have caused the lipid anchored protein to 
fractionate into the salt pellet fraction.  These data imply that the soluble viral and 
possibly soluble cellular components likely have a role in the membrane association of 
E26. 
 
4 BV/ODV E26 Localization 
Deciphering the localization of E26 is important (yet is difficult) as there are multiple 
forms of E26 detected by the antisera 7554.  In an attempt to identify how and when E26 
localizes to the nucleus in infected and uninfected cells immuno-confocal microscopy 
(ICM) was performed.  E26 localization during infection has been well studied after 6 h 
p.i. however the earlier time points during infection have not been examined.  An 
extensive time course analysis of E26 localization as detected by αE26 7554 and ICM 
detects E26 in punctate regions of the cytoplasm between 1 and 4 h p.i., figure 39 top 
row of micrographs.  By 6 h p.i. E26 is detected in discrete regions in the nuclear 
periphery, figure 39.  In Beniya et al., E26 localized to electron dense regions of the 
nucleus and cytoplasmic membranes at 6 h p.i. as detected by immuno-electron 
microscopy (IEM).  At this stage of infection the observations made in Benyia et al., 
1998 are consistent with the results as are the micrographs presented in Imai et al., 2004.  
E26 accumulates in discrete nuclear regions between 8 and 12 h p.i. and by 12-24 h p.i. 
(figure 39) starts to accumulate in regions of the nucleus not labeled by the DNA dye 




DAPI.  It is at this 12 h p.i. time point where E26 localization presented by Imai et al., 
2004 differs from my results and Benyia et al., 1998.  During the later stages of 
infection, 16-72 h p.i., E26 localized to distinct regions peripheral to but in close 
proximity to formation of the virogenic stroma, figure 39 bottom row.  For a better 
clarification of the distinct regions proximal to the virogenic stroma see figure 40 page 
106.  The E26 localization correlates with E26 localization by IEM presented by Benyia 





Figure 39.  Immunoconfocal micrographs of wild type infected Sf9 cells.  E26 localization during infection 
was determined using E26 7554 antiserum to detect E26 in fixed Sf9 cells.  The E26 antiserum was visualized 
by an Alexa 488 secondary antibody, which carries a fluorophore when excited, emits detectible light at 488 
nm.  The emission detected is pseudo-colored green in the above micrographs.  The blue color is the cellular 
and viral DNA as detected by the dye DAPI.     
 
 
I’ve shown in figures 35 and 36 (pages 98 and 99, respectively) that when the da26 
gene is transiently expressed in uninfected cells, the 28 kDa form is soluble.  ICM was 
performed to determine where the soluble 28 kDa form localizes in the cell.  The 28 kDa 
form in expressed in cells transiently expressing the da26 gene localizes to discrete 




regions of the nucleus, denoted in green as detected by the E26 antiserum 7554.  The 
INM’s location is denoted through the use of an antiserum to a drosophila lamin, ADL 
67, depicted in red and DAPI labels the DNA depicted in blue, figure 40.  There are no 
intranuclear microvesicles produced in uninfected cells, so this localization in 
conjunction with the triton extraction data (figures 35 and 36) supports the conclusion 
that the nuclear localized 28 kDa form is soluble and yet localizes to discrete nuclear 
regions.  This localization pattern maybe similar to proteins localized at transcription 
centers.  E26 has been suggested to play a role in transcription by Guarino and Summers, 





Figure 40.  Immunoconfocal micrographs of uninfected cells transiently expressing the da26 gene and 24 
and 48 h p.i. infected Sf9 cells.  E26 localization during infection was determined using E26 7554 antiserum to 
detect E26 in fixed Sf9 cells.  The E26 antiserum was visualized by an Alexa 488 secondary antibody, which 
carries a fluorophore when excited, emits detectible light at 488 nm.  The emission detected is pseudo-colored 
green in the above micrographs.  The red pseudo-color portion of the micrographs is the lamin protein detected 
by antiserum with a secondary Alexa 594 antiserum.  The blue color is the cellular and viral DNA as detected 
by the dye DAPI; in the infected cells this denotes the virogenic stroma.  In uninfected cells E26 localizes to 
discrete regions of the nucleus. 
 
 




For comparison, localization of E26 during the later stages of infection was included 
in figure 40 because confocal microscopy of the cells transiently expressing E26 was 
also performed on cells 48 h post transfection.  Localization of E26 varies when 
comparing cells transiently expressing E26 to that of infected cells.  In infected cells at 
24 and 48 h p.i. E26 localizes to the peripheral regions of the virogenic stroma and 
discrete regions of the nucleus in close proximity to the virogenic stroma, figure 40.  To 
identify the peripheral regions of the virogenic stroma compare the co-localization of 
E26 and DNA as denoted by the overlap of the green and blue areas.  The E26 in these 
areas co-localize at least partially to areas containing viral DNA.  For the localization of 
the E26 in close proximity to the stroma look at the intense green label in discrete 
regions of the nuclei.  These discrete regions detected during infection can be correlated 
to regions enriched in microvesicles, ODV envelopes, and ODV by IEM, which are 
absent in the uninfected cells.  E26 found in these regions is likely membrane associated 





Figure 41.  PCR analysis of the recombinant virus vDa26z.  Viral DNA was isolated from BV of vDA26z 
recombinant virus supplied by O’Reilly et al.  PCR analysis was then performed to determine if the E26-βgal 
gene fusion was placed in the correct locus of the genome.  Several oligonucleotides combinations were used to 
determine where the fusion was placed in the viral genome see part A.  When oligonucleotides combinations for 
the full length E26 gene were used two gene products were detected, the native level and the E26-βgal gene 
fusion, see part B.   




O’Reilly et al., 1990 developed a recombinant virus, vDA26z, in which the da26 
gene was reported as truncated by the insertion of the β-galactosidase gene after E26 
amino acid 118.  Upon inspection of the viral DNA by PCR, I determined that a second 
copy of the da26 gene existed either through an incomplete recombination event or by a 
wild type helper virus.  After 3 additional rounds of plaque purification in an attempt to 
eliminate any helper virus, detection of the second copy of the da26 gene was always 
present, figure 41.      
Detection of the ∆1-118E26-βgal recombinant fusion protein produced from vDa26z 
virally infected cells by Western blot is possible when using antiserum directed against 
the β-galactosidase protein, figure 42.  When using antiserum for E26 (7554) weak 
detection of the ∆1-118E26-βgal recombinant fusion protein is possible in a Western 
blot (data not shown), however detection of full length E26 is readily detected by this 
serum in the infected cells.  This implies that either epitopes to the c-terminal region 
make up the bulk of those recognized by the 7554 serum and/or that the β-gal addition 
masks or alters protein folding concealing the epitopes recognized by the 7554 serum.  
The ∆1-118E26-βgal recombinant fusion protein is missing the c-terminal region of the 
E26 protein including the region containing three cysteine amino acids, however the n-
terminus containing the 2 putative NLSs and amphipathic helix are present.  Therefore 
the recombinant protein’s ability to associate with membranes and its’ localization were 
examined by triton X-114 and ICM, respectively.  The 24 and 48 h p.i. wild type 
infected cells that do not produce ∆1-118E26-βgal fusion function as the negative 
control in figure 42.  ∆1-118E26-βgal was found to fractionate almost entirely into the 
insoluble fraction, figure 42 INS lanes compared to AQ lanes.  Also note that two bands 
were identified by the anitserum to βgal in the 48 hpi AQ lane (far right).  This implies 
∆1-118E26-βgal is a soluble protein and that it likely interacts with DNA which is a 
component of the INS fraction by triton X-114 extractions.  This further suggests that 
either the c-terminal portion of E26 maybe responsible for the membrane association of 
E26 or that the addition of βgal disrupts that membrane association. 
 





Figure 42.  Triton X-114 extractions of Sf9 cells infected with vDA26z.  Cells infected with the vDA26z 
virus were extracted as before with the triton X-114 detergent to determine where the E26-βgal recombinant 
protein fractionated to determine if it was capable of membrane association with its’ increased size and loss of 
c-terminal region.  The E26-βgal protein fractionated into the insoluble fraction at 24 h p.i. and into the 





Figure 43.  Localization of E26-βgal protein by immunoconfocal analysis of cells infected with vDA26z.  
Sf9 cells infected with vDa26z virus were fixed after 48 h p.i. and prepared for immuno-confocal analysis.  The 
cells were exposed to two different antisera, αE26 7554 (rabbit) and αβ-gal (mouse) antisera.  The E26 
antiserum was detected with an Alexa 594 secondary against rabbit serum and the β-gal was detected with an 
Alexa 488 secondary against mouse serum.  The E26 protein detected is pseudo-colored red, the E26-βgal 
protein is pseudo-colored green, and the DNA has been labeled by the dye DAPI.  The E26-βgal protein 
localizes to the virogenic stroma while the full length protein localizes to regions that correlate to microvesicles 
and the peripheral regions of the virogenic stroma.     
 
 
ICM was performed on cells infected with vDA26z to confirm the possible DNA 
association predicted by the triton-X114 extractions and to determine if the large fusion 
protein was also capable of nuclear localization during infection.  ∆1-118E26-βgal 
localized to the virogenic stroma (blue) inside of the nucleus in the confocal microscopy 
experiments, figure 43 3rd row in green.  Native E26 (red) was readily detected (7554 




antiserum) as seen by comparing the αE26 lanes of the E2 and vDa26z infections.  This 
supports the above observation that ∆1-118E26-βgal is soluble and likely associating or 




Figure 44.  Regional domains used in transfection/infection studies of BV/ODV E26.  The da26 gene was 
truncated to produce these regional domains.  For comparison the full length gene with the putative domains 
have been included above.  The domains include cysteine amino acids (C) possible palmitoylation sites, nuclear 
localization signal (NLS), coil-coil domains regions of protein-protein interactions, and amphipathic helix 
possible membrane association domains.   
 
 
To confirm the observations from the vDa26z virally infected cells suggesting that 
the c-terminal region of E26 is likely responsible for the membrane association and/or 
intranuclear microvesicles localization of E26 in wild type infected cells, 
transfection/infection studies were performed using two of the regional domains of E26, 
figure 44 (pIE1-E26 #1-2, B11 and pIE1-E26 #2-3, B12).  The first two regional 
domains or N-terminus of E26 are contained in the pIE1-E26 #1-2 clone and account for 
the first 148 amino acids of the E26 protein plus a 23 amino acid addition adding a T7 
epitope to the c-terminus of the truncated protein.  The second two regional domains or 
c-terminus of E26 are contained in the pIE1-E26 #2-3 clone and account for amino acid 
71 to 225 of the E26 protein plus a 23 amino acid addition adding a T7 epitope to the c-
terminus of the truncated protein.  These two truncated proteins expressed by the IE1 




promoter were transfected along with a third construct representing the full length da26 
gene, pIE1-E26 FL (B13) into uninfected cells.  After a 48 hour post transfection 
recovery period these cells were infected with wild type virus for 72 h and examined by 
ICM, figure 45.   
The N-terminal region of E26 #1-2 (1-148) co-localized with the DAPI label 
identifying the virogenic stroma as seen in the first column in the merge of the green and 
blue colors, figure 45.  This localization is consistent with that of vDa26z which 
comprises amino acids 1-118 in a fusion with βgal.  So E26 #1-2 (1-148) protein is 
unable to interact with the membrane due to missing domains or cysteine amino acids; 
or, the c-terminal T7 epitope alters folding and the exposure of the membrane 
association domain; or, E26 localized to the nucleosol and irreversibly bound to DNA 




Figure 45.  Immunoconfocal micrographs of transfected/infected Sf 9 cells expressing epitope tagged; n-
terminal 1-148 aa, c-terminal 71-225, or full length E26.  The first 148 aa direct the fusion to the virogenic 
stroma, whereas amino acids 71-225 direct the fusion to the virogenic stroma as well as membrane associations 
with intranuclear microvesicles.  The full length protein appears to be directed only to the virogenic stroma. 
  
 
The c-terminal region of E26 #2-3 (71-225) co-localized with the DAPI label 
identifying the virogenic stroma as well as discrete regions inside the nucleus, figure 45 
middle row.  This is shown the second column in the merge of the green and red colors.  
This localization is consistent with the localization of E26 in wild type infected cells 




with one exception; these cells show increased labeling of the virogenic stroma.  So E26 
#2-3 (71-225) protein appears to be able to interact with the intranuclear membranes as 
well as DNA. 
The full length construct, E26 FL (1-225), co-localized with the DAPI label 
identifying the virogenic stroma as seen in the third column in the merge of the green 
and blue colors.  This localization is consistent with transfected E26 localization and 
vDa26z which is comprised of amino acids 1-118 in a fusion with βgal.  So E26 FL (1-
225) protein is unable to interact with the membrane due the c-terminal T7 epitope 
altering protein folding and the exposure of the membrane association domain or E26 
efficiently and quickly localized to the nucleosol and bound to DNA making the 
membrane association not possible once the cells were infected.    
This series of experiments demonstrates the importance of the temporal expression of 
E26 during the proper time points of infections.  It adds support to the c-termini 
containing the membrane association domain or palmitoylated cysteine but with out 
further study complete conclusions can’t be drawn, taken with the vDa26z data it merely 
allows educated speculation.  Additional experiments were planed with the 
corresponding recombinant regional domain viruses; however these viruses did not 
produce detectable recombinant protein at the levels required for these experiments. 
 










Protein products of the da26 gene.  The 28 and 26 kDa forms have been identified during infection by multiple 
means, including mass spectrometry, epitope tagging with transient expression/infection studies, and with the 
recombinant virus polh E26-T7. 
 
 Uninfected (kDa) Infected (kDa) 
Mr 28 34, 28, 26, 18 
 
 
The proteins produced by the da26 gene, reported in Benyia et al. 1998, include: 34, 
28, 26, and 18 kDa forms, table 19.  In infected cells, all of these proteins are detected by 
the E26 antiserum 7554 in a Western blot.  The 7554 antiserum contains antibodies to an 
abundantly expressed E26 protein purified from cells infected with a polyhedrin 
expressed da26 recombinant baculovirus.  This antiserum has been extensively tested for 
cross-reactivity to the other known baculovirus proteins.  A weak cross-reactivity was 
found to exist with ODV E25, which was removed by pre-absorption to bacterial 
expressed E25 which was bound to protein beads.  After pre-absorption of the antiserum, 
detection of E26 by Western blot and confocal microscopy was consistent with the 
reported expression and localization patterns in Benyia et al., 1998.  This study 
addresses two of these protein products, the 28 and 26 kDa forms.        
In uninfected cells only the 28 kDa protein product is detected.  The 28 kDa product 
appears to be the 28 kDa form detected at lower levels during infection, as visualized on 
the Western blot in figure 24 using the 7554 antiserum.  This could be due to lower 
amounts of the 28 kDa protein product or that the 7554 antiserum exhibits a lower 
avidity for this form as compared to the 26 kDa form.  Note the 26 kDa form is not 
detected in uninfected cells.  MALDI-TOF identified molecular masses of peptide 
fragments that correspond to those predicted for the 28 and 26 kDa products from an 18 
h p.i. cell extract which was separated in a SDS-PAGE, figure 25.  In order to confirm 
the effects of infection on the production of the 26 kDa protein product by the da26 




gene, uninfected cells which were transiently expressing da26-T7 were infected and 
collected for Western blot analysis, figure 26.  The T7 epitope was used for detection of 
the E26-T7 protein in order to differentiate it from the native E26 protein, produced by 
the virus infection.  In the uninfected cells which were transiently expressing the da26-
T7 gene, a single protein product of approximately 28 kDa was detected by the T7 
antiserum in a Western blot.  When the cells were infected, multiple forms of the E26-T7 
protein were detected by the T7 antiserum in a Western blot consisting of two dominate 
protein products of approximately 28 and 26 kDa and three minor protein products.  
Infection alters the protein products of the da26 gene, resulting in the production of a 28 
and 26 kDa forms as detected by 7554 antiserum, mass spectrometry of total cell 
extracts, and epitope tagged forms of the protein using antiserum to those epitopes.   
In an attempt to produce a new rabbit polyclonal antiserum to the E26 protein the 
gene was expressed in bacteria and the protein purified.  Rabbits were injected and the 
blood serum was collected.  This serum, 12500, was used in Western blots for detection 
of E26.  12500, much like the serum produced by Imai et al., detects the 28 kDa form of 
the protein but not the 26 kDa form that is altered/produced by the baculovirus infection 
(figure 30).  The 7554 antiserum detects both forms as both were present in the infected 
cell protein products presented to the rabbits for antiserum production.  The results 
produced by Imai et al., 2004 and the 12500 antiserum can be explained because 
bacterial expression of the da26 gene produces the 28 kDa form, thus the virally 
produced 26 kDa form is absent from the antigens presented to the animals for antibody 
production.  If the 28 kDa protein has significantly different epitopes due to altered 
folding or other secondary modification, it is unlikely the two serums, Orf 8 and 12500, 
would identify the 26 kDa form.   
In order to confirm that the 26 kDa form is derived from the da26 gene during 
infection as suggested in the previously mentioned experiments, a polh E26-T7 
recombinant virus was produced.  In the polh E26-T7 virus the polyhedrin gene was 
replaced with the da26-T7 gene fusion.  Cells were infected with this virus and collected 
for analysis by Western blot.  Total cell extracts from cells transiently expressing the 




da26-T7 gene were also placed on this blot.  As infection progressed detection of 
multiple protein products containing the T7 epitope were identified by Western blot, thus 
confirming that the da26 gene produces multiple protein products during infection 
(figure 27).  As a side note, it appears that detection of the E26-T7 protein by the 7554 
antiserum demonstrates less affinity than detection of E26 protein by the 7554 
antiserum.  However, the transiently expressed da26-T7  ~28 kDa form was detected as 
well as at 48 and 72 h p.i. by the 7554 antiserum, which corresponds to bands detected 
by the T7 antiserum.  The inability to demonstrate an apparent strong antigen binding of 
the fusion protein could be due to an alteration in the protein folding, exposing different 
epitopes, or the fact that the 7554 serum has less affinity to the epitopes presented by the 
28 kDa form of the protein.        
There are no internal methionines present in the E26 protein to function as alternate 
start sites, ruling out an alternate start site to account for the 2 kDa alteration from 28 to 
26 kDa.  Splicing events are known to occur in AcNPV, but are rare.  Initial genome 
scans do not predict a splicing event.  However, primer extension identifies as many as 
four promoters for the da26 gene.  Attempts to move two of these promoters with the 
da26 gene to a non-coding region of the genome failed to produce any detectible 
recombinant protein supporting the hypothesis that trans-acting elements required for 
transcription are not present when the da26 open reading frame is moved out of context 
(for this cloning strategy reference appendix B38).  Because four promoters were 
identified for the da26 gene and only two were used to express a second copy of the 
gene (due to the extreme distance from the start of da26), splicing is still a possibility.  
The other possibilities include cleavage of a signal sequence, an unidentified post 
translational modification of the protein, or a hydrophobic addition (lipid anchor) the 
effects of could allow for the binding of more SDS.  This would add further charges to 
the protein resulting in a faster migration in an electric field.  This would result in a 
decrease in the apparent molecular weight.   
 
 




2. BV/ODV E26 Exists in Soluble and Peripheral Membrane Protein Forms  
 
Table 20 
Triton X-114 fractionation of E26 in uninfected and infected cells.  The fractionation of the 26 kDa form is 
found in the detergent fractions of extracted wild type and polh E26-T7 virally infected cells.  A soluble 26 kDa 
form is identified in the transfection/infection studies confirming that the membrane association is independent 
of the 2 kDa size modification. 
 







Insoluble & Aqueous 
(28 & 26) 
 
 
During the different stages of infection, E26 can be detected as either a soluble or 
membrane protein, table 20.  Benyia et al., 1998, reported that E26 was a peripheral 
membrane protein; however, Imai et al., 2004 reported it to be a soluble protein.  This 
confusion has led to a lot of difficulty in my studies.  When triton X-114 extractions 
were performed on total cell extracts, the 26 kDa form is detected entirely in the 
detergent fraction by Western blots using antiserum 7554, categorizing it as a membrane 
protein (figure 30).   
To further confirm the detergent fractionation or membrane association of E26, polh 
E26-T7 infected cells were triton X-114 extracted.  The E26-T7 protein fractionated into 
both the insoluble (60%) and aqueous fractions (40%) by triton X-114 extraction at 18 h 
p.i.  The timing of protein expression is consistent with the temporal patterns for the 
initiation of polh promoter, as this promoter is a late promoter of baculovirus.  By 24 h 
p.i., E26-T7 was detected in the insoluble, detergent, and aqueous fractions, which 
implies that at least some population of the protein is now membrane associated (figure 
31).  The ability of the 26 kDa form to interact with membranes could be altered by two 
different factors; 1) the presence of the T7 epitope which could alter folding or 2) the 
time of expression of the recombinant E26-T7 protein.  Because the recombinant protein 
is produced by the polh promoter, relative to the native E26 expression during normal 
infection the temporal expression of E26-T7 is altered, which relative to the putative roll 
of other viral proteins could affect modifications of the 26 kDa form to allow association 
with membranes. 




To gain further insight for the membrane association of E26, its amino acid sequence 
was closely examined.  A predicted trans-membrane sequence (TMS) could not be 
identified.  In the absence of a clearly defined TMS other options were examined 
including amphipathic helices and lipid anchors.  Detection of amphipathic helices 
traditionally uses circular dichroism spectroscopy, which is outside of my expertise; 
however a putative amphipathic helix was identified by sequence gazing and the use of a 
helical wheel between amino acids 94-111.  As the E26 protein contains 5 cysteine 
amino acids, possible palmitoylation sites, palmitoylation experiments were performed 
to determine if E26 is associating with the membrane via a lipid anchor (Figure 32).  
E26, specifically the 26 kDa form, was found to be palmitoylated.  When the E26 amino 
acid sequence is compared with the E26 homologues from other sequenced 
baculoviruses the three c-terminal cysteines are highly conserved, suggesting these as 
more probable palmitoylation sites.  Specifically, the cysteine located at amino acid 129 
is most likely the palmitoylated cysteine, as it is surrounded by charged amino acids.  
These charged amino acids have been shown to lower the pKa thus increasing the 
likelihood of the palmitoylation event (Dietrich and Ungermann, 2004; Mossner, Iwai, 
and Glockshuber, 2000). 
When cells transiently expressing the da26 gene are extracted with triton X-114 and 
the proteins fractionated into insoluble, detergent, and aqueous fractions, the 28 kDa 
form was identified in the insoluble and aqueous fractions.  These data support the 
hypothesis that the 28 kDa form is the only detectable product of da26 in uninfected 
cells and it is a soluble protein, figure 35.  To determine if the process of viral infection 
affects either the membrane association or change of 28 to 26 kDa, cells transiently 
expressing E26-T7 were infected and then extracted by triton X-114.  The E26-T7 fusion 
allows one to distinguish the transiently expressed form from the native E26 produced 
from the virus.  The insoluble fraction contained the 28 kDa form of the protein; 
however the aqueous fraction contained both the 28 and 26 kDa forms.  These data 
imply that the process of infection some how alters the 28 kDa form to become 26 kDa 
Mr and that this allows for the membrane association.  Due to the design of this 




experiment, the production of the transiently expressed protein occurs before the cells 
are infected.  Thus, if the 28 kDa protein functions as a DNA transcription binding 
factor, it likely traffics and binds to DNA before the alteration and change in Mr can 
occur.  Therefore if the alteration and change in Mr still does occur, it would happen in 
the wrong compartment of the cell making the membrane association impossible.  In 
addition, adding the T7 epitope to the c-terminal region of E26 could alter the ability of 
the E26 to be palmitoylated. This alteration could cause a change in the protein folding, 
masking the required cysteine amino acid.   
Palmitoylation is one of several ways that E26 could interact with membranes.  
Another, known, membrane interaction of E26 is via a protein-protein interaction with 
ODV E66.  In Braunagel et al., 2004 the authors were able to crosslink the ODV E66 
INM-SM with E26 from infected nuclei and infected microsomes, which implies that 
these two proteins are in close proximity and may associate in the ER.  This interaction 
could promote palmitoylation of E26 by one of two methods.  Either by increasing the 
stability, thus increasing the accessibility of the sulphydryl group, or by lowering the 
pKa of the cysteine, making the formation of the thiolate more likely (Dietrich and 
Ungermann, 2004; Duncan and Gilman, 1996; Veit, 2000). 
Da26 was in vitro translated in the presence of microsomal membranes to determine 
if the encoded proteins have the ability to interact with the membrane in the absence of 
the soluble components of the cell.  These in vitro translations were then salt extracted to 
determine the stringency of the membrane association.  These translations were 
performed in the presence of canine pancreatic, uninfected insect, and infected insect 
microsomal membranes.  The canine pancreatic and uninfected insect microsomal 
membranes should produce the 28 kDa form; whereas the infected insect microsomal 
membranes should produce both the 28 and 26 kDa forms unless soluble viral factors are 
required for the alteration and change in the Mr.  In all three cases, the proteins produced 
by the da26 gene showed minimal interactions with the membrane after all the soluble 
proteins were removed by centrifugation through a sucrose pad.  This soluble protein 
accounted for 78.3 and 89.9% of the total radio labeled protein produced in the presence 




of UIMM and IIMM, respectively as determined by a liquid scintillation counter.  The 
infected insect microsomal membranes appeared to contain the most membrane 
associated protein produced by the in vitro translations (10.5% of the total radio labeled 
protein produced).  But, the difference between the IIMM and the UIMM is minimal 
(~5% increase in the IIMM over the UIMM in the salt supernatant fraction).  So, in the 
absence of the soluble components, the membrane association of E26 does not readily 
occur.  Recall that in the E66 INM-SM/E26 crosslinking studies it was the INM-SM that 
was translated in vitro and that E26 is already associated with the infected microsomal 
membrane as it would have associated with these microsomes before they were extracted 
from infected cells. 
 
3. BV/ODV E26 is a Soluble and Peripheral Membrane Protein of the Nucleus  
E26 localization during infection has been superficially studied and reported by 
Benyia et al., 1998, and Imai et al., 2004.  A comprehensive study is presented in this 
document containing a close examination of the early times post infection table 21.  
BV/ODV E26 localizes in discrete regions of the cytoplasm in the early phases of 
infection, 1-4 h p.i.  By 6 h p.i. E26 localizes in the peripheral regions of the nucleus 
including electron dense regions inside the nucleus, confirmed by IEM presented in 




E26 localization by ICM in uninfected and infected cells.  The localization of the E26 protein in uninfected 
cells is entirely nuclear and soluble.  During infection with the modification of the proteins in various forms this 
localization pattern is more complex, early in infection, to 10 h p.i., the localization agrees with the data 
presented in both Benyia et al., 1998, and Imai et al., 2004.  However, after the 12 h p.i. time point Imai et al., 
2004 data varies from the data I have collected and that of Benyia et al., 1998.  This is due to the manner in 
which the antiserum used was produced and its ability to detect the 26 kDa form of the protein. 
 
 Uninfected Infected – Early h p.i. 
(1-10 hpi)  
Infected – Late h p.i. 
(12-72 hpi) 
Localization Nuclear (28) Cytoplasmic and 








and 12 h p.i. and by 12 h p.i. starts to accumulate in nuclear regions absent of the DNA 
dye DAPI (figure 38).  During the later phases of infection, E26 localizes to distinct 
peripheral regions of the newly forming and later mature virogenic stroma.  These 
peripheral regions have been shown by electron microscopy to be foci of intra-nuclear 
microvesicles (figure 38 & 39).  E26 is present in the nucleus as both a soluble and 
membrane associated protein depending on the time post infection, supported by this 
confocal data, triton X-114 extractions, and IEM (Benyia et al., 1998).  Nuclear E26 is 
probably predominantly a soluble protein early in infection and a membrane associated 
protein late in infection; however quantitative amounts of soluble E26 versus membrane 
associated E26 are not possible at this time. 
When cells transiently expressing the da26 gene were examined by ICM, E26 was 
found to localize and accumulate in discrete regions of the nucleus (figure 39).  Recall 
the 28 kDa form of the protein fractionates as both an insoluble (~65% of the total) and 
soluble protein (~35% of the total) as determined by Western blot of triton X-114 
extractions and analysis using the spot densitometer of the Alpha Innotech ChemiImager 
4000.  The fractionation and localization results could complement each other as the 
insoluble form could be interacting with DNA (suggested in Imai et al., 2004), due to the 
fact that DNA fractionates into the insoluble fraction by triton X-114 extractions.  The 
localization pattern of the 28 kDa form in uninfected cells resembles that of E26 at 10 h 
p.i. in wild type infected cells by the 7554 antiserum.  However, as the transiently 
expressed protein is not detected in association with membranes nor does the uninfected 
cell produce intra-nuclear microvesicles, a membrane associated form of E26 is not 
detected in an uninfected cell.  The nuclear localization of the 28 kDa form could occur 
by two different mechanisms: either free diffusion as it is below the size limit of the 
NPC; or NLS mediated as the N-terminal region of the protein contains two putative 
NLS, which could traffic this soluble form of the protein into the nucleus.  By either 
mechanism the 28 kDa form of the protein localizes to electron dense regions of the 
nucleus and potentially interacts with DNA. 




Unpublished data collected by a previous member of the Summers’ lab from a yeast 
two-hybrid library screen (data not shown) predicts an interaction between E26 and IE-1.  
This interaction provides some evidence in support of the nuclear localization of the 28 
kDa form and its association with DNA as the IE-1 protein is involved in viral 
transcription and therefore required in the nucleus.  The E26 protein, as translated in 
yeast from the da26 gene, was used as bait and the IE-1 protein was found from infected 
cell libraries.  This putative interaction was confirmed in immunoprecipitations in the 
Summers’ lab (unpublished data) and by Imai et al., 2004.  As Imai et al., 2004 reported 
a DNA interaction with E26, and IE-1 is a transcriptional activator, the 28 kDa form 
likely plays a role in transcription as previously suggested in Guarino and Summers, 
1998. 
During infection the 26 kDa form is detected in association with membranes by triton 
X-114, palmitoylation, and cross links to INM-SM of E66 in microsomes.  The 26 kDa 
form is incorporated into mature ODV envelopes and present in intra-nuclear 
microsomes (Beniya, Braunagel, and Summers, 1998; Braunagel et al., 2004).  Protein 
palmitoylation predominantly occurs in, but is not limited to the ER and is reversible, 
allowing times of solubility and membrane association (Dietrich and Ungermann, 2004; 
Linder and Deschenes, 2003).  The cross-linking studies identifying E26 used 
microsomes, which are predominantly composed of ER membranes.  These data support, 
for a population of the E26 protein, the hypothesis that the membrane association of the 
26 kDa form likely occurs in the ER and then traffics to the nucleus, similar to but 
clearly different from E66.  This membrane associated form can be clearly localized 
inside the nucleus as early as 16 h p.i. by confocal and electron microscopy (Beniya, 
Braunagel, and Summers, 1998).  The membrane association could be a result of the 
putative amphipathic helix or the palmitoylation event or both as a membrane 
association increases the likelihood of a lipid anchor modification via palmitoylation.  
As palmitoylation is the strongest membrane association identified for the protein, 
further examination of the cysteine amino acids is important.  To examine the possible 
functions of 3 c-terminal cysteines, the virus vDa26z presented in O’Reilly et al. was 




examined.  This virus contains a truncation of the E26 protein at amino acid 118, 
removing the 3 c-terminal cysteine amino acids.  However, recall that the authors could 
not purify this virus to homogeneity so antiserum to β-gal was used to study the fusion 
protein.  This fusion protein without the c-terminal region fractionates into insoluble and 
aqueous fractions by triton X-114 extractions classifying it as a soluble protein.  When 
its localization is examined by immuno-confocal microscopy it clearly co-localizes with 
the mature virogenic stroma.  Together these data support a DNA interaction with the 
fusion protein and a NLS mediated trafficking event due to the extreme size of the fusion 
protein.  This data lends support to the importance of the C-terminal region to the 
membrane association of E26.  Further studies into this region specifically mutating each 
cysteine residue should be performed starting with the cysteine at amino acid 129, due to 
its surround charged amino acids. 
Suraj Saksena, a fellow graduate student in the lab, studying INM protein integration 
at the translocon and sorting to the nucleus is the individual who confirmed the 
interaction of the INM-SM of E66 with E26.  In the manuscript identifying this 
interaction, a postulated function for E26 was presented suggesting that it could act as a 
sorting factor for E66 (Braunagel et al., 2004; Saksena et al., 2004).  Suraj identified two 
cellular proteins termed SMAP 10 and SMAP 25 that crosslinked with in vitro translated 
INM-SM protein in uninfected and canine pancreatic cells.  Reviewing Suraj’s data, I 
suggested that the SMAP proteins could be cellular homologs of E26 as the virus 
induces an amplified pulse of INM proteins to the nucleus.  Thus it stands to reason that 
the infected cell would require additional sorting factors beyond those supplied by the 
cell.  Knowing that the 12499 and 12500 antisera identified cellular proteins of similar 
size before pre-absorption, I suggested that these sera be used in an attempt to identify 
the SMAPs.  Cross reactivity between the SMAPs and the 12499 and 12500 antisera was 
successful in uninfected Sf9 and canine pancreatic cells.  A probable function of the 26 
kDa membrane associated form is disclosed by this cross reactivity.  In Suraj’s 
experiments using the 12499 and 12500 antisera the SMAP 10 gene was identified from 
a cDNA Sf9 library and the translated amino acid sequence was found to have a high 




degree of similarity with importin-α.  Recently membrane association of importin-α has 
been identified, which suggests it likely has other roles beyond importing proteins 
through the nuclear pore via NLS sequences (Hachet et al., 2004).  Suraj went on to find 
that antiserum directed against importin-α, specifically an antiserum to the region of 
similarity between importin-α and SMAP 10 cross reacted with SMAP 10.  Thus the 
current hypothesis is that SMAP 10 is a translocon associated protein, an early sorting 
factor for INM proteins, and likely an importin-α isoform.  Thus the 26 kDa membrane 
associated form by similarity likely shares these functions as antiserum directed against 
E26 initially identified these findings (Personal communication and collaboration with 
Suraj Saksena).   
 
 






1. The Model:  BV/ODV E26 Functions as Both a Soluble and a Membrane Protein 
during Infection 
 
E26 has at least two roles during infection which correspond to the stage of infection, 
summary figure 46.  Early during infection the protein has one role as a soluble protein 
and late in infection a population of E26 becomes a membrane associated protein a 
second role occurs.  That is not to say that the two roles are exclusive of each other, they 
do appear to overlap in the time course of infection.  The membrane association of E26 
is likely mediated and regulated by other viral proteins or maturation events, as E26 only 




Figure 46.  E26 production, modification, and localization during infection.  The gene is transcribed and 
translated producing the 28 kDa form, which is either or both, efficiently modified into the 26 kDa form or 
shuttled to the nucleus (NLS) to interact with DNA.  The 26 kDa form then associates with membranes, likely 
the ER by lipid anchor (palmitoylation).  From the ER the 26 kDa form traffics to the nucleus where it is 








Early in infection, 1-10 h p.i., E26 is produced from the promoters identified 
previously at -38 amino acids from the methionine (Guarino and Summers, 1986; 
O'Reilly et al., 1990).  The 28 kDa protein contains putative NLS, which traffic it to the 
nucleus where it probably interacts with both IE-1 and DNA.  This is supported by Imai 
et al., the transient expression of the gene in uninfected cells, and the polh E26-T7 
recombinant virus data I’ve presented.  Specifically, that 28 kDa form is a soluble 
protein localizing to discrete nuclear regions similar to transcription sites.  The IE-1 and 
DNA interactions could occur in the electron dense regions detected in immuno-electron 
microscopy at 6 h p.i. (Beniya, Braunagel, and Summers, 1998).  Immuno-confocal 
microscopy using both 7554 and Orf 8 antisera detected similar localization patterns for 
the forms E26 that these antiserum detect through 10 h p.i., which could indicate the 
switch from the early soluble role to the late membrane associated role.   
By 6 h p.i. the 26 kDa form is readily detected on Western blots using the 7554 
antiserum.  The post-translational modification of the 28 kDa form to the 26 kDa form 
occurs independently from the 26 kDa forms membrane association as demonstrated by 
the cells transiently expressing the da26-T7 gene followed by viral infection.  The size 
change occurs followed by the membrane association only if the protein expression and 
change in size corresponds to the proper temporal time point, implying that other viral 
factors are involved.  The timing of this change in size and the membrane association of 
E26 is supported by 6 h p.i. immuno-electron microscopy which detects E26 at the 
plasma membrane and cytoplasmic vesicles (Beniya, Braunagel, and Summers, 1998). 
By 12 h p.i., E26 is membrane associated, however the soluble form is present 
through out infection at very low levels as indicated by Western blot analysis.  This is 
supported by immuno-confocal microscopy which identifies E26 in the peripheral edges 
of the virogenic stroma, a region enriched in DNA and the presence of the 28 kDa form 
on Western blots of late and very late total cell extracts.  The localization to the 
peripheral regions of the virogenic stroma corresponds to the localization detected by 
Orf 8 antiserum.  E26 begins to accumulate in discrete nuclear regions where there is no 
detectable DNA as determined by the DNA dye DAPI at 12 h p.i.  By 16 hpi these 




regions can be co-localized to regions containing microvesicles by IEM (Beniya, 
Braunagel, and Summers, 1998).  E26 is found in microvesicles, ODV envelopes, 
nuclear envelope, the periphery of the virogenic stroma, and at very low levels in the 
cytoplasm at 18 – 72 h p.i. (Beniya, Braunagel, and Summers, 1998).  The 26 kDa form 
is detected as early as 4 h p.i. and was confirmed present by Maldi-TOF in 18 h p.i. total 
cell extracts.  Palmitoylated E26 was detected at plus 34 h p.i. (34 h p.i. infection with a 
1.5 hour starvation period and an 8 hour labeling period), correlates to a time when E26 
is found to be membrane associated.  Also, when the ODV E66 INM-SM was in vitro 
translated in the presence of these membranes, it was found to crosslink to E26.  These 
crosslinking studies were performed using 33 hour infected nuclei or microsomes, also 
correlating to a time when E26 is membrane associated.  The interaction between E26 
and E66 INM-SM along with the charges surrounding the cysteine at amino acid 129, 
make it a likely location for a lipid addition via palmitoylation.  The membrane 
association occurring later in infection corresponds to the data collected from cells 
infected with polh E26-T7 as detected in triton X-114 extractions.  Recall the 
recombinant protein is initially detected in the insoluble and aqueous fractions at 18 h 
p.i., however by 24 h p.i. E26-T7 is detected in the insoluble, detergent, and aqueous 
fractions.   
Therefore the da26 gene produces at least 2 protein products with different functions, 
which correlate with localization, solubility, membrane association, and temporal 
implications.  The 28 kDa form is likely a soluble protein that interacts with 
transcriptional activators and DNA in the nucleus in the early stages of infection.  Where 
as, a part of the 26 kDa population is a membrane bound form that interacts with an 
integral membrane protein in the ER, likely functions as a sorting factor directing INM 
proteins from the translocon to the INM, and found in the inner nuclear membrane, intra-
nuclear microvesicles, ODV envelopes, and ODV in the nucleus.   
 






Adams, J. R., and McClintock, J. T. 1991.  Baculoviridae. Nuclear Polyhedrosis Viruses.  
Part 1. Nuclear Polyhedrosis Viruses of Insects.  In: Adams, J. R. and Bonami, J. 
R. (Eds.) Atlas of Invertebrate Viruses. CRC Press, Boca Raton, FL. pp. 87-204. 
 
Allen, N. P., Huang, L., Burlingame, A., and Rexach, M., 2001. Proteomic analysis of 
nucleoporin interacting proteins. J Biol Chem 276, 29268-29274. 
 
Apel, E. D., Lewis, R. M., Grady, R. M., and Sanes, J. R., 2000. Syne-1, a dystrophin- 
and Klarsicht-related protein associated with synaptic nuclei at the 
neuromuscular junction. J Biol Chem 275, 31986-31995. 
 
Ashery-Padan, R., Ulitzur, N., Arbel, A., Goldberg, M., Weiss, A. M., Maus, N., Fisher, 
P. A., and Gruenbaum, Y., 1997a. Localization and posttranslational 
modifications of otefin, a protein required for vesicle attachment to chromatin, 
during Drosophila melanogaster development. Mol Cell Biol 17, 4114-4123. 
 
Ashery-Padan, R., Weiss, A. M., Feinstein, N., and Gruenbaum, Y., 1997b. Distinct 
regions specify the targeting of otefin to the nucleoplasmic side of the nuclear 
envelope. J Biol Chem 272, 2493-2499. 
 
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., 
and Struhl, K., Eds. 1992. Current Protocols in Molecular Biology. Vol. 1 & 2. 
Current Protocols. Greene Publishing Associates and Wiley-Interscience, New 
York.  
Bayliss, R., Corbett, A. H., and Stewart, M., 2000. The molecular mechanism of 
transport of macromolecules through nuclear pore complexes. Traffic 1, 448-456. 
 
Beames, B., and Summers, M. D., 1989. Location and nucleotide sequence of the 25K 
protein missing from baculovirus few polyhedra (FP) mutants. Virology 168, 
344-353. 
 
Ben-Efraim, I., Zhou, Q., Wiedmer, T., Gerace, L., and Sims, P. J., 2004. Phospholipid 
scramblase 1 is imported into the nucleus by a receptor-mediated pathway and 
interacts with DNA. Biochemistry 43, 3518-3526. 
 
Beniya, H., Braunagel, S. C., and Summers, M. D., 1998. Autographa californica 
nuclear polyhedrosis virus: subcellular localization and protein trafficking of 
BV/ODV-E26 to intranuclear membranes and viral envelopes. Virology 240, 64-
75. 
 




Bhattacharyya, R., and Wedegaertner, P. B., 2000. Galpha 13 requires palmitoylation for 
plasma membrane localization, Rho-dependent signaling, and promotion of 
p115-RhoGEF membrane binding. J Biol Chem 275, 14992-14999. 
 
Blobel, G., and Wozniak, R. W., 2000. Proteomics for the pore. Nature 403, 835-836. 
 
Bogan, M. J., Agnes, G. R., Pio, F., and Cornell, R. B., 2005. Interdomain and 
membrane interactions of CTP:phosphocholine cytidylyltransferase revealed via 
limited proteolysis and mass spectrometry. J Biol Chem 280, 19613-19624. 
 
Bordier, C., 1981. Phase separation of integral membrane proteins in Triton X-114 
solution. J Biol Chem 256, 1604-1607. 
 
Braunagel, S. C., Burks, J. K., Rosas-Acosta, G., Harrison, R. L., Ma, H., and Summers, 
M. D., 1999. Mutations within the Autographa californica nucleopolyhedrovirus 
FP25K gene decrease the accumulation of ODV-E66 and alter its intranuclear 
transport. J Virol 73, 8559-8570. 
 
Braunagel, S. C., Daniel, K. D., Reilly, L. M., Guarino, L. A., Hong, T., and Summers, 
M. D., 1992. Sequence, genomic organization of the EcoRI-A fragment of 
Autographa californica nuclear polyhedrosis virus, and identification of a viral-
encoded protein resembling the outer capsid protein VP8 of rotavirus. Virology 
191, 1003-1008. 
 
Braunagel, S. C., Elton, D. M., Ma, H., and Summers, M. D., 1996a. Identification and 
analysis of an Autographa californica nuclear polyhedrosis virus structural 
protein of the occlusion-derived virus envelope: ODV-E56. Virology 217, 97-
110. 
 
Braunagel, S. C., He, H., Ramamurthy, P., and Summers, M. D., 1996b. Transcription, 
translation, and cellular localization of three Autographa californica nuclear 
polyhedrosis virus structural proteins: ODV-E18, ODV-E35, and ODV-EC27. 
Virology 222, 100-114. 
 
Braunagel, S. C., Russell, W. K., Rosas-Acosta, G., Russell, D. H., and Summers, M. D., 
2003. Determination of the protein composition of the occlusion-derived virus of 
Autographa californica nucleopolyhedrovirus. Proc Natl Acad Sci U S A 100, 
9797-9802. 
 
Braunagel, S. C., and Summers, M. D., 1994. Autographa californica nuclear 
polyhedrosis virus, PDV, and ECV viral envelopes and nucleocapsids: structural 
proteins, antigens, lipid and fatty acid profiles. Virology 202, 315-328. 
 




Braunagel, S. C., Williamson, S. T., Saksena, S., Zhong, Z., Russell, W. K., Russell, D. 
H., and Summers, M. D., 2004. Trafficking of ODV-E66 is mediated via a 
sorting motif and other viral proteins: facilitated trafficking to the inner nuclear 
membrane. Proc Natl Acad Sci U S A 101, 8372-8377. 
 
Broers, J. L., Hutchison, C. J., and Ramaekers, F. C., 2004. Laminopathies. J Pathol 204, 
478-488. 
 
Broers, J. L., Machiels, B. M., van Eys, G. J., Kuijpers, H. J., Manders, E. M., van Driel, 
R., and Ramaekers, F. C., 1999. Dynamics of the nuclear lamina as monitored by 
GFP-tagged A-type lamins. J Cell Sci 112 ( Pt 20), 3463-3475. 
 
Bruni, R., Fineschi, B., Ogle, W. O., and Roizman, B., 1999. A novel cellular protein, 
p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and 
ICP0 is modified in a cell-type-specific manner and Is recruited to the nucleus 
after infection. J Virol 73, 3810-3817. 
 
Burke, B., Shanahan, C., Salina, D., and Crisp, M., 2005. Aspects of nuclear envelope 
dynamics in mitotic cells. Novartis Found Symp 264, 22-30; discussion 30-4, 
227-230. 
 
Burke, B., and Stewart, C. L., 2002. Life at the edge: the nuclear envelope and human 
disease. Nat Rev Mol Cell Biol 3, 575-585. 
 
Carson, D. D., Guarino, L. A., and Summers, M. D., 1988. Functional mapping of an 
AcNPV immediately early gene which augments expression of the IE-1 trans-
activated 39K gene. Virology 162, 444-451. 
 
Carson, D. D., Summers, M. D., and Guarino, L. A., 1991. Transient expression of the 
Autographa californica nuclear polyhedrosis virus immediate-early gene, IE-N, 
is regulated by three viral elements. J Virol 65, 945-951. 
 
Charlton, C. A., and Volkman, L. E., 1993. Penetration of Autographa californica 
nuclear polyhedrosis virus nucleocapsids into IPLB Sf 21 cells induces actin 
cable formation. Virology 197, 245-254. 
 
Chen, M. H., Ben-Efraim, I., Mitrousis, G., Walker-Kopp, N., Sims, P. J., and Cingolani, 
G., 2005. Phospholipid scramblase 1 contains a nonclassical nuclear localization 
signal with unique binding site in importin alpha. J Biol Chem 280, 10599-
10606. 
 
Clemons, W. M., Jr., Menetret, J. F., Akey, C. W., and Rapoport, T. A., 2004. Structural 
insight into the protein translocation channel. Curr Opin Struct Biol 14, 390-396. 
 




Cornell, R. B., and Northwood, I. C., 2000. Regulation of CTP:phosphocholine 
cytidylyltransferase by amphitropism and relocalization. Trends Biochem Sci 25, 
441-447. 
 
Cronshaw, J. M., Krutchinsky, A. N., Zhang, W., Chait, B. T., and Matunis, M. J., 2002. 
Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 158, 
915-927. 
 
Dechat, T., Gotzmann, J., Stockinger, A., Harris, C. A., Talle, M. A., Siekierka, J. J., and 
Foisner, R., 1998. Detergent-salt resistance of LAP2alpha in interphase nuclei 
and phosphorylation-dependent association with chromosomes early in nuclear 
assembly implies functions in nuclear structure dynamics. EMBO J 17, 4887-
4902. 
 
Dechat, T., Vlcek, S., and Foisner, R., 2000. Review: lamina-associated polypeptide 2 
isoforms and related proteins in cell cycle-dependent nuclear structure dynamics. 
J Struct Biol 129, 335-345. 
 
DeLong, C. J., Qin, L., and Cui, Z., 2000. Nuclear localization of enzymatically active 
green fluorescent protein-CTP:phosphocholine cytidylyltransferase alpha fusion 
protein is independent of cell cycle conditions and cell types. J Biol Chem 275, 
32325-32330. 
 
Denning, D., Mykytka, B., Allen, N. P., Huang, L., Al, B., and Rexach, M., 2001. The 
nucleoporin Nup60p functions as a Gsp1p-GTP-sensitive tether for Nup2p at the 
nuclear pore complex. J Cell Biol 154, 937-950. 
 
Denning, D. P., Patel, S. S., Uversky, V., Fink, A. L., and Rexach, M., 2003. Disorder in 
the nuclear pore complex: the FG repeat regions of nucleoporins are natively 
unfolded. Proc Natl Acad Sci U S A 100, 2450-2455. 
 
Dietrich, L. E., and Ungermann, C., 2004. On the mechanism of protein palmitoylation. 
EMBO Rep 5, 1053-1057. 
 
Donnelly, M., and Elliott, G., 2001. Fluorescent tagging of herpes simplex virus 
tegument protein VP13/14 in virus infection. J Virol 75, 2575-2583. 
 
Dreger, M., Bengtsson, L., Schoneberg, T., Otto, H., and Hucho, F., 2001. Nuclear 
envelope proteomics: novel integral membrane proteins of the inner nuclear 
membrane. Proc Natl Acad Sci U S A 98, 11943-11948. 
 
Duncan, J. A., and Gilman, A. G., 1996. Autoacylation of G protein alpha subunits. J 
Biol Chem 271, 23594-23600. 
 




Ellenberg, J., and Lippincott-Schwartz, J., 1999. Dynamics and mobility of nuclear 
envelope proteins in interphase and mitotic cells revealed by green fluorescent 
protein chimeras. Methods 19, 362-372. 
 
Ellenberg, J., Siggia, E. D., Moreira, J. E., Smith, C. L., Presley, J. F., Worman, H. J., 
and Lippincott-Schwartz, J., 1997. Nuclear membrane dynamics and reassembly 
in living cells: targeting of an inner nuclear membrane protein in interphase and 
mitosis. J Cell Biol 138, 1193-1206. 
 
Engelhard, E. K., Kam-Morgan, L. N., Washburn, J. O., and Volkman, L. E., 1994. The 
insect tracheal system: a conduit for the systemic spread of Autographa 
californica M nuclear polyhedrosis virus. Proc Natl Acad Sci U S A 91, 3224-
3227. 
 
Fiore, L., Greenberg, H. B., and Mackow, E. R., 1991. The VP8 fragment of VP4 is the 
rhesus rotavirus hemagglutinin. Virology 181, 553-563. 
 
Foisner, R., 2001. Inner nuclear membrane proteins and the nuclear lamina. J Cell Sci 
114, 3791-3792. 
 
Fricker, M., Hollinshead, M., White, N., and Vaux, D., 1997. Interphase nuclei of many 
mammalian cell types contain deep, dynamic, tubular membrane-bound 
invaginations of the nuclear envelope. J. Cell. Biol. 136, 531-544. 
 
Gant, T. M., Goldberg, M. W., and Allen, T. D., 1998. Nuclear envelope and nuclear 
pore assembly: analysis of assembly intermediates by electron microscopy. Curr 
Opin Cell Biol 10, 409-415. 
 
Gilchrist, S., Gilbert, N., Perry, P., Ostlund, C., Worman, H. J., and Bickmore, W. A., 
2004. Altered protein dynamics of disease-associated lamin A mutants. BMC 
Cell Biol 5, 46. 
 
Goldberg, M., Lu, H., Stuurman, N., Ashery-Padan, R., Weiss, A. M., Yu, J., 
Bhattacharyya, D., Fisher, P. A., Gruenbaum, Y., and Wolfner, M. F., 1998. 
Interactions among Drosophila nuclear envelope proteins lamin, otefin, and YA. 
Mol Cell Biol 18, 4315-4323. 
 
Goldberg, M. W., and Allen, T. D., 1995. Structural and functional organization of the 
nuclear envelope. Curr Opin Cell Biol 7, 301-309. 
 
Gong, M., Jin, J., and Guarino, L. A., 1998. Mapping of ORF121, a factor that activates 
baculovirus early gene expression. Virology 244, 495-503. 
 




Gorlich, D., and Kutay, U., 1999. Transport between the cell nucleus and the cytoplasm. 
Annu Rev Cell Dev Biol 15, 607-660. 
 
Granados, R. R., 1978. Early events in the infection of Hiliothis zea midgut cells by a 
baculovirus. Virology 90, 170-174. 
 
Gruenbaum, Y., Wilson, K. L., Harel, A., Goldberg, M., and Cohen, M., 2000. Review: 
nuclear lamins--structural proteins with fundamental functions. J Struct Biol 129, 
313-323. 
 
Guarino, L. A., and Summers, M. D., 1986. Functional mapping of a trans-activating 
gene required for expression of a baculovirus delayed-early gene. J Virol 57, 
563-571. 
 
Guarino, L. A., and Summers, M. D., 1988. Functional mapping of Autographa 
californica nuclear polyhedrosis virus genes required for late gene expression. J 
Virol 62, 463-471. 
 
Guo, J., and Amemiya, S., 2005. Permeability of the nuclear envelope at isolated 
Xenopus oocyte nuclei studied by scanning electrochemical microscopy. Anal 
Chem 77, 2147-2156. 
 
Hachet, V., Kocher, T., Wilm, M., and Mattaj, I. W., 2004. Importin alpha associates 
with membranes and participates in nuclear envelope assembly in vitro. EMBO J 
23, 1526-1535. 
 
Harlow, E., and Lane, D., 1999. Using Antibodies:  A Laboratory Manual. Cold Spring 
Harbor Laboratory Press, Cold Spring Harbor, NY. 
 
Harrap, K. A., 1970. Cell infection by a nuclear polyhedrosis virus. Virology 42, 311-
318. 
 
Harris, J. R., 1978. The biochemistry and ultrastructure of the nuclear envelope. Biochim 
Biophys Acta 515, 55-104. 
 
Harrison, R. L., and Summers, M. D., 1995a. Biosynthesis and localization of the 
Autographa californica nuclear polyhedrosis virus 25K gene product. Virology 
208, 279-288. 
 
Harrison, R. L., and Summers, M. D., 1995b. Mutations in the Autographa californica 
multinucleocapsid nuclear polyhedrosis virus 25 kDa protein gene result in 
reduced virion occlusion, altered intranuclear envelopment and enhanced virus 
production. J Gen Virol 76 ( Pt 6), 1451-1459. 
 




Herniou, E. A., Olszewski, J. A., Cory, J. S., and O'Reilly, D. R., 2003. The genome 
sequence and evolution of baculoviruses. Annu Rev Entomol 48, 211-234. 
 
Hess, R. T., Summers, M. D., and Falcon, L. A., 1978. A mixed virus infection in 
midgut cells of Autographa californica and Trichoplusia ni larvae. J Ultrastruct 
Res 65, 253-265. 
 
Hetzer, M., Walther, T. C., and Mattaj, I. W., 2005. Pushing the envelope: structure, 
function, and dynamics of the nuclear periphery. Annu Rev Cell Dev Biol 21, 
347-380. 
 
Hinshaw, J. E., Carragher, B. O., and Milligan, R. A., 1992. Architecture and design of 
the nuclear pore complex. Cell 69, 1133-1141. 
 
Hofemeister, H., and O'Hare, P., 2005. Analysis of the localization and topology of 
nurim, a polytopic protein tightly associated with the inner nuclear membrane. J 
Biol Chem 280, 2512-2521. 
 
Hofemeister, H., Weber, K., and Stick, R., 2000. Association of prenylated proteins with 
the plasma membrane and the inner nuclear membrane is mediated by the same 
membrane-targeting motifs. Mol Biol Cell 11, 3233-3246. 
 
Holmer, L., and Worman, H. J., 2001. Inner nuclear membrane proteins: functions and 
targeting. Cell Mol Life Sci 58, 1741-1747. 
 
Hong, T., Summers, M. D., and Braunagel, S. C., 1997. N-terminal sequences from 
Autographa californica nuclear polyhedrosis virus envelope proteins ODV-E66 
and ODV-E25 are sufficient to direct reporter proteins to the nuclear envelope, 
intranuclear microvesicles and the envelope of occlusion derived virus. Proc Natl 
Acad Sci U S A 94, 4050-4055. 
 
Huh, N. E., and Weaver, R. F., 1990. Identifying the RNA polymerases that synthesize 
specific transcripts of the Autographa californica nuclear polyhedrosis virus. J 
Gen Virol 71 ( Pt 1), 195-201. 
 
Imai, N., Kurihara, M., Matsumoto, S., and Kang, W. K., 2004. Bombyx mori 
nucleopolyhedrovirus orf8 encodes a nucleic acid binding protein that colocalizes 
with IE1 during infection. Arch Virol 149, 1581-1594. 
 
Invitrogen 2000. MaxBac 2.0 Transfection and Expression Manual:  A Manual of 
Methods for Baculovirus Expression. H 000829 ed. Invitrogen Corporation. 
Carlsbad, CA. 
 




Jahedi, S., Markovitz, N. S., Filatov, F., and Roizman, B., 1999. Colocalization of the 
herpes simplex virus 1 UL4 protein with infected cell protein 22 in small, dense 
nuclear structures formed prior to onset of DNA synthesis. J Virol 73, 5132-
5138. 
 
Jarvik, J. W., and Telmer, C. A., 1998. Epitope tagging. Annu Rev Genet 32, 601-618. 
 
Johnson, A. E., 2003. Maintaining the permeability barrier during protein trafficking at 
the endoplasmic reticulum membrane. Biochem Soc Trans 31, 1227-1231. 
 
Johnson, A. E., 2005. The co-translational folding and interactions of nascent protein 
chains: a new approach using fluorescence resonance energy transfer. FEBS Lett 
579, 916-920. 
 
Johnson, A. E., and van Waes, M. A., 1999. The translocon: a dynamic gateway at the 
ER membrane. Annu Rev Cell Dev Biol 15, 799-842. 
 
Kaffman, A., and O'Shea, E. K., 1999. Regulation of nuclear localization: a key to a 
door. Annu Rev Cell Dev Biol 15, 291-339. 
 
Kalderon, D., Richardson, W. D., Markham, A. F., and Smith, A. E., 1984a. Sequence 
requirements for nuclear location of simian virus 40 large-T antigen. Nature 311, 
33-38. 
 
Kalderon, D., Roberts, B. L., Richardson, W. D., and Smith, A. E., 1984b. A short amino 
acid sequence able to specify nuclear location. Cell 39, 499-509. 
 
Kalies, K. U., and Hartmann, E., 1998. Protein translocation into the endoplasmic 
reticulum (ER)--two similar routes with different modes. Eur J Biochem 254, 1-
5. 
 
Keenan, R. J., Freymann, D. M., Stroud, R. M., and Walter, P., 2001. The signal 
recognition particle. Annu Rev Biochem 70, 755-775. 
 
Kirkpatrick, B. A., Washburn, J. O., Engelhard, E. K., and Volkman, L. E., 1994. 
Primary infection of insect tracheae by Autographa californica M nuclear 
polyhedrosis virus. Virology 203, 184-186. 
 
Knudson, D. L., and Harrap, K. A., 1976. Replication of nuclear polyhedrosis virus in a 
continuous cell culture of Spodoptera frugiperda: microscopy study of the 
sequence of events of the virus infection. J Virol 17, 254-268. 
 




Kovacs, G. R., Choi, J., Guarino, L. A., and Summers, M. D., 1992. Functional 
dissection of the Autographa californica nuclear polyhedrosis virus immediate-
early 1 transcriptional regulatory protein. J Virol 66, 7429-7437. 
 
Lanier, L. M., and Volkman, L. E., 1998. Actin binding and nucleation by Autographa 
californica M nucleopolyhedrovirus. Virology 243, 167-177. 
 
Lecuit, T., 2004. Junctions and vesicular trafficking during Drosophila cellularization. J 
Cell Sci 117, 3427-3433. 
 
Liang, L., and Baines, J. D., 2005. Identification of an essential domain in the herpes 
simplex virus 1 UL34 protein that is necessary and sufficient to interact with 
UL31 protein. J Virol 79, 3797-3806. 
 
Liang, L., Tanaka, M., Kawaguchi, Y., and Baines, J. D., 2004. Cell lines that support 
replication of a novel herpes simplex virus 1 UL31 deletion mutant can properly 
target UL34 protein to the nuclear rim in the absence of UL31. Virology 329, 68-
76. 
 
Lin, F., Blake, D. L., Callebaut, I., Skerjanc, I. S., Holmer, L., McBurney, M. W., 
Paulin-Levasseur, M., and Worman, H. J., 2000. MAN1, an inner nuclear 
membrane protein that shares the LEM domain with lamina-associated 
polypeptide 2 and emerin. J Biol Chem 275, 4840-4847. 
 
Linder, M. E., and Deschenes, R. J., 2003. New insights into the mechanisms of protein 
palmitoylation. Biochemistry 42, 4311-4320. 
 
Liu, J., and Wolfner, M. F., 1998. Functional dissection of YA, an essential, 
developmentally regulated nuclear lamina protein in Drosophila melanogaster. 
Mol Cell Biol 18, 188-197. 
 
Lizano, M., Lopez, S., and Arias, C. F., 1991. The amino-terminal half of rotavirus 
SA114fM VP4 protein contains a hemagglutination domain and primes for 
neutralizing antibodies to the virus. J Virol 65, 1383-1391. 
 
Lopez, J. M., and Wolfner, M. F., 1997. The developmentally regulated Drosophila 
embryonic nuclear lamina protein 'Young Arrest' (fs(1)Ya) is capable of 
associating with chromatin. J Cell Sci 110 ( Pt 5), 643-651. 
 
Mani, S. S., Rajagopal, R., Garfinkel, A. B., Fan, X., and Wolfner, M. F., 2003. A 
hydrophilic lamin-binding domain from the Drosophila YA protein can target 
proteins to the nuclear envelope. J Cell Sci 116, 2067-2072. 
 




Mazzanti, M., Bustamante, J. O., and Oberleithner, H., 2001. Electrical dimension of the 
nuclear envelope. Physiol Rev 81, 1-19. 
 
Mikhailov, V. S., Marlyev, K. A., Ataeva, J. O., Kullyev, P. K., and Atrazhev, A. M., 
1986. Characterization of 3'----5' exonuclease associated with DNA polymerase 
of silkworm nuclear polyhedrosis virus. Nucleic Acids Res 14, 3841-3857. 
 
Miller, B. R., and Forbes, D. J., 2000. Purification of the vertebrate nuclear pore 
complex by biochemical criteria. Traffic 1, 941-951. 
 
Miller, L. K., Ed. 1997. The Baculoviruses. The Viruses. Plenum Press, New York. 
 
Miller, L. K., Jewell, J. E., and Browne, D., 1981. Baculovirus induction of a DNA 
polymerase. J Virol 40, 305-308. 
 
Mislow, J. M., Holaska, J. M., Kim, M. S., Lee, K. K., Segura-Totten, M., Wilson, K. L., 
and McNally, E. M., 2002a. Nesprin-1alpha self-associates and binds directly to 
emerin and lamin A in vitro. FEBS Lett 525, 135-140. 
 
Mislow, J. M., Kim, M. S., Davis, D. B., and McNally, E. M., 2002b. Myne-1, a spectrin 
repeat transmembrane protein of the myocyte inner nuclear membrane, interacts 
with lamin A/C. J Cell Sci 115, 61-70. 
 
Mortz, E., Vorm, O., Mann, M., and Roepstorff, P., 1994. Identification of proteins in 
polyacrylamide gels by mass spectrometric peptide mapping combined with 
database search. Biol Mass Spectrom 23, 249-261. 
 
Mosammaparast, N., and Pemberton, L. F., 2004. Karyopherins: from nuclear-transport 
mediators to nuclear-function regulators. Trends Cell Biol 14, 547-556. 
 
Mossner, E., Iwai, H., and Glockshuber, R., 2000. Influence of the pK(a) value of the 
buried, active-site cysteine on the redox properties of thioredoxin-like 
oxidoreductases. FEBS Lett 477, 21-26. 
 
Mounkes, L., Kozlov, S., Burke, B., and Stewart, C. L., 2003. The laminopathies: 
nuclear structure meets disease. Curr Opin Genet Dev 13, 223-230. 
 
Ogawa, H., Inouye, S., Tsuji, F. I., Yasuda, K., and Umesono, K., 1995. Localization, 
trafficking, and temperature-dependence of the Aequorea green fluorescent 
protein in cultured vertebrate cells. Proc Natl Acad Sci U S A 92, 11899-11903. 
 
Ohba, T., Schirmer, E. C., Nishimoto, T., and Gerace, L., 2004. Energy- and 
temperature-dependent transport of integral proteins to the inner nuclear 
membrane via the nuclear pore. J Cell Biol 167, 1051-1062. 





O'Reilly, D. R., Passarelli, A. L., Goldman, I. F., and Miller, L. K., 1990. 
Characterization of the DA26 gene in a hypervariable region of the Autographa 
californica nuclear polyhedrosis virus genome. J Gen Virol 71 ( Pt 5), 1029-
1037. 
 
Osborne, A. R., Rapoport, T. A., and van den Berg, B., 2005. Protein translocation by 
the Sec61/SecY channel. Annu Rev Cell Dev Biol 21, 529-550. 
 
Ostlund, C., Ellenberg, J., Hallberg, E., Lippincott-Schwartz, J., and Worman, H. J., 
1999. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy 
protein. J Cell Sci 112 ( Pt 11), 1709-1719. 
 
Ostlund, C., and Worman, H. J., 2003. Nuclear envelope proteins and neuromuscular 
diseases. Muscle Nerve 27, 393-406. 
 
Ostlund, C., and Worman, H. J., 2004. Lamin-associated proteins. Methods Cell Biol 78, 
829-859. 
 
Padan, R., Nainudel-Epszteyn, S., Goitein, R., Fainsod, A., and Gruenbaum, Y., 1990. 
Isolation and characterization of the Drosophila nuclear envelope otefin cDNA. J 
Biol Chem 265, 7808-7813. 
 
Pante, N., and Kann, M., 2002. Nuclear pore complex is able to transport 
macromolecules with diameters of about 39 nm. Mol Biol Cell 13, 425-434. 
 
Pemberton, L. F., and Paschal, B. M., 2005. Mechanisms of receptor-mediated nuclear 
import and nuclear export. Traffic 6, 187-198. 
 
Phoenix, D. A., Harris, F., Daman, O. A., and Wallace, J., 2002. The prediction of 
amphiphilic alpha-helices. Curr Protein Pept Sci 3, 201-221. 
 
Quimby, B. B., and Corbett, A. H., 2001. Nuclear transport mechanisms. Cell Mol Life 
Sci 58, 1766-1773. 
 
Rapoport, T. A., Goder, V., Heinrich, S. U., and Matlack, K. E., 2004. Membrane-
protein integration and the role of the translocation channel. Trends Cell Biol 14, 
568-575. 
 
Reilander, H., Haase, W., and Maul, G., 1996. Functional expression of the Aequorea 
victoria green fluorescent protein in insect cells using the baculovirus expression 
system. Biochem Biophys Res Commun 219, 14-20. 
 




Reynolds, A. E., Ryckman, B. J., Baines, J. D., Zhou, Y., Liang, L., and Roller, R. J., 
2001. U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a 
complex that accumulates at the nuclear rim and is required for envelopment of 
nucleocapsids. J Virol 75, 8803-8817. 
 
Riddick, G., and Macara, I. G., 2005. A systems analysis of importin-{alpha}-{beta} 
mediated nuclear protein import. J Cell Biol 168, 1027-1038. 
 
Rolls, M. M., Stein, P. A., Taylor, S. S., Ha, E., McKeon, F., and Rapoport, T. A., 1999. 
A visual screen of a GFP-fusion library identifies a new type of nuclear envelope 
membrane protein. J Cell Biol 146, 29-44. 
 
Rosas-Acosta, G., Braunagel, S. C., and Summers, M. D., 2001. Effects of deletion and 
overexpression of the Autographa californica nuclear polyhedrosis virus FP25K 
gene on synthesis of two occlusion-derived virus envelope proteins and their 
transport into virus-induced intranuclear membranes. J Virol 75, 10829-10842. 
 
Rosenberg, I. M., 1996. Protein Analysis and Purification: Benchtop Techniques.  
Birkhauser, Boston. 253-254. 
 
Rosseneu, M., Vanloo, B., Lins, L., De Pauw, M., Ruysschaert, J.-M., and Brasseur, R., 
1992.  Analysis of primary and of the secondary structure of the apolipoproteins.  
In: Rosseneu, M. (Ed.), Structure and Function of Apolipoproteins. CRC Press.  
Boca Raton, FL. pp. 159-184. 
 
Rout, M. P., and Aitchison, J. D., 2001. The nuclear pore complex as a transport 
machine. J Biol Chem 276, 16593-16596. 
 
Rout, M. P., Aitchison, J. D., Magnasco, M. O., and Chait, B. T., 2003. Virtual gating 
and nuclear transport: the hole picture. Trends Cell Biol 13, 622-668. 
 
Rout, M. P., Aitchison, J. D., Suprapto, A., Hjertaas, K., Zhao, Y., and Chait, B. T., 
2000. The yeast nuclear pore complex: composition, architecture, and transport 
mechanism. J Cell Biol 148, 635-651. 
 
Rzepecki, R., and Fisher, P. A., 2002. In vivo phosphorylation of Drosophila 
melanogaster nuclear lamins during both interphase and mitosis. Cell Mol Biol 
Lett 7, 859-876. 
 
Saksena, S., Shao, Y., Braunagel, S. C., Summers, M. D., and Johnson, A. E., 2004. 
Cotranslational integration and initial sorting at the endoplasmic reticulum 
translocon of proteins destined for the inner nuclear membrane. Proc Natl Acad 
Sci U S A 101, 12537-12542. 
 




Sambrook, J., Fritsch, E. F., and Maniatis, T., 1989. Molecular Cloning:  A Laboratory 
Manual, Second Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 
NY.  
 
Scott, E. S., and O'Hare, P., 2001. Fate of the inner nuclear membrane protein lamin B 
receptor and nuclear lamins in herpes simplex virus type 1 infection. J Virol 75, 
8818-8830. 
 
Shumaker, D. K., Kuczmarski, E. R., and Goldman, R. D., 2003. The nucleoskeleton: 
lamins and actin are major players in essential nuclear functions. Curr Opin Cell 
Biol 15, 358-366. 
 
Smith, S., and Blobel, G., 1993. The first membrane spanning region of the lamin B 
receptor is sufficient for sorting to the inner nuclear membrane. J Cell Biol 120, 
631-637. 
 
Somech, R., Shaklai, S., Amariglio, N., Rechavi, G., and Simon, A. J., 2005. Nuclear 
envelopathies--raising the nuclear veil. Pediatr Res 57, 8R-15R. 
 
Soullam, B., and Worman, H. J., 1993. The amino-terminal domain of the lamin B 
receptor is a nuclear envelope targeting signal. J Cell Biol 120, 1093-1100. 
 
Soullam, B., and Worman, H. J., 1995. Signals and structural features involved in 
integral membrane protein targeting to the inner nuclear membrane. J Cell Biol 
130, 15-27. 
 
Summers, M. D., 1969. Apparent in vivo pathway of granulosis virus invasion and 
infection. Journal of Virology 4, 188-190. 
 
Summers, M. D., 1971. Electron microscopic observations on granulosis virus entry, 
uncoating and replication processes during infection of the midgut cells of 
Trichoplusia ni. J Ultrastruct Res 35, 606-625. 
 
Summers, M. D., and Smith, G. E., 1975a. Comparative studies of baculovirus granulins 
and polyhedrins. Intervirology 6, 168-180. 
 
Summers, M. D., and Smith, G. E., 1975b. Trichoplusia ni granulosis virus granulin: a 
phenol-soluble, phosphorylated protein. J Virol 16, 1108-1116. 
 
Summers, M. D., and Smith, G. E., 1987. A Manual of Methods for Baculovirus Vectors 
and Insect Cell Culture Procedures. Texas Agricultural Experiment Station 
Bulletin, College Station, TX. 
 




Suntharalingam, M., and Wente, S. R., 2003. Peering through the pore: nuclear pore 
complex structure, assembly, and function. Dev Cell 4, 775-789. 
 
Taddei, A., Hediger, F., Neumann, F. R., and Gasser, S. M., 2004. The function of 
nuclear architecture: a genetic approach. Annu Rev Genet 38, 305-345. 
 
Talcott, B., and Moore, M. S., 1999. Getting across the nuclear pore complex. Trends 
Cell Biol 9, 312-318. 
 
Tews, D. S., 1999. Emerin. Int J Biochem Cell Biol 31, 891-894. 
 
Theilmann, D. A., Chantler, J. K., Stweart, S., Flipsen, H. T., Vlak, J. M., and Crook, N. 
E., 1996. Characterization of a highly conserved baculovirus structural protein 
that is specific for occlusion-derived virions. Virology 218, 148-158. 
 
Thompson, J. D., Plewniak, F., Thierry, J., and Poch, O., 2000. DbClustal: rapid and 
reliable global multiple alignments of protein sequences detected by database 
searches. Nucleic Acids Res 28, 2919-2926. 
 
van Regenmortel, M. H. V., Fauquet, C. M., Bishop, D. H. L., Carstens, E. B., Estes, M. 
K., Lemon, S. M., Maniloff, J., Mayo, M. A., McGeoch, D. J., Pringle, C. R., and 
Wickner, R. B. 2000. Seventh Report of the International Committee on 
Taxonomy of Viruses. Seventh ed. Academic Press, New York. 
 
Vanarsdall, A. L., Okano, K., and Rohrmann, G. F., 2005. Characterization of the 
replication of a baculovirus mutant lacking the DNA polymerase gene. Virology 
331, 175-180. 
 
Veit, M., 2000. Palmitoylation of the 25-kDa synaptosomal protein (SNAP-25) in vitro 
occurs in the absence of an enzyme, but is stimulated by binding to syntaxin. 
Biochem J 345 Pt 1, 145-151. 
 
von Heijne, G., 1996. Principles of membrane protein assembly and structure. Prog 
Biophys Mol Biol 66, 113-139. 
 
Wagner, N., Schmitt, J., and Krohne, G., 2004. Two novel LEM-domain proteins are 
splice products of the annotated Drosophila melanogaster gene CG9424 
(Bocksbeutel). Eur J Cell Biol 82, 605-616. 
 
Wang, P., Hammer, D. A., and Granados, R. R., 1997. Binding and fusion of 
Autographa californica nucleopolyhedrovirus to cultured insect cells. J Gen 
Virol 78 ( Pt 12), 3081-3089. 
 




Wang, X., Lescott, T., De Clercq, E., and Kelly, D. C., 1983. Baculovirus replication: 
inhibition of Trichoplusia ni multiple nuclear polyhedrosis virus by [E]-5-(2-
bromovinyl)-2'-deoxyuridine. J Gen Virol 64 (Pt 6), 1221-1227. 
 
Wente, S. R., 2000. Gatekeepers of the nucleus. Science 288, 1374-1377. 
 
Wilkinson, B. M., Regnacq, M., and Stirling, C. J., 1997. Protein translocation across the 
membrane of the endoplasmic reticulum. J Membr Biol 155, 189-197. 
 
Worman, H. J., 2005. Components of the nuclear envelope and their role in human 
disease. Novartis Found Symp 264, 35-42; discussion 42-50, 227-230. 
 
Worman, H. J., and Courvalin, J. C., 2000. The inner nuclear membrane. J Membr Biol 
177, 1-11. 
 
Xie, M., Smith, J. L., Ding, Z., Zhang, D., and Cornell, R. B., 2004. Membrane binding 
modulates the quaternary structure of CTP:phosphocholine cytidylyltransferase. J 
Biol Chem 279, 28817-28825. 
 
Yamauchi, Y., Shiba, C., Goshima, F., Nawa, A., Murata, T., and Nishiyama, Y., 2001. 
Herpes simplex virus type 2 UL34 protein requires UL31 protein for its 
relocation to the internal nuclear membrane in transfected cells. J Gen Virol 82, 
1423-1428. 
 
Ye, G. J., Vaughan, K. T., Vallee, R. B., and Roizman, B., 2000. The herpes simplex 
virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain 
and targets nuclear membrane. J Virol 74, 1355-1363. 
 
Zapikian, L., and Chanock, R. M., 1990.  Virology.  In: Field, B.N. (Ed.), Field’s 
Virology., Lippincott Williams & Wilkins, Portland, OR.  pp. 1353-1404. 
 
Zhang, Q., Ragnauth, C. D., Skepper, J. N., Worth, N. F., Warren, D. T., Roberts, R. G., 
Weissberg, P. L., Ellis, J. A., and Shanahan, C. M., 2005. Nesprin-2 is a multi-
isomeric protein that binds lamin and emerin at the nuclear envelope and forms a 
subcellular network in skeletal muscle. J Cell Sci 118, 673-687. 
 
Zhang, Q., Skepper, J. N., Yang, F., Davies, J. D., Hegyi, L., Roberts, R. G., Weissberg, 
P. L., Ellis, J. A., and Shanahan, C. M., 2001. Nesprins: a novel family of 
spectrin-repeat-containing proteins that localize to the nuclear membrane in 
multiple tissues. J Cell Sci 114, 4485-4498. 
 
Zhang, S. X., Han, Y., and Blissard, G. W., 2003. Palmitoylation of the Autographa 
californica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: 
mapping, functional studies, and lipid rafts. J Virol 77, 6265-6273.  





PRELIMINARY OR INCOMPLETE DATA 
 
 
Figure A1.  Molecular weight standards for SDS-PAGE.  E26 protein sizes were originally determined by 
unstained standards, most experiments in this dissertation utilize prestained standards, and as such molecular 
weights for the various forms were established and kept for consistency.  Note the variation in the 31 to 14 kDa 
region of the two standards.   
 
 
Figure A2.  DTT vs β-Mercaptoethanol as a protein denaturant.  β-Mercaptoethanol does not denature the 
26 kDa forms of E26 as effectively as 100 mM DTT.  When DTT is used the 3 band smear identified in Benyia 
et al., 1998 resolves to two bands.  Samples above are 24 h p.i. wild type infected cell extracts loaded at 20 and 
40 µg of total protein per lane as determined by Bradford’s assay. 





Figure A3.  DTT vs β-Mercaptoethanol as a protein denaturant.  β-Mercaptoethanol does not denature the 
protein produced by the da26-T7 gene as effectively as 125 mM DTT.  When DTT is used smearing results, 
however when DTT is used the proteins are more fully denatured resulting in greater resolution.  Samples 
above in the 24 and 48 h p.i. polh E26-T7 infected total cell extracts (TCE) lanes are loaded at 25 µg of total 
protein per lane as determined by Bradford’s assay and the triton X-114 extractions were loaded by equal 
volume.  Protein is detected by the T7 antiserum (1:8,000).  INS = Insoluble fraction, DT = Detergent fraction, 












Figure A4.  Triton X-114 extraction of E26 from two different recombinant viruses.  Cells infected with 
∆FP25K and pVLDA26 viruses were collected and extracted by triton X-114 at various time points post 
infection.  Note that E26, including the 34, 28, 26, and 18 kDa forms are detected in the detergent fractions at 
48 h p.i. in both recombinant viruses.  Specifically note that a ~28 kDa band is detected in the insoluble fraction 
of the pVLDA26 virus extraction.  ∆FP25K virus has had the fp25k gene removed, which alters E66 
localization.  The pVLDA26 virus is a recombinant virus where a second copy of the da26 gene was placed 
under the control of the polh promoter, resulting in higher than normal expression of E26.  Total protein loaded 
in the TCE lanes was 10 µg as determined by Braford’s assay and the triton X-114 extractions were loaded by 
equal volume.  Protein is detected by the 7554 antiserum (1:20,000).  INS = Insoluble fraction, DT = Detergent 












Figure A5.  Immuno-confocal micrographs of E26 localization throughout infection from several viruses.  
E26 localization as detected by the 7554 antiserum (1:1000) in wild type (E2), vDa26z, pVLDa26, and 
∆FP25K.  Recall that the vDa26z virus is the virus made in error and presented in O’Reilly et al., 1990, the 
7554 antiserum would be detecting the E26 protein produced by the intact gene in this virus as such its’ 
localization is not distinguishable from wild type throughout infection.  The pVLDa26 virus contains a second 
copy of the da26 gene under the control of the polh promoter.  IEM detects a hyper-condensation of the 
virogenic stroma and while this structure does appear smaller in these micrographs correlation is not possible in 
these ICMs.  ∆FP25K virus has had the fp25k gene removed, which alters E66 localization.  E26 localization in 
this virus is not distinguishable from wild type throughout infection.  The red color denotes cellular actin as 
detected by αactin mAb C6 (Sigma)(1:500) the green denotes E26 as detected by 7554, and the blue denotes 
DNA as labeled by the dye DAPI.   
 
 





Figure A6.  Pre-absorption of the 7554 antiserum to remove cross-reactivity with E25.  Bacterial 
expressed E25 fusion protein (10 µl of the induced soluble fraction) was separated on a SDS-PAGE gel and 
exposed to various antisera including treated 7554 antiserum.  The antiserums used were E25 (1:10,000), 7554 
(1:40,000), 7554 + 75 µl of protein beads with bacterial expressed E25 bound (1:34,783), 7554 + 150 µl of 
protein beads with bacterial expressed E25 bound (1:30,769), and 7554 + 500 µl of protein beads with bacterial 
expressed E25 bound (1:20,000).  The 7554 antiserums various dilutions account for the additional diluting 
volumes.  Exposure time on this Western blot is 5 minutes, which is extreme, displaying the minimal cross-
reactivity that exists and the removal in the + 500 µl sample.  This pre-absorbed antiserum (7554 + 500 µl of 
protein beads) was used in all experiments using the 7554 antiserum in this dissertation. 
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B48 :  pEcoRV-MCS/E26 2-3/HIS-T7 
 
 




B49 :  pEcoRV-MCS/E26 FL-FLAG-T7 
 
 




B50 :  pEcoRV-MCS/E26 FL/HIS-T7 
 
 




B51 :  pBACgus-MCS 
 
 




B52 :  pBACgus-E26 1 
 
 




B53 :  pBACgus-E26 2 
 
 




B54 :  pBACgus-E26 3 
 
 




B55 :  pBACgus-E26 1-2 
 
 




B56 :  pBACgus-E26 2-3 
 
 




B57 :  pBACgus-E26 FL (NO T7 TAG) 
 
 




B58 :  pBACgus-E26 FL-T7 
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